activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
Not Active	1650909	CHEMBL861048	Average Binding Constant for PTK6; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL4601	Homo sapiens	Kd		
Not Active	1650909	CHEMBL861048	Average Binding Constant for PTK6; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL4601	Homo sapiens	Kd		
Not Active	1650910	CHEMBL861048	Average Binding Constant for PTK6; NA=Not Active at 10 uM	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707		Kd			CHEMBL4601	Homo sapiens	Kd		
	1650911	CHEMBL861048	Average Binding Constant for PTK6; NA=Not Active at 10 uM	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	Kd	nM	2700.0	CHEMBL4601	Homo sapiens	Kd	uM	2.7
Not Active	1650912	CHEMBL861048	Average Binding Constant for PTK6; NA=Not Active at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Kd			CHEMBL4601	Homo sapiens	Kd		
Not Active	1650913	CHEMBL861048	Average Binding Constant for PTK6; NA=Not Active at 10 uM	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660		Kd			CHEMBL4601	Homo sapiens	Kd		
Not Active	1650914	CHEMBL861048	Average Binding Constant for PTK6; NA=Not Active at 10 uM	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829		Kd			CHEMBL4601	Homo sapiens	Kd		
Not Active	1650915	CHEMBL861048	Average Binding Constant for PTK6; NA=Not Active at 10 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336		Kd			CHEMBL4601	Homo sapiens	Kd		
Not Active	1650916	CHEMBL861048	Average Binding Constant for PTK6; NA=Not Active at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762		Kd			CHEMBL4601	Homo sapiens	Kd		
Not Active	1650917	CHEMBL861048	Average Binding Constant for PTK6; NA=Not Active at 10 uM	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690		Kd			CHEMBL4601	Homo sapiens	Kd		
Not Active	1651280	CHEMBL861048	Average Binding Constant for PTK6; NA=Not Active at 10 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978		Kd			CHEMBL4601	Homo sapiens	Kd		
	1651281	CHEMBL861048	Average Binding Constant for PTK6; NA=Not Active at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Kd	nM	3000.0	CHEMBL4601	Homo sapiens	Kd	uM	3.0
	1651282	CHEMBL861048	Average Binding Constant for PTK6; NA=Not Active at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	9000.0	CHEMBL4601	Homo sapiens	Kd	uM	9.0
Not Active	1651283	CHEMBL861048	Average Binding Constant for PTK6; NA=Not Active at 10 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385		Kd			CHEMBL4601	Homo sapiens	Kd		
Not Active	1651284	CHEMBL861048	Average Binding Constant for PTK6; NA=Not Active at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667		Kd			CHEMBL4601	Homo sapiens	Kd		
Not Active	1651285	CHEMBL861048	Average Binding Constant for PTK6; NA=Not Active at 10 uM	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279		Kd			CHEMBL4601	Homo sapiens	Kd		
Not Active	1651286	CHEMBL861048	Average Binding Constant for PTK6; NA=Not Active at 10 uM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Kd			CHEMBL4601	Homo sapiens	Kd		
Not Active	1651287	CHEMBL861048	Average Binding Constant for PTK6; NA=Not Active at 10 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939		Kd			CHEMBL4601	Homo sapiens	Kd		
Not Active	1651288	CHEMBL861048	Average Binding Constant for PTK6; NA=Not Active at 10 uM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553		Kd			CHEMBL4601	Homo sapiens	Kd		
	1651289	CHEMBL861048	Average Binding Constant for PTK6; NA=Not Active at 10 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	33.0	CHEMBL4601	Homo sapiens	Kd	uM	0.033
	1651290	CHEMBL861048	Average Binding Constant for PTK6; NA=Not Active at 10 uM	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	1100.0	CHEMBL4601	Homo sapiens	Kd	uM	1.1
	1857052	CHEMBL920661	Inhibition of BRK	B	C/C(O)=C(\C#N)C(=O)Nc1cc(Br)ccc1Br	Outside typical range	CHEMBL228043	=	IC50	nM	267000.0	CHEMBL4601	Homo sapiens	IC50	uM	267.0
	2081777	CHEMBL928799	Inhibition of Brk at 10 uM	B	CC[C@@H](C)Nc1nc2ccc(-c3c(-c4ccccc4F)n[nH]c3N)cc2s1		CHEMBL404115	<=	Inhibition	%	20.0	CHEMBL4601	Homo sapiens	Inhibition	%	20.0
	2147198	CHEMBL927942	Activity of human BRK kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	104.0	CHEMBL4601	Homo sapiens	Activity	%	104.0
	2341441	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(N3CCN(C(=O)Cc4c[nH]c5ccccc45)CC3)ncn2)c1		CHEMBL524898	=	Inhibition	%	16.0	CHEMBL4601	Homo sapiens	INH	%	16.0
	2341482	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	CN(C)CC(C)(C)CNC(=O)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL501459	=	Inhibition	%	97.0	CHEMBL4601	Homo sapiens	INH	%	97.0
	2341523	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	Nc1nc(N2CCOCC2)cc(N2CCC(C(=O)NCCc3ccc(O)cc3)CC2)n1		CHEMBL501728	=	Inhibition	%	0.0	CHEMBL4601	Homo sapiens	INH	%	0.0
	2341564	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	O=C(NCCc1ccc(O)cc1)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL499617	=	Inhibition	%	18.0	CHEMBL4601	Homo sapiens	INH	%	18.0
	2341604	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	O=C(c1nc(SCc2ccc(Cl)cc2)n2ccccc12)N1CCN(c2cc(Nc3cccc(Br)c3)ncn2)CC1		CHEMBL501200	=	Inhibition	%	24.0	CHEMBL4601	Homo sapiens	INH	%	24.0
	2341646	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccc3ncsc3c2)cc(N2CCC[C@H]2C(=O)N[C@@H](CO)c2ccccc2)n1		CHEMBL525070	=	Inhibition	%	4.0	CHEMBL4601	Homo sapiens	INH	%	4.0
	2341687	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccc3ncsc3c2)cc(N2CCC[C@H]2C(=O)NCCc2cccc(I)c2)n1		CHEMBL501463	=	Inhibition	%	0.0	CHEMBL4601	Homo sapiens	INH	%	0.0
	2341728	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	O=C(NC1Cc2ccccc2C1)c1cccc(Nc2ccnc(N3CCN(c4ccccc4)CC3)n2)c1		CHEMBL499624	=	Inhibition	%	0.0	CHEMBL4601	Homo sapiens	INH	%	0.0
	2341769	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)NCc4ccc(N(C)C)cc4)c3)ncn2)c1		CHEMBL502826	=	Inhibition	%	3.0	CHEMBL4601	Homo sapiens	INH	%	3.0
	2341810	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3ccc(CC(=O)Nc4ccc5ncsc5c4)cc3)ncn2)c1		CHEMBL502827	=	Inhibition	%	29.0	CHEMBL4601	Homo sapiens	INH	%	29.0
	2341851	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	COc1ccc(NC(=O)Cc2ccc(Nc3cc(N(C)c4cccc(C)c4)ncn3)cc2)cn1		CHEMBL526914	=	Inhibition	%	4.0	CHEMBL4601	Homo sapiens	INH	%	4.0
	2341892	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2nccc(Nc3cccc(C(=O)NCc4ccc(N(C)C)cc4)c3)n2)c1		CHEMBL501471	=	Inhibition	%	33.0	CHEMBL4601	Homo sapiens	INH	%	33.0
	2341933	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	O=C(NCc1cccnc1)c1cccc(-c2ccc(Nc3ccc4ncsc4c3)nn2)c1		CHEMBL501182	=	Inhibition	%	48.0	CHEMBL4601	Homo sapiens	INH	%	48.0
	2341974	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N4CCCC5CCCCC54)c3)ncn2)c1		CHEMBL499606	=	Inhibition	%	32.0	CHEMBL4601	Homo sapiens	INH	%	32.0
	2342015	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)nc(N)n2)c1		CHEMBL499865	=	Inhibition	%	21.0	CHEMBL4601	Homo sapiens	INH	%	21.0
	2342056	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2nccc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)n2)c1		CHEMBL499866	=	Inhibition	%	36.0	CHEMBL4601	Homo sapiens	INH	%	36.0
	2342097	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	O=C(CN1CCN(c2ncnc3c2CN(Cc2ccccc2)CC3)CC1)Nc1cc(F)ccc1F		CHEMBL520451	=	Inhibition	%	9.0	CHEMBL4601	Homo sapiens	INH	%	9.0
	2342138	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	O=C(NCc1ccncc1)c1cccc(Nc2cc(Nc3cccc(Br)c3)ncn2)c1		CHEMBL482513	=	Inhibition	%	10.0	CHEMBL4601	Homo sapiens	INH	%	10.0
	2342179	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2cc(Nc3cccc(C(=O)N(CC(C)O)CC(C)O)c3)ncn2)c1		CHEMBL483318	=	Inhibition	%	23.0	CHEMBL4601	Homo sapiens	INH	%	23.0
	2342226	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)NCCCn4ccnc4)c3)ncn2)c1		CHEMBL520971	=	Inhibition	%	12.0	CHEMBL4601	Homo sapiens	INH	%	12.0
	2342264	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)ncn2)c1		CHEMBL521469	=	Inhibition	%	11.0	CHEMBL4601	Homo sapiens	INH	%	11.0
	2342302	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	CC(=O)N1CCN(C(=O)c2cccc(Nc3cc(N(C)c4cccc(C)c4)ncn3)c2)CC1		CHEMBL521478	=	Inhibition	%	1.0	CHEMBL4601	Homo sapiens	INH	%	1.0
	2342343	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)NCc4ccncc4)c3)ncn2)c1		CHEMBL483506	=	Inhibition	%	0.0	CHEMBL4601	Homo sapiens	INH	%	0.0
	2342384	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	CN(CCc1ccccn1)C(=O)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL483507	=	Inhibition	%	78.0	CHEMBL4601	Homo sapiens	INH	%	78.0
	2342425	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(Nc3cccc(C(=O)NCCCn4ccnc4)c3)nc(N)n2)c1		CHEMBL520980	=	Inhibition	%	16.0	CHEMBL4601	Homo sapiens	INH	%	16.0
	2342466	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	COC[C@@H]1CCCN1C(=O)[C@@H]1CCCN1c1cc(Nc2cccc(OC)c2)nc(N)n1		CHEMBL519962	=	Inhibition	%	17.0	CHEMBL4601	Homo sapiens	INH	%	17.0
	2342507	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(N3CCC[C@H]3C(=O)NCCN3CCCCC3)nc(N)n2)c1		CHEMBL526526	=	Inhibition	%	7.0	CHEMBL4601	Homo sapiens	INH	%	7.0
	2342548	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	O=C(COc1ccccc1)N1CCN(c2nccc(Nc3ccc4ncsc4c3)n2)CC1		CHEMBL482488	=	Inhibition	%	54.0	CHEMBL4601	Homo sapiens	INH	%	54.0
	2342579	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	O=C(C1CCN(c2nccc(Nc3ccccc3)n2)CC1)N1CC[C@@H](O)C1		CHEMBL484706	=	Inhibition	%	4.0	CHEMBL4601	Homo sapiens	INH	%	4.0
	2342580	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2ncnc3c2CN(C(=O)c2ccc(N(C)C)c4ccccc24)CC3)c1		CHEMBL484324	=	Inhibition	%	10.0	CHEMBL4601	Homo sapiens	INH	%	10.0
	2342581	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccccc2)cc(N2CCC(C(=O)NCCc3ccccn3)CC2)n1		CHEMBL521002	=	Inhibition	%	10.0	CHEMBL4601	Homo sapiens	INH	%	10.0
	2342582	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	CN(CCCn1ccnc1)C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL519658	=	Inhibition	%	4.0	CHEMBL4601	Homo sapiens	INH	%	4.0
	2342583	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	CN(C)CC(C)(C)CNC(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL521000	=	Inhibition	%	4.0	CHEMBL4601	Homo sapiens	INH	%	4.0
	2342584	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	CC(=O)CCCCC(=O)N1CCN(c2nccc(Oc3cccc(C)c3)n2)CC1		CHEMBL484713	=	Inhibition	%	3.0	CHEMBL4601	Homo sapiens	INH	%	3.0
	2342585	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	COC[C@@H]1CCCN1C(=O)C1CCCN1c1cc(Nc2cccc(Br)c2)ncn1		CHEMBL484521	=	Inhibition	%	3.0	CHEMBL4601	Homo sapiens	INH	%	3.0
	2342586	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	CN(C)CC(C)(C)CNC(=O)C1CCN(c2cc(N3CCOCC3)nc(N)n2)CC1		CHEMBL519311	=	Inhibition	%	3.0	CHEMBL4601	Homo sapiens	INH	%	3.0
	2342587	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	COc1ccc(-c2noc(CN3CCN(c4cc(Nc5cccc(O)c5)ncn4)CC3)n2)cc1		CHEMBL483715	=	Inhibition	%	5.0	CHEMBL4601	Homo sapiens	INH	%	5.0
	2342588	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	COC[C@@H]1CCCN1C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL519349	=	Inhibition	%	5.0	CHEMBL4601	Homo sapiens	INH	%	5.0
	2342589	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCN(CC(=O)Nc4cccc5c4CCCC5)CC3)n2)c1		CHEMBL520512	=	Inhibition	%	0.0	CHEMBL4601	Homo sapiens	INH	%	0.0
	2342590	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	Cc1ccc(CN2CCN(c3nccc(C(C#N)c4ccccn4)n3)CC2)cc1		CHEMBL521145	=	Inhibition	%	0.0	CHEMBL4601	Homo sapiens	INH	%	0.0
	2342591	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	CN(CCc1ccccn1)C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL521479	=	Inhibition	%	0.0	CHEMBL4601	Homo sapiens	INH	%	0.0
	2342592	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	CN(C)c1ccc(C(=O)N2CCN(c3ncnc4c3CN(Cc3ccccc3)CC4)CC2)c2ccccc12		CHEMBL520331	=	Inhibition	%	0.0	CHEMBL4601	Homo sapiens	INH	%	0.0
	2342593	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCC[C@H]3C(=O)NCCCn3ccnc3)n2)c1		CHEMBL482722	=	Inhibition	%	0.0	CHEMBL4601	Homo sapiens	INH	%	0.0
	2342594	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCC[C@H]3C(=O)NCc3cccnc3)n2)c1		CHEMBL482717	=	Inhibition	%	0.0	CHEMBL4601	Homo sapiens	INH	%	0.0
	2342595	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccc(C(=O)NCCc3ccncc3)cc2)cc(N2CCOCC2)n1		CHEMBL485524	=	Inhibition	%	0.0	CHEMBL4601	Homo sapiens	INH	%	0.0
	2342596	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(N3CCN(CC(=O)Nc4nc(-c5ccccc5)cs4)CC3)ncn2)c1		CHEMBL519534	=	Inhibition	%	22.0	CHEMBL4601	Homo sapiens	INH	%	22.0
	2342597	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	Cc1cc(C(=O)N2CCN(c3ncnc4c3CN(Cc3ccccc3)CC4)CC2)c(C)n1C		CHEMBL482710	=	Inhibition	%	22.0	CHEMBL4601	Homo sapiens	INH	%	22.0
	2342598	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2nccc3c2CN(C(=O)c2cc(C)n(C)c2C)CC3)c1		CHEMBL519146	=	Inhibition	%	13.0	CHEMBL4601	Homo sapiens	INH	%	13.0
	2342599	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	COC(=O)C(CO)NC(=O)[C@@H]1CCCN1c1nccc(Oc2cccc(C)c2)n1		CHEMBL519310	=	Inhibition	%	13.0	CHEMBL4601	Homo sapiens	INH	%	13.0
	2342600	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	Nc1nc(N2CCOCC2)cc(N2CCC(C(=O)NCc3cccs3)CC2)n1		CHEMBL482910	=	Inhibition	%	15.0	CHEMBL4601	Homo sapiens	INH	%	15.0
	2342601	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(N3CCC[C@H]3C(=O)NCCc3ccc(O)cc3)nc(N)n2)c1		CHEMBL483518	=	Inhibition	%	14.0	CHEMBL4601	Homo sapiens	INH	%	14.0
	2342602	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCN(C(=O)c4c(C)noc4C)CC3)n2)c1		CHEMBL482721	=	Inhibition	%	2.0	CHEMBL4601	Homo sapiens	INH	%	2.0
	2342603	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	Clc1ccc2sc(CN3CCN(c4ncnc5c4CN(Cc4ccccc4)CC5)CC3)cc2c1		CHEMBL483710	=	Inhibition	%	2.0	CHEMBL4601	Homo sapiens	INH	%	2.0
	2342604	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	O=C(c1nc(SCc2ccc(Cl)cc2)n2ccccc12)N1CCN(c2ncnc3c2CN(Cc2ccccc2)CC3)CC1		CHEMBL446637	=	Inhibition	%	9.0	CHEMBL4601	Homo sapiens	INH	%	9.0
	2342605	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N(CC(C)C)CC(C)C)c3)ncn2)c1		CHEMBL484707	=	Inhibition	%	7.0	CHEMBL4601	Homo sapiens	INH	%	7.0
	2342606	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	Cc1cccc(CN2CCN(c3cc(N(C)c4cccc(C)c4)ncn3)CC2)c1		CHEMBL446087	=	Inhibition	%	7.0	CHEMBL4601	Homo sapiens	INH	%	7.0
	2342607	CHEMBL953402	Inhibition of Brk at 10 uM by HTRF assay relative to control	B	O=C(NC[C@@H]1CCCO1)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL500661	=	Inhibition	%	81.0	CHEMBL4601	Homo sapiens	INH	%	81.0
	2470331	CHEMBL992508	Inhibition of PTK6 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL4601	Homo sapiens	INH	%	10.0
	2476616	CHEMBL1035880	Binding affinity to human BRK at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Activity	%	29.2	CHEMBL4601	Homo sapiens	Activity	%	29.2
Not Evaluated	2476819	CHEMBL1035880	Binding affinity to human BRK at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL4601	Homo sapiens	Activity		
Not Evaluated	2478658	CHEMBL1035880	Binding affinity to human BRK at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL4601	Homo sapiens	Activity		
Not Evaluated	2478861	CHEMBL1035880	Binding affinity to human BRK at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755		Activity			CHEMBL4601	Homo sapiens	Activity		
	2479535	CHEMBL988929	Binding affinity to human BRK	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097	=	Kd	nM	2.0	CHEMBL4601	Homo sapiens	Kd	nM	2.0
	2479569	CHEMBL988929	Binding affinity to human BRK	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519	=	Kd	nM	2.0	CHEMBL4601	Homo sapiens	Kd	nM	2.0
Not Evaluated	2479716	CHEMBL1035880	Binding affinity to human BRK at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL4601	Homo sapiens	Activity		
	2480715	CHEMBL1035880	Binding affinity to human BRK at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409	=	Activity	%	1.8	CHEMBL4601	Homo sapiens	Activity	%	1.8
Not Evaluated	2577337	CHEMBL1035880	Binding affinity to human BRK at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL4601	Homo sapiens	Activity		
Not Evaluated	2577540	CHEMBL1035880	Binding affinity to human BRK at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL4601	Homo sapiens	Activity		
Not Evaluated	2593542	CHEMBL1035880	Binding affinity to human BRK at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878		Activity			CHEMBL4601	Homo sapiens	Activity		
Active	2593745	CHEMBL1035880	Binding affinity to human BRK at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097		Activity			CHEMBL4601	Homo sapiens	Activity		
Active	2594011	CHEMBL1035880	Binding affinity to human BRK at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519		Activity			CHEMBL4601	Homo sapiens	Activity		
Not Evaluated	2594954	CHEMBL1035880	Binding affinity to human BRK at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL4601	Homo sapiens	Activity		
Not Evaluated	2595157	CHEMBL1035880	Binding affinity to human BRK at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL4601	Homo sapiens	Activity		
Not Evaluated	2595223	CHEMBL1035880	Binding affinity to human BRK at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL4601	Homo sapiens	Activity		
	2596354	CHEMBL1035880	Binding affinity to human BRK at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342	=	Activity	%	11.0	CHEMBL4601	Homo sapiens	Activity	%	11.0
Not Evaluated	2597623	CHEMBL1035880	Binding affinity to human BRK at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL4601	Homo sapiens	Activity		
Not Evaluated	2597826	CHEMBL1035880	Binding affinity to human BRK at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL4601	Homo sapiens	Activity		
	2721557	CHEMBL1060965	Inhibition of BRK at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL4601	Homo sapiens	INH	%	50.0
	2906547	CHEMBL1061159	Binding constant for PTK6 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	uM	10.0
	2906548	CHEMBL1061159	Binding constant for PTK6 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	=	Kd	nM	1000.0	CHEMBL4601	Homo sapiens	Kd	nM	1000.0
	2906549	CHEMBL1061159	Binding constant for PTK6 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	uM	10.0
	2906550	CHEMBL1061159	Binding constant for PTK6 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	uM	10.0
	2906551	CHEMBL1061159	Binding constant for PTK6 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	uM	10.0
	2906552	CHEMBL1061159	Binding constant for PTK6 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	uM	10.0
	2906553	CHEMBL1061159	Binding constant for PTK6 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	uM	10.0
	2906554	CHEMBL1061159	Binding constant for PTK6 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	3600.0	CHEMBL4601	Homo sapiens	Kd	nM	3600.0
	2906555	CHEMBL1061159	Binding constant for PTK6 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	3800.0	CHEMBL4601	Homo sapiens	Kd	nM	3800.0
	2906556	CHEMBL1061159	Binding constant for PTK6 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	uM	10.0
	2906557	CHEMBL1061159	Binding constant for PTK6 kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	uM	10.0
	2906558	CHEMBL1061159	Binding constant for PTK6 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	7.8	CHEMBL4601	Homo sapiens	Kd	nM	7.8
	2906559	CHEMBL1061159	Binding constant for PTK6 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	uM	10.0
	2906560	CHEMBL1061159	Binding constant for PTK6 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	uM	10.0
	2906561	CHEMBL1061159	Binding constant for PTK6 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	uM	10.0
	2906562	CHEMBL1061159	Binding constant for PTK6 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	uM	10.0
	2906563	CHEMBL1061159	Binding constant for PTK6 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	uM	10.0
	2906564	CHEMBL1061159	Binding constant for PTK6 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	2300.0	CHEMBL4601	Homo sapiens	Kd	nM	2300.0
	2906565	CHEMBL1061159	Binding constant for PTK6 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	uM	10.0
	2906566	CHEMBL1061159	Binding constant for PTK6 kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	uM	10.0
	2906567	CHEMBL1061159	Binding constant for PTK6 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	uM	10.0
	2906568	CHEMBL1061159	Binding constant for PTK6 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	uM	10.0
	2906569	CHEMBL1061159	Binding constant for PTK6 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	uM	10.0
	2906570	CHEMBL1061159	Binding constant for PTK6 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	uM	10.0
	2906571	CHEMBL1061159	Binding constant for PTK6 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	uM	10.0
	2906572	CHEMBL1061159	Binding constant for PTK6 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	uM	10.0
	2906573	CHEMBL1061159	Binding constant for PTK6 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	Kd	nM	2400.0	CHEMBL4601	Homo sapiens	Kd	nM	2400.0
	2906574	CHEMBL1061159	Binding constant for PTK6 kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	uM	10.0
	2906575	CHEMBL1061159	Binding constant for PTK6 kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Kd	nM	6800.0	CHEMBL4601	Homo sapiens	Kd	nM	6800.0
	2906576	CHEMBL1061159	Binding constant for PTK6 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	3900.0	CHEMBL4601	Homo sapiens	Kd	nM	3900.0
	2906577	CHEMBL1061159	Binding constant for PTK6 kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	uM	10.0
	2906578	CHEMBL1061159	Binding constant for PTK6 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	uM	10.0
	2906579	CHEMBL1061159	Binding constant for PTK6 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	2300.0	CHEMBL4601	Homo sapiens	Kd	nM	2300.0
	2906580	CHEMBL1061159	Binding constant for PTK6 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	uM	10.0
	2906581	CHEMBL1061159	Binding constant for PTK6 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	uM	10.0
	2906582	CHEMBL1061159	Binding constant for PTK6 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	uM	10.0
	2906583	CHEMBL1061159	Binding constant for PTK6 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	uM	10.0
	2906584	CHEMBL1061159	Binding constant for PTK6 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	160.0	CHEMBL4601	Homo sapiens	Kd	nM	160.0
	2921970	CHEMBL1052938	Inhibition of PTK6 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	13.0	CHEMBL4601	Homo sapiens	Activity	%	13.0
	2928465	CHEMBL1049963	Binding affinity to BRK assessed as percentage of kinase remaining bound to the bead at 1 uM by T7 phage display based binding assay	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	12.0	CHEMBL4601	Homo sapiens	Activity	%	12.0
	3052537	CHEMBL1047788	Residual activity of BRK at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	4.0	CHEMBL4601	Homo sapiens	Residual activity	%	4.0
	3052789	CHEMBL1047815	Residual activity of BRK at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	0.0	CHEMBL4601	Homo sapiens	Residual activity	%	0.0
	3054098	CHEMBL1066616	Residual activity of BRK at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	65.0	CHEMBL4601	Homo sapiens	Residual activity	%	65.0
	3055385	CHEMBL1047788	Residual activity of BRK at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	7.0	CHEMBL4601	Homo sapiens	Residual activity	%	7.0
	3055637	CHEMBL1047815	Residual activity of BRK at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	1.0	CHEMBL4601	Homo sapiens	Residual activity	%	1.0
	3056942	CHEMBL1066616	Residual activity of BRK at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	57.0	CHEMBL4601	Homo sapiens	Residual activity	%	57.0
	3058262	CHEMBL1047788	Residual activity of BRK at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	8.0	CHEMBL4601	Homo sapiens	Residual activity	%	8.0
	3058514	CHEMBL1047815	Residual activity of BRK at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	0.0	CHEMBL4601	Homo sapiens	Residual activity	%	0.0
	3072860	CHEMBL1066616	Residual activity of BRK at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	35.0	CHEMBL4601	Homo sapiens	Residual activity	%	35.0
	3104112	CHEMBL1066410	Inhibition of recombinant BRK by TR-FRET assay	B	C[C@@H](Oc1ccc2ncc(/C=C/C(N)=O)cc2c1)c1c(Cl)ccc(F)c1Cl		CHEMBL602471	=	IC50	nM	32000.0	CHEMBL4601	Homo sapiens	IC50	uM	32.0
	3104138	CHEMBL1066410	Inhibition of recombinant BRK by TR-FRET assay	B	C[C@@H](Oc1ccc2ncccc2c1)c1c(Cl)ccc(F)c1Cl		CHEMBL600795	>	IC50	nM	50000.0	CHEMBL4601	Homo sapiens	IC50	uM	50.0
	3104185	CHEMBL1066410	Inhibition of recombinant BRK by TR-FRET assay	B	C[C@@H](Oc1ccc2ncc(C3CC3C(N)=O)cc2c1)c1c(Cl)ccc(F)c1Cl		CHEMBL602472	>	IC50	nM	50000.0	CHEMBL4601	Homo sapiens	IC50	uM	50.0
	3117916	CHEMBL1072192	Inhibition of BRK	B	CC(=O)N1CCC(Nc2ncc3c(n2)-c2c(c(C(N)=O)nn2C)CC3)CC1		CHEMBL599224	>	IC50	nM	10000.0	CHEMBL4601	Homo sapiens	IC50	uM	10.0
	3117969	CHEMBL1072192	Inhibition of BRK	B	Cn1nc(C(N)=O)c2c1-c1nc(NC3CCN(C(=O)c4ccccc4)CC3)ncc1CC2		CHEMBL599428	>	IC50	nM	10000.0	CHEMBL4601	Homo sapiens	IC50	uM	10.0
	3118022	CHEMBL1072192	Inhibition of BRK	B	CNC(=O)c1nn(C)c2c1CCc1cnc(NC3CCN(C(=O)C4CCN(S(C)(=O)=O)CC4)CC3)nc1-2		CHEMBL597754	>	IC50	nM	10000.0	CHEMBL4601	Homo sapiens	IC50	uM	10.0
	3213785	CHEMBL1107589	Inhibition of BRK at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	100.0	CHEMBL4601	Homo sapiens	INH	%	100.0
	3224944	CHEMBL1101497	Inhibition of Brk at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL4601	Homo sapiens	INH	%	50.0
	3226323	CHEMBL1101497	Inhibition of Brk at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL4601	Homo sapiens	INH	%	50.0
	3331844	CHEMBL1168803	Inhibition of BRK at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL4601	Homo sapiens	INH	%	50.0
	3333259	CHEMBL1168803	Inhibition of BRK at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL4601	Homo sapiens	INH	%	50.0
	3334664	CHEMBL1168803	Inhibition of BRK at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL4601	Homo sapiens	INH	%	50.0
	3336084	CHEMBL1168803	Inhibition of BRK at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL4601	Homo sapiens	INH	%	50.0
	3337465	CHEMBL1168803	Inhibition of BRK at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL4601	Homo sapiens	INH	%	50.0
	3337713	CHEMBL1168803	Inhibition of BRK at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL4601	Homo sapiens	INH	%	50.0
	3339045	CHEMBL1168803	Inhibition of BRK at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL4601	Homo sapiens	INH	%	50.0
	3339301	CHEMBL1168803	Inhibition of BRK at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL4601	Homo sapiens	INH	%	50.0
	3340612	CHEMBL1168803	Inhibition of BRK at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL4601	Homo sapiens	INH	%	50.0
	3342028	CHEMBL1168803	Inhibition of BRK at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL4601	Homo sapiens	INH	%	50.0
	3358471	CHEMBL1174085	Inhibition of BRK at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	2.8	CHEMBL4601	Homo sapiens	INH	%	2.8
	3358913	CHEMBL1174085	Inhibition of BRK at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	2.5	CHEMBL4601	Homo sapiens	INH	%	2.5
	3443507	CHEMBL1244273	Inhibition of Brk at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	99.0	CHEMBL4601	Homo sapiens	INH	%	99.0
	3443724	CHEMBL1244273	Inhibition of Brk at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	98.0	CHEMBL4601	Homo sapiens	INH	%	98.0
	3444879	CHEMBL1244273	Inhibition of Brk at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	89.0	CHEMBL4601	Homo sapiens	INH	%	89.0
	3445043	CHEMBL1244741	Binding affinity to BRK	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	1700.0	CHEMBL4601	Homo sapiens	Kd	nM	1700.0
	3445503	CHEMBL1244273	Inhibition of Brk at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	96.0	CHEMBL4601	Homo sapiens	INH	%	96.0
	3445720	CHEMBL1244273	Inhibition of Brk at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	12.0	CHEMBL4601	Homo sapiens	INH	%	12.0
	3445915	CHEMBL1244273	Inhibition of Brk at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	97.0	CHEMBL4601	Homo sapiens	INH	%	97.0
	3446105	CHEMBL1244273	Inhibition of Brk at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	86.0	CHEMBL4601	Homo sapiens	INH	%	86.0
	3448702	CHEMBL1244741	Binding affinity to BRK	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	uM	10.0
	3449577	CHEMBL1244741	Binding affinity to BRK	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	uM	10.0
	3450001	CHEMBL1244741	Binding affinity to BRK	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	uM	10.0
	3450297	CHEMBL1244741	Binding affinity to BRK	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	uM	10.0
	3450925	CHEMBL1244741	Binding affinity to BRK	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	uM	10.0
	3451216	CHEMBL1244741	Binding affinity to BRK	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	uM	10.0
	3463340	CHEMBL1251600	Inhibition of PTK6 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	0.0	CHEMBL4601	Homo sapiens	INH	%	0.0
	3463884	CHEMBL1251600	Inhibition of PTK6 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	2.0	CHEMBL4601	Homo sapiens	INH	%	2.0
	3464103	CHEMBL1251600	Inhibition of PTK6 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	9.0	CHEMBL4601	Homo sapiens	INH	%	9.0
	3504204	CHEMBL1260181	Inhibition of BRK	B	O=C(Nc1n[nH]c2cc(C(=O)N[C@H](CN3CCCC3)c3ccccc3)sc12)c1ccc(N2CCOCC2)cc1		CHEMBL1258913	>	IC50	nM	10000.0	CHEMBL4601	Homo sapiens	IC50	uM	10.0
	3526994	CHEMBL1275113	Inhibition of BRK	B	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccccc1		CHEMBL1270230	>	IC50	nM	10000.0	CHEMBL4601	Homo sapiens	IC50	uM	10.0
	5120327	CHEMBL1648181	Inhibition of human BRK at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	101.0	CHEMBL4601	Homo sapiens	INH	%	101.0
	5223280	CHEMBL1679276	Binding affinity to BRK at 10 uM by immobilized ligand displacement assay	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2		CHEMBL1672987	>	Inhibition	%	90.0	CHEMBL4601	Homo sapiens	INH	%	90.0
	6198105	CHEMBL1776516	Inhibition of BRK assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3CCO)CC4)c2)CC1		CHEMBL1738758	>	IC50	nM	10000.0	CHEMBL4601	Homo sapiens	IC50	uM	10.0
	6341024	CHEMBL1827754	Activity of BRK kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	100.0	CHEMBL4601	Homo sapiens	Activity	%	100.0
	6341244	CHEMBL1827046	Inhibition of PTK6 at 1 uM	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)Nc2cnc3[nH]nc(OC)c3c2)c1F		CHEMBL1822067	=	Inhibition	%	83.0	CHEMBL4601	Homo sapiens	INH	%	83.0
	6341245	CHEMBL1827046	Inhibition of PTK6 at 1 uM	B	COc1n[nH]c2ncc(NC(=O)c3c(F)ccc(NS(=O)(=O)N4CCCC4)c3F)cc12		CHEMBL1822099	=	Inhibition	%	105.0	CHEMBL4601	Homo sapiens	INH	%	105.0
	6341246	CHEMBL1827046	Inhibition of PTK6 at 1 uM	B	COc1n[nH]c2ncc(NC(=O)c3c(F)ccc(NS(=O)(=O)c4cccc(F)c4)c3F)cc12		CHEMBL1822258	=	Inhibition	%	101.0	CHEMBL4601	Homo sapiens	INH	%	101.0
	6390236	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	IC50	nM	9.0	CHEMBL4601	Homo sapiens	IC50	nM	9.0
	6390237	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	CCc1nc2c(Nc3ccc(C(=O)N4CCNCC4)c(Cl)c3)nc(C)cn2c1-c1cn[nH]c1		CHEMBL1836744	>	IC50	nM	10000.0	CHEMBL4601	Homo sapiens	IC50	nM	10000.0
	6390238	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	Cc1cn2c(-c3cn[nH]c3)c(C3CC3)nc2c(Nc2ccc(C(=O)N3CCNCC3)c(Cl)c2)n1		CHEMBL1836745	>	IC50	nM	10000.0	CHEMBL4601	Homo sapiens	IC50	nM	10000.0
	6390239	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	Cc1cn2c(-c3cn[nH]c3)c(C(C)C)nc2c(Nc2ccc(C(=O)N3CCNCC3)c(Cl)c2)n1		CHEMBL1836746	>	IC50	nM	10000.0	CHEMBL4601	Homo sapiens	IC50	nM	10000.0
	6390240	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	CC1(C)CNCCN1C(=O)c1ccc(Nc2nc(C3CC3)cn3c(-c4cn[nH]c4)cnc23)cc1Cl		CHEMBL1836842	=	IC50	nM	2.0	CHEMBL4601	Homo sapiens	IC50	nM	2.0
	6390241	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNC(=O)C3)c(Cl)c2)n1		CHEMBL1836806	=	IC50	nM	3.0	CHEMBL4601	Homo sapiens	IC50	nM	3.0
	6390242	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	CC1(C)CN(C(=O)c2ccc(Nc3nc(C4CC4)cn4c(-c5cn[nH]c5)cnc34)cc2Cl)CCN1		CHEMBL1836844	=	IC50	nM	3.0	CHEMBL4601	Homo sapiens	IC50	nM	3.0
	6390243	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	O=C(c1ccc(Nc2nc(C3CC3)cn3c(-c4cn[nH]c4)cnc23)c(F)c1)N1CCNCC1		CHEMBL1836854	=	IC50	nM	3.0	CHEMBL4601	Homo sapiens	IC50	nM	3.0
	6390244	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	CC1(C)CNCCN1C(=O)c1ccc(Nc2nc(C3CC3)cn3c(-c4cn[nH]c4)cnc23)c(F)c1		CHEMBL1836863	=	IC50	nM	3.0	CHEMBL4601	Homo sapiens	IC50	nM	3.0
	6390245	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	O=C(c1ccc(Nc2nc(C3CC3)cn3c(-c4cn[nH]c4)cnc23)cc1Cl)N1C[C@H]2CC[C@@H]1CN2		CHEMBL1836846	=	IC50	nM	5.0	CHEMBL4601	Homo sapiens	IC50	nM	5.0
	6390246	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	O=C(c1ccc(Nc2nc(C3CC3)cn3c(-c4cn[nH]c4)cnc23)cc1Cl)N1CCNCC1		CHEMBL1836755	=	IC50	nM	6.0	CHEMBL4601	Homo sapiens	IC50	nM	6.0
	6390247	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	CC1(C)CN(C(=O)c2ccc(Nc3nc(C4CC4)cn4c(-c5cn[nH]c5)cnc34)c(F)c2)CCN1		CHEMBL1836865	=	IC50	nM	6.0	CHEMBL4601	Homo sapiens	IC50	nM	6.0
	6390248	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNCC3)c(C(F)(F)F)c2)n1		CHEMBL1836802	=	IC50	nM	7.0	CHEMBL4601	Homo sapiens	IC50	nM	7.0
	6390249	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3C[C@H]4CC[C@@H]3CN4)c(Cl)c2)n1		CHEMBL1836840	=	IC50	nM	7.0	CHEMBL4601	Homo sapiens	IC50	nM	7.0
	6390250	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNCC3)c(Cl)c2)n1		CHEMBL1836867	=	IC50	nM	7.0	CHEMBL4601	Homo sapiens	IC50	nM	7.0
	6390251	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCN(C)CC3)c(Cl)c2)n1		CHEMBL1836805	=	IC50	nM	8.0	CHEMBL4601	Homo sapiens	IC50	nM	8.0
	6390252	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCOCC3)c(Cl)c2)n1		CHEMBL1836810	=	IC50	nM	8.0	CHEMBL4601	Homo sapiens	IC50	nM	8.0
	6390253	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNCC3(C)C)cc2F)n1		CHEMBL1836862	=	IC50	nM	9.0	CHEMBL4601	Homo sapiens	IC50	nM	9.0
	6390254	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	CCc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNCC3)c(Cl)c2)n1		CHEMBL1836754	=	IC50	nM	10.0	CHEMBL4601	Homo sapiens	IC50	nM	10.0
	6390255	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	CCOc1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sc1C(=O)N1CCCC(C)C1		CHEMBL1836760	=	IC50	nM	10.0	CHEMBL4601	Homo sapiens	IC50	nM	10.0
	6390256	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCC(O)CC3)cs2)n1		CHEMBL1836799	=	IC50	nM	10.0	CHEMBL4601	Homo sapiens	IC50	nM	10.0
	6390257	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNCC3(C)C)c(Cl)c2)n1		CHEMBL1836815	=	IC50	nM	10.0	CHEMBL4601	Homo sapiens	IC50	nM	10.0
	6390258	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	O=C(c1ccc(Nc2nc(C3CC3)cn3c(-c4cn[nH]c4)cnc23)cc1Cl)N1CCNCC12CC2		CHEMBL1836843	=	IC50	nM	10.0	CHEMBL4601	Homo sapiens	IC50	nM	10.0
	6390259	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	O=C(c1ccc(Nc2nc(C3CC3)cn3c(-c4cn[nH]c4)cnc23)cc1Cl)N1C[C@@H]2CC[C@H](C1)N2		CHEMBL1836847	=	IC50	nM	10.0	CHEMBL4601	Homo sapiens	IC50	nM	10.0
	6390260	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNCC3)cc2F)n1		CHEMBL1836853	=	IC50	nM	10.0	CHEMBL4601	Homo sapiens	IC50	nM	10.0
	6390261	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNC(C)(C)C3)cc2F)n1		CHEMBL1836864	=	IC50	nM	10.0	CHEMBL4601	Homo sapiens	IC50	nM	10.0
	6390262	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccnc(N3CCNCC3)c2)n1		CHEMBL1836796	=	IC50	nM	11.0	CHEMBL4601	Homo sapiens	IC50	nM	11.0
	6390263	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3C[C@@H]4CC[C@H](C3)N4)c(Cl)c2)n1		CHEMBL1836841	=	IC50	nM	11.0	CHEMBL4601	Homo sapiens	IC50	nM	11.0
	6390264	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C(=O)N(C)C)ns2)n1		CHEMBL1836761	=	IC50	nM	12.0	CHEMBL4601	Homo sapiens	IC50	nM	12.0
	6390265	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL1739550	=	IC50	nM	13.0	CHEMBL4601	Homo sapiens	IC50	nM	13.0
	6390266	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	O=C(c1ccc(Nc2nc(C3CC3)cn3c(-c4cn[nH]c4)cnc23)cc1Cl)N1CCNC2(CC2)C1		CHEMBL1836845	=	IC50	nM	13.0	CHEMBL4601	Homo sapiens	IC50	nM	13.0
	6390267	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNCC3)cc2)n1		CHEMBL1836800	=	IC50	nM	15.0	CHEMBL4601	Homo sapiens	IC50	nM	15.0
	6390268	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	CC(=O)N1CCN(C(=O)c2ccc(Nc3nc(C)cn4c(-c5cn[nH]c5)cnc34)cc2Cl)CC1		CHEMBL1836807	=	IC50	nM	16.0	CHEMBL4601	Homo sapiens	IC50	nM	16.0
	6390269	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNCC34CC4)c(Cl)c2)n1		CHEMBL1836837	=	IC50	nM	16.0	CHEMBL4601	Homo sapiens	IC50	nM	16.0
	6390270	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNC(C)(C)C3)c(Cl)c2)n1		CHEMBL1836838	=	IC50	nM	18.0	CHEMBL4601	Homo sapiens	IC50	nM	18.0
	6390271	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNC4(CC4)C3)c(Cl)c2)n1		CHEMBL1836839	=	IC50	nM	19.0	CHEMBL4601	Homo sapiens	IC50	nM	19.0
	6390272	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	COc1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)ccc1C(=O)N1CCNCC1		CHEMBL1836803	=	IC50	nM	23.0	CHEMBL4601	Homo sapiens	IC50	nM	23.0
	6390273	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	O=C(c1ccc(Nc2nc(C3CC3)cn3c(-c4cn[nH]c4)cnc23)c(F)c1)N1CCOCC1		CHEMBL1836861	=	IC50	nM	30.0	CHEMBL4601	Homo sapiens	IC50	nM	30.0
	6390274	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNCC3)c(F)c2)n1		CHEMBL1836801	=	IC50	nM	32.0	CHEMBL4601	Homo sapiens	IC50	nM	32.0
	6390275	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCCNCC3)c(Cl)c2)n1		CHEMBL1836814	=	IC50	nM	34.0	CHEMBL4601	Homo sapiens	IC50	nM	34.0
	6390276	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNCC3)c(C3CC3)c2)n1		CHEMBL1836804	=	IC50	nM	38.0	CHEMBL4601	Homo sapiens	IC50	nM	38.0
	6390277	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	Cc1cn2c(-c3ccsc3)cnc2c(Nc2ccc(C(=O)N3CCNCC3)c(Cl)c2)n1		CHEMBL1836748	=	IC50	nM	51.0	CHEMBL4601	Homo sapiens	IC50	nM	51.0
	6390278	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	COC1CCN(C(=O)c2ccc(Nc3nc(C)cn4c(-c5cn[nH]c5)cnc34)cc2Cl)CC1		CHEMBL1836813	=	IC50	nM	60.0	CHEMBL4601	Homo sapiens	IC50	nM	60.0
	6390279	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	O=C(c1ccc(Nc2nc(C3CC3)cn3c(-c4cn[nH]c4)cnc23)c(Cl)c1)N1CCNCC1		CHEMBL1836850	=	IC50	nM	63.0	CHEMBL4601	Homo sapiens	IC50	nM	63.0
	6390280	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNCC3)cc2Cl)n1		CHEMBL1836849	=	IC50	nM	64.0	CHEMBL4601	Homo sapiens	IC50	nM	64.0
	6390281	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCN(CCO)CC3)c(Cl)c2)n1		CHEMBL1836808	=	IC50	nM	68.0	CHEMBL4601	Homo sapiens	IC50	nM	68.0
	6390282	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCOCC3)cc2F)n1		CHEMBL1836855	=	IC50	nM	70.0	CHEMBL4601	Homo sapiens	IC50	nM	70.0
	6390283	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCC(O)CC3)c(Cl)c2)n1		CHEMBL1836812	=	IC50	nM	72.0	CHEMBL4601	Homo sapiens	IC50	nM	72.0
	6390284	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cncc(N3CCNCC3)c2)n1		CHEMBL1836797	=	IC50	nM	75.0	CHEMBL4601	Homo sapiens	IC50	nM	75.0
	6390285	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCCCC3)c(Cl)c2)n1		CHEMBL1836809	=	IC50	nM	93.0	CHEMBL4601	Homo sapiens	IC50	nM	93.0
	6390286	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)O)c(Cl)c2)n1		CHEMBL1836757	=	IC50	nM	97.0	CHEMBL4601	Homo sapiens	IC50	nM	97.0
	6390287	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cl)cc(C(=O)N3CCNCC3)c2)n1		CHEMBL1836758	=	IC50	nM	104.0	CHEMBL4601	Homo sapiens	IC50	nM	104.0
	6390288	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	O=C(c1ccc(Nc2nc(C3CC3)cn3c(-c4cn[nH]c4)cnc23)cc1Cl)N1CCOCC1		CHEMBL1836848	=	IC50	nM	124.0	CHEMBL4601	Homo sapiens	IC50	nM	124.0
	6390289	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCOCC3)cc2Cl)n1		CHEMBL1836851	=	IC50	nM	156.0	CHEMBL4601	Homo sapiens	IC50	nM	156.0
	6390290	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	O=C(c1ccc(Nc2nc(C3CC3)cn3c(-c4cn[nH]c4)cnc23)c(Cl)c1)N1CCOCC1		CHEMBL1836852	=	IC50	nM	156.0	CHEMBL4601	Homo sapiens	IC50	nM	156.0
	6390291	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	Cc1cn2c(-c3cccs3)cnc2c(Nc2ccc(C(=O)N3CCNCC3)c(Cl)c2)n1		CHEMBL1836749	=	IC50	nM	177.0	CHEMBL4601	Homo sapiens	IC50	nM	177.0
	6390292	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	Cc1cn2c(-c3cnn(C)c3)cnc2c(Nc2ccc(C(=O)N3CCNCC3)c(Cl)c2)n1		CHEMBL1836747	=	IC50	nM	256.0	CHEMBL4601	Homo sapiens	IC50	nM	256.0
	6390293	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	Cc1cn2c(-c3cccnc3)cnc2c(Nc2ccc(C(=O)N3CCNCC3)c(Cl)c2)n1		CHEMBL1836751	=	IC50	nM	319.0	CHEMBL4601	Homo sapiens	IC50	nM	319.0
	6390294	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	Cc1cn2c(-c3ccncc3)cnc2c(Nc2ccc(C(=O)N3CCNCC3)c(Cl)c2)n1		CHEMBL1836750	=	IC50	nM	355.0	CHEMBL4601	Homo sapiens	IC50	nM	355.0
	6390295	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCOCC3(C)C)c(Cl)c2)n1		CHEMBL1836811	=	IC50	nM	379.0	CHEMBL4601	Homo sapiens	IC50	nM	379.0
	6390296	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	O=C(c1ccc(Nc2nccn3c(-c4cn[nH]c4)cnc23)cc1Cl)N1CCNCC1		CHEMBL1836753	=	IC50	nM	391.0	CHEMBL4601	Homo sapiens	IC50	nM	391.0
	6390297	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	CC(C)c1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNCC3)c(Cl)c2)n1		CHEMBL1836756	=	IC50	nM	477.0	CHEMBL4601	Homo sapiens	IC50	nM	477.0
	6390298	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(N3CCOCC3)nc2)n1		CHEMBL1836798	=	IC50	nM	495.0	CHEMBL4601	Homo sapiens	IC50	nM	495.0
	6390299	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	Cc1cc(Nc2nc(Sc3ccccc3Cl)cn3c(-c4cn[nH]c4)cnc23)sn1		CHEMBL1836866	=	IC50	nM	500.0	CHEMBL4601	Homo sapiens	IC50	nM	500.0
	6390300	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(N[C@H]2CC[C@H](C(=O)N3CCNCC3)CC2)n1		CHEMBL1836759	=	IC50	nM	799.0	CHEMBL4601	Homo sapiens	IC50	nM	799.0
	6390301	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	Cc1cn2c(-c3cn[nH]c3)c(C)nc2c(Nc2ccc(C(=O)N3CCNCC3)c(Cl)c2)n1		CHEMBL1836743	=	IC50	nM	1524.0	CHEMBL4601	Homo sapiens	IC50	nM	1524.0
	6390302	CHEMBL1839617	Inhibition of BRK pretreated for 30 mins by microplate reader	B	Cc1cn2c(-c3cncnc3)cnc2c(Nc2ccc(C(=O)N3CCNCC3)c(Cl)c2)n1		CHEMBL1836752	=	IC50	nM	2643.0	CHEMBL4601	Homo sapiens	IC50	nM	2643.0
Not Determined	6390303	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	Cc1cn2c(-c3cn[nH]c3)c(C)nc2c(Nc2ccc(C(=O)N3CCNCC3)c(Cl)c2)n1		CHEMBL1836743		IC50			CHEMBL4601	Homo sapiens	IC50		
Not Determined	6390304	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	CCc1nc2c(Nc3ccc(C(=O)N4CCNCC4)c(Cl)c3)nc(C)cn2c1-c1cn[nH]c1		CHEMBL1836744		IC50			CHEMBL4601	Homo sapiens	IC50		
Not Determined	6390305	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	Cc1cn2c(-c3cn[nH]c3)c(C3CC3)nc2c(Nc2ccc(C(=O)N3CCNCC3)c(Cl)c2)n1		CHEMBL1836745		IC50			CHEMBL4601	Homo sapiens	IC50		
Not Determined	6390306	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	Cc1cn2c(-c3cn[nH]c3)c(C(C)C)nc2c(Nc2ccc(C(=O)N3CCNCC3)c(Cl)c2)n1		CHEMBL1836746		IC50			CHEMBL4601	Homo sapiens	IC50		
Not Determined	6390307	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	Cc1cn2c(-c3ccsc3)cnc2c(Nc2ccc(C(=O)N3CCNCC3)c(Cl)c2)n1		CHEMBL1836748		IC50			CHEMBL4601	Homo sapiens	IC50		
Not Determined	6390308	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	Cc1cn2c(-c3cccs3)cnc2c(Nc2ccc(C(=O)N3CCNCC3)c(Cl)c2)n1		CHEMBL1836749		IC50			CHEMBL4601	Homo sapiens	IC50		
Not Determined	6390309	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	Cc1cn2c(-c3ccncc3)cnc2c(Nc2ccc(C(=O)N3CCNCC3)c(Cl)c2)n1		CHEMBL1836750		IC50			CHEMBL4601	Homo sapiens	IC50		
Not Determined	6390310	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	Cc1cn2c(-c3cccnc3)cnc2c(Nc2ccc(C(=O)N3CCNCC3)c(Cl)c2)n1		CHEMBL1836751		IC50			CHEMBL4601	Homo sapiens	IC50		
Not Determined	6390311	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	Cc1cn2c(-c3cncnc3)cnc2c(Nc2ccc(C(=O)N3CCNCC3)c(Cl)c2)n1		CHEMBL1836752		IC50			CHEMBL4601	Homo sapiens	IC50		
Not Determined	6390312	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	O=C(c1ccc(Nc2nccn3c(-c4cn[nH]c4)cnc23)cc1Cl)N1CCNCC1		CHEMBL1836753		IC50			CHEMBL4601	Homo sapiens	IC50		
Not Determined	6390313	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	CC(C)c1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNCC3)c(Cl)c2)n1		CHEMBL1836756		IC50			CHEMBL4601	Homo sapiens	IC50		
Not Determined	6390314	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)O)c(Cl)c2)n1		CHEMBL1836757		IC50			CHEMBL4601	Homo sapiens	IC50		
Not Determined	6390315	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cl)cc(C(=O)N3CCNCC3)c2)n1		CHEMBL1836758		IC50			CHEMBL4601	Homo sapiens	IC50		
Not Determined	6390316	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	Cc1cn2c(-c3cn[nH]c3)cnc2c(N[C@H]2CC[C@H](C(=O)N3CCNCC3)CC2)n1		CHEMBL1836759		IC50			CHEMBL4601	Homo sapiens	IC50		
Not Determined	6390317	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	CCOc1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sc1C(=O)N1CCCC(C)C1		CHEMBL1836760		IC50			CHEMBL4601	Homo sapiens	IC50		
Not Determined	6390318	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C(=O)N(C)C)ns2)n1		CHEMBL1836761		IC50			CHEMBL4601	Homo sapiens	IC50		
Not Determined	6390319	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(N3CCOCC3)nc2)n1		CHEMBL1836798		IC50			CHEMBL4601	Homo sapiens	IC50		
Not Determined	6390320	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCC(O)CC3)cs2)n1		CHEMBL1836799		IC50			CHEMBL4601	Homo sapiens	IC50		
Not Determined	6390321	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCOCC3(C)C)c(Cl)c2)n1		CHEMBL1836811		IC50			CHEMBL4601	Homo sapiens	IC50		
Not Determined	6390322	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNCC3)cc2Cl)n1		CHEMBL1836849		IC50			CHEMBL4601	Homo sapiens	IC50		
Not Determined	6390323	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	O=C(c1ccc(Nc2nc(C3CC3)cn3c(-c4cn[nH]c4)cnc23)c(Cl)c1)N1CCNCC1		CHEMBL1836850		IC50			CHEMBL4601	Homo sapiens	IC50		
Not Determined	6390324	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCOCC3)cc2Cl)n1		CHEMBL1836851		IC50			CHEMBL4601	Homo sapiens	IC50		
Not Determined	6390325	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	O=C(c1ccc(Nc2nc(C3CC3)cn3c(-c4cn[nH]c4)cnc23)c(Cl)c1)N1CCOCC1		CHEMBL1836852		IC50			CHEMBL4601	Homo sapiens	IC50		
Not Determined	6390326	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCOCC3)cc2F)n1		CHEMBL1836855		IC50			CHEMBL4601	Homo sapiens	IC50		
	6390327	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	CC1(C)CN(C(=O)c2ccc(Nc3nc(C4CC4)cn4c(-c5cn[nH]c5)cnc34)c(F)c2)CCN1		CHEMBL1836865	<	IC50	nM	7.0	CHEMBL4601	Homo sapiens	IC50	nM	7.0
	6390328	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNCC3)c(Cl)c2)n1		CHEMBL1836867	=	IC50	nM	157.0	CHEMBL4601	Homo sapiens	IC50	nM	157.0
	6390329	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCN(C)CC3)c(Cl)c2)n1		CHEMBL1836805	>	IC50	nM	600.0	CHEMBL4601	Homo sapiens	IC50	nM	600.0
	6390330	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	O=C(c1ccc(Nc2nc(C3CC3)cn3c(-c4cn[nH]c4)cnc23)cc1Cl)N1CCOCC1		CHEMBL1836848	>	IC50	nM	600.0	CHEMBL4601	Homo sapiens	IC50	nM	600.0
	6390331	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	Cc1cn2c(-c3cnn(C)c3)cnc2c(Nc2ccc(C(=O)N3CCNCC3)c(Cl)c2)n1		CHEMBL1836747	>	IC50	nM	3000.0	CHEMBL4601	Homo sapiens	IC50	nM	3000.0
	6390332	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNC(=O)C3)c(Cl)c2)n1		CHEMBL1836806	>	IC50	nM	3000.0	CHEMBL4601	Homo sapiens	IC50	nM	3000.0
	6390333	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	CC(=O)N1CCN(C(=O)c2ccc(Nc3nc(C)cn4c(-c5cn[nH]c5)cnc34)cc2Cl)CC1		CHEMBL1836807	>	IC50	nM	3000.0	CHEMBL4601	Homo sapiens	IC50	nM	3000.0
	6390334	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	CC1(C)CNCCN1C(=O)c1ccc(Nc2nc(C3CC3)cn3c(-c4cn[nH]c4)cnc23)cc1Cl		CHEMBL1836842	=	IC50	nM	5.0	CHEMBL4601	Homo sapiens	IC50	nM	5.0
	6390335	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	O=C(c1ccc(Nc2nc(C3CC3)cn3c(-c4cn[nH]c4)cnc23)c(F)c1)N1CCNCC1		CHEMBL1836854	=	IC50	nM	7.0	CHEMBL4601	Homo sapiens	IC50	nM	7.0
	6390336	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	CC1(C)CNCCN1C(=O)c1ccc(Nc2nc(C3CC3)cn3c(-c4cn[nH]c4)cnc23)c(F)c1		CHEMBL1836863	=	IC50	nM	7.0	CHEMBL4601	Homo sapiens	IC50	nM	7.0
	6390337	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	O=C(c1ccc(Nc2nc(C3CC3)cn3c(-c4cn[nH]c4)cnc23)cc1Cl)N1CCNCC12CC2		CHEMBL1836843	=	IC50	nM	14.0	CHEMBL4601	Homo sapiens	IC50	nM	14.0
	6390338	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	O=C(c1ccc(Nc2nc(C3CC3)cn3c(-c4cn[nH]c4)cnc23)cc1Cl)N1C[C@@H]2CC[C@H](C1)N2		CHEMBL1836847	=	IC50	nM	17.0	CHEMBL4601	Homo sapiens	IC50	nM	17.0
	6390339	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNC(C)(C)C3)c(Cl)c2)n1		CHEMBL1836838	=	IC50	nM	19.0	CHEMBL4601	Homo sapiens	IC50	nM	19.0
	6390340	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	O=C(c1ccc(Nc2nc(C3CC3)cn3c(-c4cn[nH]c4)cnc23)cc1Cl)N1CCNCC1		CHEMBL1836755	=	IC50	nM	22.0	CHEMBL4601	Homo sapiens	IC50	nM	22.0
	6390341	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	COc1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)ccc1C(=O)N1CCNCC1		CHEMBL1836803	=	IC50	nM	22.0	CHEMBL4601	Homo sapiens	IC50	nM	22.0
	6390342	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNCC3(C)C)c(Cl)c2)n1		CHEMBL1836815	=	IC50	nM	23.0	CHEMBL4601	Homo sapiens	IC50	nM	23.0
	6390343	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	O=C(c1ccc(Nc2nc(C3CC3)cn3c(-c4cn[nH]c4)cnc23)cc1Cl)N1CCNC2(CC2)C1		CHEMBL1836845	=	IC50	nM	33.0	CHEMBL4601	Homo sapiens	IC50	nM	33.0
	6390344	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNCC3)c(C(F)(F)F)c2)n1		CHEMBL1836802	=	IC50	nM	35.0	CHEMBL4601	Homo sapiens	IC50	nM	35.0
	6390345	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	CCc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNCC3)c(Cl)c2)n1		CHEMBL1836754	=	IC50	nM	38.0	CHEMBL4601	Homo sapiens	IC50	nM	38.0
	6390346	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNC(C)(C)C3)cc2F)n1		CHEMBL1836864	=	IC50	nM	38.0	CHEMBL4601	Homo sapiens	IC50	nM	38.0
	6390347	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNCC3)c(C3CC3)c2)n1		CHEMBL1836804	=	IC50	nM	40.0	CHEMBL4601	Homo sapiens	IC50	nM	40.0
	6390348	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNCC34CC4)c(Cl)c2)n1		CHEMBL1836837	=	IC50	nM	42.0	CHEMBL4601	Homo sapiens	IC50	nM	42.0
	6390349	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	O=C(c1ccc(Nc2nc(C3CC3)cn3c(-c4cn[nH]c4)cnc23)cc1Cl)N1C[C@H]2CC[C@@H]1CN2		CHEMBL1836846	=	IC50	nM	45.0	CHEMBL4601	Homo sapiens	IC50	nM	45.0
	6390350	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNCC3(C)C)cc2F)n1		CHEMBL1836862	=	IC50	nM	46.0	CHEMBL4601	Homo sapiens	IC50	nM	46.0
	6390351	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3C[C@H]4CC[C@@H]3CN4)c(Cl)c2)n1		CHEMBL1836840	=	IC50	nM	47.0	CHEMBL4601	Homo sapiens	IC50	nM	47.0
	6390352	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	CC1(C)CN(C(=O)c2ccc(Nc3nc(C4CC4)cn4c(-c5cn[nH]c5)cnc34)cc2Cl)CCN1		CHEMBL1836844	=	IC50	nM	47.0	CHEMBL4601	Homo sapiens	IC50	nM	47.0
	6390353	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	O=C(c1ccc(Nc2nc(C3CC3)cn3c(-c4cn[nH]c4)cnc23)c(F)c1)N1CCOCC1		CHEMBL1836861	=	IC50	nM	52.0	CHEMBL4601	Homo sapiens	IC50	nM	52.0
	6390354	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNCC3)cc2F)n1		CHEMBL1836853	=	IC50	nM	54.0	CHEMBL4601	Homo sapiens	IC50	nM	54.0
	6390355	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNC4(CC4)C3)c(Cl)c2)n1		CHEMBL1836839	=	IC50	nM	62.0	CHEMBL4601	Homo sapiens	IC50	nM	62.0
	6390356	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL1739550	=	IC50	nM	94.0	CHEMBL4601	Homo sapiens	IC50	nM	94.0
	6390357	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccnc(N3CCNCC3)c2)n1		CHEMBL1836796	=	IC50	nM	109.0	CHEMBL4601	Homo sapiens	IC50	nM	109.0
	6390358	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCCNCC3)c(Cl)c2)n1		CHEMBL1836814	=	IC50	nM	113.0	CHEMBL4601	Homo sapiens	IC50	nM	113.0
	6390359	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCC(O)CC3)c(Cl)c2)n1		CHEMBL1836812	=	IC50	nM	120.0	CHEMBL4601	Homo sapiens	IC50	nM	120.0
	6390360	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCN(CCO)CC3)c(Cl)c2)n1		CHEMBL1836808	=	IC50	nM	132.0	CHEMBL4601	Homo sapiens	IC50	nM	132.0
	6390361	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	COC1CCN(C(=O)c2ccc(Nc3nc(C)cn4c(-c5cn[nH]c5)cnc34)cc2Cl)CC1		CHEMBL1836813	=	IC50	nM	137.0	CHEMBL4601	Homo sapiens	IC50	nM	137.0
	6390362	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNCC3)c(F)c2)n1		CHEMBL1836801	=	IC50	nM	153.0	CHEMBL4601	Homo sapiens	IC50	nM	153.0
	6390363	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNCC3)cc2)n1		CHEMBL1836800	=	IC50	nM	167.0	CHEMBL4601	Homo sapiens	IC50	nM	167.0
	6390364	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3C[C@@H]4CC[C@H](C3)N4)c(Cl)c2)n1		CHEMBL1836841	=	IC50	nM	177.0	CHEMBL4601	Homo sapiens	IC50	nM	177.0
	6390365	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cncc(N3CCNCC3)c2)n1		CHEMBL1836797	=	IC50	nM	244.0	CHEMBL4601	Homo sapiens	IC50	nM	244.0
	6390366	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCOCC3)c(Cl)c2)n1		CHEMBL1836810	=	IC50	nM	254.0	CHEMBL4601	Homo sapiens	IC50	nM	254.0
	6390367	CHEMBL1839618	Inhibition of phosphorylation of SAM68 in 293 WT-PTK6 cells after 3 hrs	F	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCCCC3)c(Cl)c2)n1		CHEMBL1836809	=	IC50	nM	608.0	CHEMBL4601	Homo sapiens	IC50	nM	608.0
	7567427	CHEMBL1908726	Binding constant for BRK kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Kd	nM	560.0	CHEMBL4601	Homo sapiens	Kd	nM	560.0
	7567915	CHEMBL1908726	Binding constant for BRK kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7568383	CHEMBL1908726	Binding constant for BRK kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	48.0	CHEMBL4601	Homo sapiens	Kd	nM	48.0
	7568815	CHEMBL1908726	Binding constant for BRK kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7569418	CHEMBL1908726	Binding constant for BRK kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7569890	CHEMBL1908726	Binding constant for BRK kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7570353	CHEMBL1908726	Binding constant for BRK kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7570780	CHEMBL1908726	Binding constant for BRK kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	4600.0	CHEMBL4601	Homo sapiens	Kd	nM	4600.0
	7570934	CHEMBL1908726	Binding constant for BRK kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7571391	CHEMBL1908726	Binding constant for BRK kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7571867	CHEMBL1908726	Binding constant for BRK kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7572330	CHEMBL1908726	Binding constant for BRK kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7572746	CHEMBL1908726	Binding constant for BRK kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	36.0	CHEMBL4601	Homo sapiens	Kd	nM	36.0
	7572915	CHEMBL1908726	Binding constant for BRK kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7573372	CHEMBL1908726	Binding constant for BRK kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	7.8	CHEMBL4601	Homo sapiens	Kd	nM	7.8
	7573848	CHEMBL1908726	Binding constant for BRK kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7574317	CHEMBL1908726	Binding constant for BRK kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7574725	CHEMBL1908726	Binding constant for BRK kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	=	Kd	nM	5000.0	CHEMBL4601	Homo sapiens	Kd	nM	5000.0
	7574893	CHEMBL1908726	Binding constant for BRK kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7575354	CHEMBL1908726	Binding constant for BRK kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7575825	CHEMBL1908726	Binding constant for BRK kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	=	Kd	nM	70.0	CHEMBL4601	Homo sapiens	Kd	nM	70.0
	7576290	CHEMBL1908726	Binding constant for BRK kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	=	Kd	nM	48.0	CHEMBL4601	Homo sapiens	Kd	nM	48.0
	7576867	CHEMBL1908726	Binding constant for BRK kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7577326	CHEMBL1908726	Binding constant for BRK kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	4.3	CHEMBL4601	Homo sapiens	Kd	nM	4.3
	7577804	CHEMBL1908726	Binding constant for BRK kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7578237	CHEMBL1908726	Binding constant for BRK kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	1200.0	CHEMBL4601	Homo sapiens	Kd	nM	1200.0
	7578875	CHEMBL1908726	Binding constant for BRK kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7579249	CHEMBL1908726	Binding constant for BRK kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7579699	CHEMBL1908726	Binding constant for BRK kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7580200	CHEMBL1908726	Binding constant for BRK kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	1000.0	CHEMBL4601	Homo sapiens	Kd	nM	1000.0
	7580603	CHEMBL1908726	Binding constant for BRK kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	160.0	CHEMBL4601	Homo sapiens	Kd	nM	160.0
	7581233	CHEMBL1908726	Binding constant for BRK kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7581618	CHEMBL1908726	Binding constant for BRK kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7582063	CHEMBL1908726	Binding constant for BRK kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7582092	CHEMBL1908726	Binding constant for BRK kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7582556	CHEMBL1908726	Binding constant for BRK kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	Kd	nM	2400.0	CHEMBL4601	Homo sapiens	Kd	nM	2400.0
	7582956	CHEMBL1908726	Binding constant for BRK kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7583579	CHEMBL1908726	Binding constant for BRK kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7583976	CHEMBL1908726	Binding constant for BRK kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7584450	CHEMBL1908726	Binding constant for BRK kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7584912	CHEMBL1908726	Binding constant for BRK kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	360.0	CHEMBL4601	Homo sapiens	Kd	nM	360.0
	7585316	CHEMBL1908726	Binding constant for BRK kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7586321	CHEMBL1908726	Binding constant for BRK kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7586792	CHEMBL1908726	Binding constant for BRK kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7587246	CHEMBL1908726	Binding constant for BRK kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7587428	CHEMBL1908726	Binding constant for BRK kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7587847	CHEMBL1908726	Binding constant for BRK kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7588300	CHEMBL1908726	Binding constant for BRK kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7588771	CHEMBL1908726	Binding constant for BRK kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7589222	CHEMBL1908726	Binding constant for BRK kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	3900.0	CHEMBL4601	Homo sapiens	Kd	nM	3900.0
	7589393	CHEMBL1908726	Binding constant for BRK kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7589817	CHEMBL1908726	Binding constant for BRK kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	1700.0	CHEMBL4601	Homo sapiens	Kd	nM	1700.0
	7590284	CHEMBL1908726	Binding constant for BRK kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7590758	CHEMBL1908726	Binding constant for BRK kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7591209	CHEMBL1908726	Binding constant for BRK kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7591366	CHEMBL1908726	Binding constant for BRK kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	=	Kd	nM	1000.0	CHEMBL4601	Homo sapiens	Kd	nM	1000.0
	7591788	CHEMBL1908726	Binding constant for BRK kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7592260	CHEMBL1908726	Binding constant for BRK kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7592733	CHEMBL1908726	Binding constant for BRK kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7593333	CHEMBL1908726	Binding constant for BRK kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7593768	CHEMBL1908726	Binding constant for BRK kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	3600.0	CHEMBL4601	Homo sapiens	Kd	nM	3600.0
	7594240	CHEMBL1908726	Binding constant for BRK kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7594723	CHEMBL1908726	Binding constant for BRK kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7595301	CHEMBL1908726	Binding constant for BRK kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7595745	CHEMBL1908726	Binding constant for BRK kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	3800.0	CHEMBL4601	Homo sapiens	Kd	nM	3800.0
	7596219	CHEMBL1908726	Binding constant for BRK kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7596248	CHEMBL1908726	Binding constant for BRK kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7596695	CHEMBL1908726	Binding constant for BRK kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7597273	CHEMBL1908726	Binding constant for BRK kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7597726	CHEMBL1908726	Binding constant for BRK kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL4601	Homo sapiens	Kd	nM	10000.0
	7598227	CHEMBL1908726	Binding constant for BRK kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	2300.0	CHEMBL4601	Homo sapiens	Kd	nM	2300.0
	7598669	CHEMBL1908726	Binding constant for BRK kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	2300.0	CHEMBL4601	Homo sapiens	Kd	nM	2300.0
	7931144	CHEMBL1919063	Inhibition of BRK relative to control	B	Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916891	=	Inhibition	%	-4.0	CHEMBL4601	Homo sapiens	INH	%	-4.0
	7948000	CHEMBL1924389	Inhibition of BRK at 10 uM	B	CNc1nc2[nH]c(-c3cccc(CNC(=O)COC)n3)cc2c2c1ncn2C		CHEMBL1923983	>	Inhibition	%	75.0	CHEMBL4601	Homo sapiens	INH	%	75.0
	7948007	CHEMBL1924438	Inhibition of BRK	B	CNc1nc2[nH]c(-c3cccc(CNC(=O)COC)n3)cc2c2c1ncn2C		CHEMBL1923983	=	IC50	nM	310.0	CHEMBL4601	Homo sapiens	IC50	uM	0.31
	7959687	CHEMBL1932334	Inhibition of BRK	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	>	IC50	nM	30000.0	CHEMBL4601	Homo sapiens	IC50	uM	30.0
	7959688	CHEMBL1932334	Inhibition of BRK	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	IC50	nM	30000.0	CHEMBL4601	Homo sapiens	IC50	uM	30.0
	7969695	CHEMBL1930951	Inhibition of BRK assessed as residual activity at 10 uM using [33P-ATP] by radiometric filter binding assay	B	Cc1ccc(F)cc1-c1nc2[nH]nc(N)c2c2c1CCCC2		CHEMBL1927262	=	Activity	%	71.0	CHEMBL4601	Homo sapiens	Activity	%	71.0
	7984060	CHEMBL1936506	Inhibition of BRK	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3nccc(-c4cc(C(N)=O)cn4C)n3)c2)CC1		CHEMBL1933576	>	IC50	nM	10000.0	CHEMBL4601	Homo sapiens	IC50	uM	10.0
	7984061	CHEMBL1936506	Inhibition of BRK	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3nccc(-c4cc5c(n4C)CCNC5=O)n3)c2)CC1		CHEMBL1933582	>	IC50	nM	10000.0	CHEMBL4601	Homo sapiens	IC50	uM	10.0
	8017839	CHEMBL1948813	Inhibition of BRK assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CC1CCOCC1		CHEMBL1945953	=	Activity	%	93.0	CHEMBL4601	Homo sapiens	Activity	%	93.0
	8017840	CHEMBL1948813	Inhibition of BRK assessed as activity remaining at 10 uM	B	CC(C)(O)c1ccc(-c2cnc3[nH]c(=O)n(CC4CCCCC4)c3n2)cc1		CHEMBL1945950	=	Activity	%	92.0	CHEMBL4601	Homo sapiens	Activity	%	92.0
	8017841	CHEMBL1948813	Inhibition of BRK assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc4[nH]cnc4c3)nc2n1CC1CCCCC1		CHEMBL1946262	=	Activity	%	82.0	CHEMBL4601	Homo sapiens	Activity	%	82.0
	8039304	CHEMBL1953281	Inhibition of BRK	B	COc1ccc(C(=O)NC[C@@H](O)CO)cc1/C=C/c1ccc(Cl)cc1		CHEMBL1949788	>	IC50	nM	50000.0	CHEMBL4601	Homo sapiens	IC50	uM	50.0
	8039305	CHEMBL1953281	Inhibition of BRK	B	COc1ccc(C(=O)NC[C@H](O)CO)cc1/C=C/c1ccc(Cl)cc1		CHEMBL1949789	>	IC50	nM	50000.0	CHEMBL4601	Homo sapiens	IC50	uM	50.0
	8047164	CHEMBL1959389	Inhibition of PTK6 at 1 uM	B	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1		CHEMBL1956070	<	Inhibition	%	50.0	CHEMBL4601	Homo sapiens	INH	%	50.0
	8061359	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	13.86	CHEMBL4601	Homo sapiens	Inhibition	%	13.86
	8061536	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-0.85	CHEMBL4601	Homo sapiens	Inhibition	%	-0.85
	8061867	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	13.24	CHEMBL4601	Homo sapiens	Inhibition	%	13.24
	8062058	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	0.63	CHEMBL4601	Homo sapiens	Inhibition	%	0.63
	8062398	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	4.32	CHEMBL4601	Homo sapiens	Inhibition	%	4.32
	8062560	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	9.38	CHEMBL4601	Homo sapiens	Inhibition	%	9.38
	8062882	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	-3.65	CHEMBL4601	Homo sapiens	Inhibition	%	-3.65
	8063238	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	58.72	CHEMBL4601	Homo sapiens	Inhibition	%	58.72
	8063405	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	3.82	CHEMBL4601	Homo sapiens	Inhibition	%	3.82
	8063737	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	1.72	CHEMBL4601	Homo sapiens	Inhibition	%	1.72
	8063919	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	2.28	CHEMBL4601	Homo sapiens	Inhibition	%	2.28
	8064258	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	4.24	CHEMBL4601	Homo sapiens	Inhibition	%	4.24
	8064468	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	-0.15	CHEMBL4601	Homo sapiens	Inhibition	%	-0.15
	8064830	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	0.75	CHEMBL4601	Homo sapiens	Inhibition	%	0.75
	8064996	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	4.81	CHEMBL4601	Homo sapiens	Inhibition	%	4.81
	8065336	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	1.4	CHEMBL4601	Homo sapiens	Inhibition	%	1.4
	8065511	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	4.61	CHEMBL4601	Homo sapiens	Inhibition	%	4.61
	8065735	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	28.46	CHEMBL4601	Homo sapiens	Inhibition	%	28.46
	8065850	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	-0.08	CHEMBL4601	Homo sapiens	Inhibition	%	-0.08
	8066060	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	2.41	CHEMBL4601	Homo sapiens	Inhibition	%	2.41
	8066284	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	-3.14	CHEMBL4601	Homo sapiens	Inhibition	%	-3.14
	8066420	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	2.71	CHEMBL4601	Homo sapiens	Inhibition	%	2.71
	8066586	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	0.93	CHEMBL4601	Homo sapiens	Inhibition	%	0.93
	8066810	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	2.88	CHEMBL4601	Homo sapiens	Inhibition	%	2.88
	8066934	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	3.81	CHEMBL4601	Homo sapiens	Inhibition	%	3.81
	8067333	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	2.94	CHEMBL4601	Homo sapiens	Inhibition	%	2.94
	8067454	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	-0.57	CHEMBL4601	Homo sapiens	Inhibition	%	-0.57
	8067678	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	-1.18	CHEMBL4601	Homo sapiens	Inhibition	%	-1.18
	8067888	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	-0.37	CHEMBL4601	Homo sapiens	Inhibition	%	-0.37
	8068023	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	0.23	CHEMBL4601	Homo sapiens	Inhibition	%	0.23
	8068411	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	3.51	CHEMBL4601	Homo sapiens	Inhibition	%	3.51
	8068536	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	4.63	CHEMBL4601	Homo sapiens	Inhibition	%	4.63
	8068760	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	-0.11	CHEMBL4601	Homo sapiens	Inhibition	%	-0.11
	8068934	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	2.51	CHEMBL4601	Homo sapiens	Inhibition	%	2.51
	8069283	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	7.58	CHEMBL4601	Homo sapiens	Inhibition	%	7.58
	8069354	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	17.58	CHEMBL4601	Homo sapiens	Inhibition	%	17.58
	8069578	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	6.1	CHEMBL4601	Homo sapiens	Inhibition	%	6.1
	8069739	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	3.45	CHEMBL4601	Homo sapiens	Inhibition	%	3.45
	8070089	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	-2.0	CHEMBL4601	Homo sapiens	Inhibition	%	-2.0
	8070261	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	8.25	CHEMBL4601	Homo sapiens	Inhibition	%	8.25
	8070610	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	-0.52	CHEMBL4601	Homo sapiens	Inhibition	%	-0.52
	8070908	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	28.47	CHEMBL4601	Homo sapiens	Inhibition	%	28.47
	8071065	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	-0.72	CHEMBL4601	Homo sapiens	Inhibition	%	-0.72
	8071415	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.3	CHEMBL4601	Homo sapiens	Inhibition	%	0.3
	8071588	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	41.96	CHEMBL4601	Homo sapiens	Inhibition	%	41.96
	8071812	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	6.01	CHEMBL4601	Homo sapiens	Inhibition	%	6.01
	8071937	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	0.14	CHEMBL4601	Homo sapiens	Inhibition	%	0.14
	8072251	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	-1.63	CHEMBL4601	Homo sapiens	Inhibition	%	-1.63
	8072408	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	1.77	CHEMBL4601	Homo sapiens	Inhibition	%	1.77
	8072632	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	1.45	CHEMBL4601	Homo sapiens	Inhibition	%	1.45
	8072757	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	2.48	CHEMBL4601	Homo sapiens	Inhibition	%	2.48
	8073148	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	3.67	CHEMBL4601	Homo sapiens	Inhibition	%	3.67
	8073273	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	1.06	CHEMBL4601	Homo sapiens	Inhibition	%	1.06
	8073616	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	-3.49	CHEMBL4601	Homo sapiens	Inhibition	%	-3.49
	8073849	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	-2.33	CHEMBL4601	Homo sapiens	Inhibition	%	-2.33
	8074225	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	2.78	CHEMBL4601	Homo sapiens	Inhibition	%	2.78
	8074355	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	-0.28	CHEMBL4601	Homo sapiens	Inhibition	%	-0.28
	8074736	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	2.9	CHEMBL4601	Homo sapiens	Inhibition	%	2.9
	8074863	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	0.36	CHEMBL4601	Homo sapiens	Inhibition	%	0.36
	8075087	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-1.05	CHEMBL4601	Homo sapiens	Inhibition	%	-1.05
	8075198	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	-3.16	CHEMBL4601	Homo sapiens	Inhibition	%	-3.16
	8075435	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-2.67	CHEMBL4601	Homo sapiens	Inhibition	%	-2.67
	8075659	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-1.74	CHEMBL4601	Homo sapiens	Inhibition	%	-1.74
	8075800	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	3.64	CHEMBL4601	Homo sapiens	Inhibition	%	3.64
	8075942	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	-0.8	CHEMBL4601	Homo sapiens	Inhibition	%	-0.8
	8076166	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-0.2	CHEMBL4601	Homo sapiens	Inhibition	%	-0.2
	8076314	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	1.21	CHEMBL4601	Homo sapiens	Inhibition	%	1.21
	8076672	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-2.93	CHEMBL4601	Homo sapiens	Inhibition	%	-2.93
	8076774	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-4.64	CHEMBL4601	Homo sapiens	Inhibition	%	-4.64
	8076998	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-0.48	CHEMBL4601	Homo sapiens	Inhibition	%	-0.48
	8077245	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	-1.39	CHEMBL4601	Homo sapiens	Inhibition	%	-1.39
	8077373	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	5.12	CHEMBL4601	Homo sapiens	Inhibition	%	5.12
	8077748	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-0.61	CHEMBL4601	Homo sapiens	Inhibition	%	-0.61
	8077891	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	-0.83	CHEMBL4601	Homo sapiens	Inhibition	%	-0.83
	8078254	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-4.55	CHEMBL4601	Homo sapiens	Inhibition	%	-4.55
	8078580	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-0.84	CHEMBL4601	Homo sapiens	Inhibition	%	-0.84
	8078830	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	-2.85	CHEMBL4601	Homo sapiens	Inhibition	%	-2.85
	8078946	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	2.27	CHEMBL4601	Homo sapiens	Inhibition	%	2.27
	8079170	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	2.95	CHEMBL4601	Homo sapiens	Inhibition	%	2.95
	8079328	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl	Outside typical range	CHEMBL1794067	=	Inhibition	%	-11.83	CHEMBL4601	Homo sapiens	Inhibition	%	-11.83
	8079470	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	4.33	CHEMBL4601	Homo sapiens	Inhibition	%	4.33
	8079694	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	0.34	CHEMBL4601	Homo sapiens	Inhibition	%	0.34
	8079833	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-9.05	CHEMBL4601	Homo sapiens	Inhibition	%	-9.05
	8080162	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-2.02	CHEMBL4601	Homo sapiens	Inhibition	%	-2.02
	8080414	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	-2.24	CHEMBL4601	Homo sapiens	Inhibition	%	-2.24
	8080753	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	0.54	CHEMBL4601	Homo sapiens	Inhibition	%	0.54
	8080917	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-0.38	CHEMBL4601	Homo sapiens	Inhibition	%	-0.38
	8081276	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	6.21	CHEMBL4601	Homo sapiens	Inhibition	%	6.21
	8081420	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	13.49	CHEMBL4601	Homo sapiens	Inhibition	%	13.49
	8081747	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	-2.09	CHEMBL4601	Homo sapiens	Inhibition	%	-2.09
	8081999	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	-2.63	CHEMBL4601	Homo sapiens	Inhibition	%	-2.63
	8082336	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	9.39	CHEMBL4601	Homo sapiens	Inhibition	%	9.39
	8082509	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-3.88	CHEMBL4601	Homo sapiens	Inhibition	%	-3.88
	8082856	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	1.28	CHEMBL4601	Homo sapiens	Inhibition	%	1.28
	8083012	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	64.75	CHEMBL4601	Homo sapiens	Inhibition	%	64.75
	8083236	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	4.87	CHEMBL4601	Homo sapiens	Inhibition	%	4.87
	8083335	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	-2.04	CHEMBL4601	Homo sapiens	Inhibition	%	-2.04
	8083589	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-5.22	CHEMBL4601	Homo sapiens	Inhibition	%	-5.22
	8083813	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-3.0	CHEMBL4601	Homo sapiens	Inhibition	%	-3.0
	8083923	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	3.49	CHEMBL4601	Homo sapiens	Inhibition	%	3.49
	8084108	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	2.01	CHEMBL4601	Homo sapiens	Inhibition	%	2.01
	8084332	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	5.86	CHEMBL4601	Homo sapiens	Inhibition	%	5.86
	8084450	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	1.95	CHEMBL4601	Homo sapiens	Inhibition	%	1.95
	8084835	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	6.65	CHEMBL4601	Homo sapiens	Inhibition	%	6.65
	8084933	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	-1.65	CHEMBL4601	Homo sapiens	Inhibition	%	-1.65
	8085157	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	-2.5	CHEMBL4601	Homo sapiens	Inhibition	%	-2.5
	8085413	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-4.22	CHEMBL4601	Homo sapiens	Inhibition	%	-4.22
	8085521	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	8.09	CHEMBL4601	Homo sapiens	Inhibition	%	8.09
	8085745	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	2.56	CHEMBL4601	Homo sapiens	Inhibition	%	2.56
	8085934	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	31.86	CHEMBL4601	Homo sapiens	Inhibition	%	31.86
	8086049	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	5.3	CHEMBL4601	Homo sapiens	Inhibition	%	5.3
	8086273	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	29.24	CHEMBL4601	Homo sapiens	Inhibition	%	29.24
	8086435	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	4.15	CHEMBL4601	Homo sapiens	Inhibition	%	4.15
	8086758	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	-0.74	CHEMBL4601	Homo sapiens	Inhibition	%	-0.74
	8086969	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	13.52	CHEMBL4601	Homo sapiens	Inhibition	%	13.52
	8087351	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	4.7	CHEMBL4601	Homo sapiens	Inhibition	%	4.7
	8087465	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	79.35	CHEMBL4601	Homo sapiens	Inhibition	%	79.35
	8087827	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	29.47	CHEMBL4601	Homo sapiens	Inhibition	%	29.47
	8087969	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	4.01	CHEMBL4601	Homo sapiens	Inhibition	%	4.01
	8088193	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	5.31	CHEMBL4601	Homo sapiens	Inhibition	%	5.31
	8088341	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	0.76	CHEMBL4601	Homo sapiens	Inhibition	%	0.76
	8088693	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	-0.13	CHEMBL4601	Homo sapiens	Inhibition	%	-0.13
	8088786	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	4.51	CHEMBL4601	Homo sapiens	Inhibition	%	4.51
	8089010	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	3.44	CHEMBL4601	Homo sapiens	Inhibition	%	3.44
	8089138	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	2.81	CHEMBL4601	Homo sapiens	Inhibition	%	2.81
	8089510	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	1.35	CHEMBL4601	Homo sapiens	Inhibition	%	1.35
	8089630	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	-0.69	CHEMBL4601	Homo sapiens	Inhibition	%	-0.69
	8089854	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	-0.35	CHEMBL4601	Homo sapiens	Inhibition	%	-0.35
	8090034	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-4.29	CHEMBL4601	Homo sapiens	Inhibition	%	-4.29
	8090199	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	-1.33	CHEMBL4601	Homo sapiens	Inhibition	%	-1.33
	8090590	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	-2.39	CHEMBL4601	Homo sapiens	Inhibition	%	-2.39
	8090729	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	0.97	CHEMBL4601	Homo sapiens	Inhibition	%	0.97
	8090953	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	16.1	CHEMBL4601	Homo sapiens	Inhibition	%	16.1
	8091158	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	2.05	CHEMBL4601	Homo sapiens	Inhibition	%	2.05
	8091295	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	56.05	CHEMBL4601	Homo sapiens	Inhibition	%	56.05
	8091674	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	5.22	CHEMBL4601	Homo sapiens	Inhibition	%	5.22
	8091790	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	2.03	CHEMBL4601	Homo sapiens	Inhibition	%	2.03
	8092014	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	6.6	CHEMBL4601	Homo sapiens	Inhibition	%	6.6
	8092151	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	2.9	CHEMBL4601	Homo sapiens	Inhibition	%	2.9
	8092526	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	1.27	CHEMBL4601	Homo sapiens	Inhibition	%	1.27
	8092674	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	3.55	CHEMBL4601	Homo sapiens	Inhibition	%	3.55
	8093027	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	7.91	CHEMBL4601	Homo sapiens	Inhibition	%	7.91
	8093339	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	1.91	CHEMBL4601	Homo sapiens	Inhibition	%	1.91
	8093479	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	14.75	CHEMBL4601	Homo sapiens	Inhibition	%	14.75
	8093842	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	-1.64	CHEMBL4601	Homo sapiens	Inhibition	%	-1.64
	8094186	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	5.66	CHEMBL4601	Homo sapiens	Inhibition	%	5.66
	8094366	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	0.11	CHEMBL4601	Homo sapiens	Inhibition	%	0.11
	8094541	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	3.54	CHEMBL4601	Homo sapiens	Inhibition	%	3.54
	8094765	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	4.84	CHEMBL4601	Homo sapiens	Inhibition	%	4.84
	8094921	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	2.23	CHEMBL4601	Homo sapiens	Inhibition	%	2.23
	8095285	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	77.12	CHEMBL4601	Homo sapiens	Inhibition	%	77.12
	8095488	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	13.73	CHEMBL4601	Homo sapiens	Inhibition	%	13.73
	8095629	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	1.91	CHEMBL4601	Homo sapiens	Inhibition	%	1.91
	8095853	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	17.35	CHEMBL4601	Homo sapiens	Inhibition	%	17.35
	8096001	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	13.07	CHEMBL4601	Homo sapiens	Inhibition	%	13.07
	8096342	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	5.49	CHEMBL4601	Homo sapiens	Inhibition	%	5.49
	8096481	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	3.59	CHEMBL4601	Homo sapiens	Inhibition	%	3.59
	8096705	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	0.38	CHEMBL4601	Homo sapiens	Inhibition	%	0.38
	8096861	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	5.98	CHEMBL4601	Homo sapiens	Inhibition	%	5.98
	8097008	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	-1.94	CHEMBL4601	Homo sapiens	Inhibition	%	-1.94
	8097232	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	2.02	CHEMBL4601	Homo sapiens	Inhibition	%	2.02
	8097319	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	4.71	CHEMBL4601	Homo sapiens	Inhibition	%	4.71
	8097539	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	5.03	CHEMBL4601	Homo sapiens	Inhibition	%	5.03
	8097689	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	0.79	CHEMBL4601	Homo sapiens	Inhibition	%	0.79
	8097913	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-0.34	CHEMBL4601	Homo sapiens	Inhibition	%	-0.34
	8098046	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	0.95	CHEMBL4601	Homo sapiens	Inhibition	%	0.95
	8098390	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-0.05	CHEMBL4601	Homo sapiens	Inhibition	%	-0.05
	8098570	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	3.58	CHEMBL4601	Homo sapiens	Inhibition	%	3.58
	8098979	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	31.17	CHEMBL4601	Homo sapiens	Inhibition	%	31.17
	8099123	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	-1.1	CHEMBL4601	Homo sapiens	Inhibition	%	-1.1
	8099489	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	-3.46	CHEMBL4601	Homo sapiens	Inhibition	%	-3.46
	8099683	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	-1.17	CHEMBL4601	Homo sapiens	Inhibition	%	-1.17
	8100054	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	3.4	CHEMBL4601	Homo sapiens	Inhibition	%	3.4
	8100200	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	53.2	CHEMBL4601	Homo sapiens	Inhibition	%	53.2
	8100540	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	7.39	CHEMBL4601	Homo sapiens	Inhibition	%	7.39
	8100904	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	10.96	CHEMBL4601	Homo sapiens	Inhibition	%	10.96
	8101064	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	3.09	CHEMBL4601	Homo sapiens	Inhibition	%	3.09
	8101430	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	0.16	CHEMBL4601	Homo sapiens	Inhibition	%	0.16
	8101615	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-0.06	CHEMBL4601	Homo sapiens	Inhibition	%	-0.06
	8101868	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	2.51	CHEMBL4601	Homo sapiens	Inhibition	%	2.51
	8102247	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	68.62	CHEMBL4601	Homo sapiens	Inhibition	%	68.62
	8102378	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-0.37	CHEMBL4601	Homo sapiens	Inhibition	%	-0.37
	8102602	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	-0.82	CHEMBL4601	Homo sapiens	Inhibition	%	-0.82
	8102722	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	1.34	CHEMBL4601	Homo sapiens	Inhibition	%	1.34
	8102900	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.6	CHEMBL4601	Homo sapiens	Inhibition	%	1.6
	8103124	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	2.35	CHEMBL4601	Homo sapiens	Inhibition	%	2.35
	8103320	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	2.66	CHEMBL4601	Homo sapiens	Inhibition	%	2.66
	8103458	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	10.89	CHEMBL4601	Homo sapiens	Inhibition	%	10.89
	8103682	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	4.3	CHEMBL4601	Homo sapiens	Inhibition	%	4.3
	8103832	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	3.98	CHEMBL4601	Homo sapiens	Inhibition	%	3.98
	8104017	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	2.88	CHEMBL4601	Homo sapiens	Inhibition	%	2.88
	8104241	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	0.55	CHEMBL4601	Homo sapiens	Inhibition	%	0.55
	8104389	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	5.43	CHEMBL4601	Homo sapiens	Inhibition	%	5.43
	8104535	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	3.53	CHEMBL4601	Homo sapiens	Inhibition	%	3.53
	8104759	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	4.99	CHEMBL4601	Homo sapiens	Inhibition	%	4.99
	8104873	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	4.1	CHEMBL4601	Homo sapiens	Inhibition	%	4.1
	8105237	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	2.34	CHEMBL4601	Homo sapiens	Inhibition	%	2.34
	8105403	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	3.57	CHEMBL4601	Homo sapiens	Inhibition	%	3.57
	8105765	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	4.16	CHEMBL4601	Homo sapiens	Inhibition	%	4.16
	8106045	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	1.35	CHEMBL4601	Homo sapiens	Inhibition	%	1.35
	8106210	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	4.81	CHEMBL4601	Homo sapiens	Inhibition	%	4.81
	8106434	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	2.2	CHEMBL4601	Homo sapiens	Inhibition	%	2.2
	8106590	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	99.72	CHEMBL4601	Homo sapiens	Inhibition	%	99.72
	8106943	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	3.3	CHEMBL4601	Homo sapiens	Inhibition	%	3.3
	8107064	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	3.04	CHEMBL4601	Homo sapiens	Inhibition	%	3.04
	8107460	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	2.49	CHEMBL4601	Homo sapiens	Inhibition	%	2.49
	8107661	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	2.72	CHEMBL4601	Homo sapiens	Inhibition	%	2.72
	8108020	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	36.25	CHEMBL4601	Homo sapiens	Inhibition	%	36.25
	8108178	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	0.08	CHEMBL4601	Homo sapiens	Inhibition	%	0.08
	8108577	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	-0.38	CHEMBL4601	Homo sapiens	Inhibition	%	-0.38
	8108724	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	5.93	CHEMBL4601	Homo sapiens	Inhibition	%	5.93
	8109090	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.18	CHEMBL4601	Homo sapiens	Inhibition	%	0.18
	8109204	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	4.81	CHEMBL4601	Homo sapiens	Inhibition	%	4.81
	8109428	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	0.87	CHEMBL4601	Homo sapiens	Inhibition	%	0.87
	8109558	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	1.01	CHEMBL4601	Homo sapiens	Inhibition	%	1.01
	8109729	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	2.72	CHEMBL4601	Homo sapiens	Inhibition	%	2.72
	8109953	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	3.15	CHEMBL4601	Homo sapiens	Inhibition	%	3.15
	8110085	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	0.81	CHEMBL4601	Homo sapiens	Inhibition	%	0.81
	8110364	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	1.55	CHEMBL4601	Homo sapiens	Inhibition	%	1.55
	8110754	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	4.39	CHEMBL4601	Homo sapiens	Inhibition	%	4.39
	8110912	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-6.06	CHEMBL4601	Homo sapiens	Inhibition	%	-6.06
	8111259	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	1.3	CHEMBL4601	Homo sapiens	Inhibition	%	1.3
	8111386	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	16.23	CHEMBL4601	Homo sapiens	Inhibition	%	16.23
	8111610	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	3.05	CHEMBL4601	Homo sapiens	Inhibition	%	3.05
	8111776	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	0.4	CHEMBL4601	Homo sapiens	Inhibition	%	0.4
	8111981	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	2.06	CHEMBL4601	Homo sapiens	Inhibition	%	2.06
	8112342	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-1.24	CHEMBL4601	Homo sapiens	Inhibition	%	-1.24
	8112510	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	2.98	CHEMBL4601	Homo sapiens	Inhibition	%	2.98
	8112734	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	7.08	CHEMBL4601	Homo sapiens	Inhibition	%	7.08
	8112906	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	1.71	CHEMBL4601	Homo sapiens	Inhibition	%	1.71
	8113058	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	6.07	CHEMBL4601	Homo sapiens	Inhibition	%	6.07
	8113282	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	5.42	CHEMBL4601	Homo sapiens	Inhibition	%	5.42
	8113418	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	1.77	CHEMBL4601	Homo sapiens	Inhibition	%	1.77
	8113766	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	4.02	CHEMBL4601	Homo sapiens	Inhibition	%	4.02
	8113882	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	0.32	CHEMBL4601	Homo sapiens	Inhibition	%	0.32
	8114282	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	2.67	CHEMBL4601	Homo sapiens	Inhibition	%	2.67
	8114414	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	7.86	CHEMBL4601	Homo sapiens	Inhibition	%	7.86
	8114638	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	3.39	CHEMBL4601	Homo sapiens	Inhibition	%	3.39
	8114690	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	1.79	CHEMBL4601	Homo sapiens	Inhibition	%	1.79
	8114914	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	3.75	CHEMBL4601	Homo sapiens	Inhibition	%	3.75
	8115080	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	3.76	CHEMBL4601	Homo sapiens	Inhibition	%	3.76
	8115245	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-3.37	CHEMBL4601	Homo sapiens	Inhibition	%	-3.37
	8115469	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-2.54	CHEMBL4601	Homo sapiens	Inhibition	%	-2.54
	8115589	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	1.76	CHEMBL4601	Homo sapiens	Inhibition	%	1.76
	8115946	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	2.47	CHEMBL4601	Homo sapiens	Inhibition	%	2.47
	8116105	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	-2.27	CHEMBL4601	Homo sapiens	Inhibition	%	-2.27
	8116308	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	0.15	CHEMBL4601	Homo sapiens	Inhibition	%	0.15
	8116532	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	1.28	CHEMBL4601	Homo sapiens	Inhibition	%	1.28
	8116666	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-0.15	CHEMBL4601	Homo sapiens	Inhibition	%	-0.15
	8117062	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	47.46	CHEMBL4601	Homo sapiens	Inhibition	%	47.46
	8117233	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	8.3	CHEMBL4601	Homo sapiens	Inhibition	%	8.3
	8117615	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	3.09	CHEMBL4601	Homo sapiens	Inhibition	%	3.09
	8117745	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	0.7	CHEMBL4601	Homo sapiens	Inhibition	%	0.7
	8118107	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	2.61	CHEMBL4601	Homo sapiens	Inhibition	%	2.61
	8118223	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-1.18	CHEMBL4601	Homo sapiens	Inhibition	%	-1.18
	8118447	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	3.21	CHEMBL4601	Homo sapiens	Inhibition	%	3.21
	8118619	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	3.19	CHEMBL4601	Homo sapiens	Inhibition	%	3.19
	8118979	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	3.91	CHEMBL4601	Homo sapiens	Inhibition	%	3.91
	8119250	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	3.06	CHEMBL4601	Homo sapiens	Inhibition	%	3.06
	8119409	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	4.26	CHEMBL4601	Homo sapiens	Inhibition	%	4.26
	8119800	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	1.12	CHEMBL4601	Homo sapiens	Inhibition	%	1.12
	8119919	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	1.05	CHEMBL4601	Homo sapiens	Inhibition	%	1.05
	8120282	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	0.39	CHEMBL4601	Homo sapiens	Inhibition	%	0.39
	8120442	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	-0.34	CHEMBL4601	Homo sapiens	Inhibition	%	-0.34
	8120666	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	1.71	CHEMBL4601	Homo sapiens	Inhibition	%	1.71
	8120867	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	1.62	CHEMBL4601	Homo sapiens	Inhibition	%	1.62
	8120995	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	0.98	CHEMBL4601	Homo sapiens	Inhibition	%	0.98
	8121219	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	1.26	CHEMBL4601	Homo sapiens	Inhibition	%	1.26
	8121391	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	-0.08	CHEMBL4601	Homo sapiens	Inhibition	%	-0.08
	8121558	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	-0.69	CHEMBL4601	Homo sapiens	Inhibition	%	-0.69
	8121945	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	1.74	CHEMBL4601	Homo sapiens	Inhibition	%	1.74
	8122066	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	14.65	CHEMBL4601	Homo sapiens	Inhibition	%	14.65
	8122290	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-0.33	CHEMBL4601	Homo sapiens	Inhibition	%	-0.33
	8122428	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	5.39	CHEMBL4601	Homo sapiens	Inhibition	%	5.39
	8122772	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	4.09	CHEMBL4601	Homo sapiens	Inhibition	%	4.09
	8122939	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	4.75	CHEMBL4601	Homo sapiens	Inhibition	%	4.75
	8123305	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	3.25	CHEMBL4601	Homo sapiens	Inhibition	%	3.25
	8123583	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	23.83	CHEMBL4601	Homo sapiens	Inhibition	%	23.83
	8123733	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	2.93	CHEMBL4601	Homo sapiens	Inhibition	%	2.93
	8124124	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	0.43	CHEMBL4601	Homo sapiens	Inhibition	%	0.43
	8124243	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	5.15	CHEMBL4601	Homo sapiens	Inhibition	%	5.15
	8124467	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	1.39	CHEMBL4601	Homo sapiens	Inhibition	%	1.39
	8124606	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	3.26	CHEMBL4601	Homo sapiens	Inhibition	%	3.26
	8124995	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	2.7	CHEMBL4601	Homo sapiens	Inhibition	%	2.7
	8125196	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	2.72	CHEMBL4601	Homo sapiens	Inhibition	%	2.72
	8125550	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-0.91	CHEMBL4601	Homo sapiens	Inhibition	%	-0.91
	8125718	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	18.17	CHEMBL4601	Homo sapiens	Inhibition	%	18.17
	8125882	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	-1.07	CHEMBL4601	Homo sapiens	Inhibition	%	-1.07
	8126106	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-0.63	CHEMBL4601	Homo sapiens	Inhibition	%	-0.63
	8126270	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	7.25	CHEMBL4601	Homo sapiens	Inhibition	%	7.25
	8126609	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	3.06	CHEMBL4601	Homo sapiens	Inhibition	%	3.06
	8126745	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	2.1	CHEMBL4601	Homo sapiens	Inhibition	%	2.1
	8127091	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	1.09	CHEMBL4601	Homo sapiens	Inhibition	%	1.09
	8127258	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	4.97	CHEMBL4601	Homo sapiens	Inhibition	%	4.97
	8127482	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	9.28	CHEMBL4601	Homo sapiens	Inhibition	%	9.28
	8127624	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	5.16	CHEMBL4601	Homo sapiens	Inhibition	%	5.16
	8127912	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	1.26	CHEMBL4601	Homo sapiens	Inhibition	%	1.26
	8128064	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	14.2	CHEMBL4601	Homo sapiens	Inhibition	%	14.2
	8128288	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	2.85	CHEMBL4601	Homo sapiens	Inhibition	%	2.85
	8128455	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	15.2	CHEMBL4601	Homo sapiens	Inhibition	%	15.2
	8128798	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	10.08	CHEMBL4601	Homo sapiens	Inhibition	%	10.08
	8128935	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	1.7	CHEMBL4601	Homo sapiens	Inhibition	%	1.7
	8129159	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	2.07	CHEMBL4601	Homo sapiens	Inhibition	%	2.07
	8129330	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	1.76	CHEMBL4601	Homo sapiens	Inhibition	%	1.76
	8129519	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	2.5	CHEMBL4601	Homo sapiens	Inhibition	%	2.5
	8129882	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-0.57	CHEMBL4601	Homo sapiens	Inhibition	%	-0.57
	8130043	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	-1.25	CHEMBL4601	Homo sapiens	Inhibition	%	-1.25
	8130439	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-0.63	CHEMBL4601	Homo sapiens	Inhibition	%	-0.63
	8130599	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	3.93	CHEMBL4601	Homo sapiens	Inhibition	%	3.93
	8130939	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	4.09	CHEMBL4601	Homo sapiens	Inhibition	%	4.09
	8131078	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	4.82	CHEMBL4601	Homo sapiens	Inhibition	%	4.82
	8131302	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	2.68	CHEMBL4601	Homo sapiens	Inhibition	%	2.68
	8131422	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	1.93	CHEMBL4601	Homo sapiens	Inhibition	%	1.93
	8131813	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	29.77	CHEMBL4601	Homo sapiens	Inhibition	%	29.77
	8131954	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	2.23	CHEMBL4601	Homo sapiens	Inhibition	%	2.23
	8132240	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	1.89	CHEMBL4601	Homo sapiens	Inhibition	%	1.89
	8132611	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	6.32	CHEMBL4601	Homo sapiens	Inhibition	%	6.32
	8132779	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	0.17	CHEMBL4601	Homo sapiens	Inhibition	%	0.17
	8133124	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	0.74	CHEMBL4601	Homo sapiens	Inhibition	%	0.74
	8133486	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	2.53	CHEMBL4601	Homo sapiens	Inhibition	%	2.53
	8133658	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	15.01	CHEMBL4601	Homo sapiens	Inhibition	%	15.01
	8133838	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	-1.96	CHEMBL4601	Homo sapiens	Inhibition	%	-1.96
	8134062	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	13.47	CHEMBL4601	Homo sapiens	Inhibition	%	13.47
	8134210	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	0.01	CHEMBL4601	Homo sapiens	Inhibition	%	0.01
	8134370	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	3.34	CHEMBL4601	Homo sapiens	Inhibition	%	3.34
	8134594	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	0.58	CHEMBL4601	Homo sapiens	Inhibition	%	0.58
	8134778	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-4.62	CHEMBL4601	Homo sapiens	Inhibition	%	-4.62
	8134938	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	15.72	CHEMBL4601	Homo sapiens	Inhibition	%	15.72
	8135162	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	9.43	CHEMBL4601	Homo sapiens	Inhibition	%	9.43
	8135277	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	5.67	CHEMBL4601	Homo sapiens	Inhibition	%	5.67
	8135642	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	4.31	CHEMBL4601	Homo sapiens	Inhibition	%	4.31
	8135763	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	3.52	CHEMBL4601	Homo sapiens	Inhibition	%	3.52
	8135987	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	3.45	CHEMBL4601	Homo sapiens	Inhibition	%	3.45
	8136155	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	2.5	CHEMBL4601	Homo sapiens	Inhibition	%	2.5
	8136299	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	7.46	CHEMBL4601	Homo sapiens	Inhibition	%	7.46
	8136523	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	4.19	CHEMBL4601	Homo sapiens	Inhibition	%	4.19
	8136589	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	0.54	CHEMBL4601	Homo sapiens	Inhibition	%	0.54
	8136813	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	1.53	CHEMBL4601	Homo sapiens	Inhibition	%	1.53
	8136948	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	3.17	CHEMBL4601	Homo sapiens	Inhibition	%	3.17
	8137111	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	10.0	CHEMBL4601	Homo sapiens	Inhibition	%	10.0
	8137335	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	8.53	CHEMBL4601	Homo sapiens	Inhibition	%	8.53
	8137455	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	3.52	CHEMBL4601	Homo sapiens	Inhibition	%	3.52
	8137827	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	1.16	CHEMBL4601	Homo sapiens	Inhibition	%	1.16
	8137993	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	0.56	CHEMBL4601	Homo sapiens	Inhibition	%	0.56
	8138396	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	-0.74	CHEMBL4601	Homo sapiens	Inhibition	%	-0.74
	8138544	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	2.82	CHEMBL4601	Homo sapiens	Inhibition	%	2.82
	8138926	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	4.58	CHEMBL4601	Homo sapiens	Inhibition	%	4.58
	8139111	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-2.23	CHEMBL4601	Homo sapiens	Inhibition	%	-2.23
	8139494	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	51.04	CHEMBL4601	Homo sapiens	Inhibition	%	51.04
	8139608	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	3.06	CHEMBL4601	Homo sapiens	Inhibition	%	3.06
	8139832	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	3.52	CHEMBL4601	Homo sapiens	Inhibition	%	3.52
	8139973	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	4.81	CHEMBL4601	Homo sapiens	Inhibition	%	4.81
	8140320	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	1.43	CHEMBL4601	Homo sapiens	Inhibition	%	1.43
	8140479	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	5.61	CHEMBL4601	Homo sapiens	Inhibition	%	5.61
	8140846	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	5.5	CHEMBL4601	Homo sapiens	Inhibition	%	5.5
	8141148	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	1.24	CHEMBL4601	Homo sapiens	Inhibition	%	1.24
	8141278	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	3.02	CHEMBL4601	Homo sapiens	Inhibition	%	3.02
	8141662	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	51.03	CHEMBL4601	Homo sapiens	Inhibition	%	51.03
	8141781	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	13.38	CHEMBL4601	Homo sapiens	Inhibition	%	13.38
	8142005	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	61.86	CHEMBL4601	Homo sapiens	Inhibition	%	61.86
	8142166	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	11.98	CHEMBL4601	Homo sapiens	Inhibition	%	11.98
	8142334	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-1.93	CHEMBL4601	Homo sapiens	Inhibition	%	-1.93
	8142558	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-0.71	CHEMBL4601	Homo sapiens	Inhibition	%	-0.71
	8142734	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	1.75	CHEMBL4601	Homo sapiens	Inhibition	%	1.75
	8142883	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-3.3	CHEMBL4601	Homo sapiens	Inhibition	%	-3.3
	8143107	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-4.09	CHEMBL4601	Homo sapiens	Inhibition	%	-4.09
	8143262	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	0.17	CHEMBL4601	Homo sapiens	Inhibition	%	0.17
	8143449	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	3.26	CHEMBL4601	Homo sapiens	Inhibition	%	3.26
	8143673	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	6.68	CHEMBL4601	Homo sapiens	Inhibition	%	6.68
	8143832	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	15.47	CHEMBL4601	Homo sapiens	Inhibition	%	15.47
	8144170	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	4.61	CHEMBL4601	Homo sapiens	Inhibition	%	4.61
	8144309	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	7.3	CHEMBL4601	Homo sapiens	Inhibition	%	7.3
	8144663	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	1.47	CHEMBL4601	Homo sapiens	Inhibition	%	1.47
	8144816	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	1.87	CHEMBL4601	Homo sapiens	Inhibition	%	1.87
	8145040	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	1.57	CHEMBL4601	Homo sapiens	Inhibition	%	1.57
	8145177	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	6.2	CHEMBL4601	Homo sapiens	Inhibition	%	6.2
	8145490	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	0.03	CHEMBL4601	Homo sapiens	Inhibition	%	0.03
	8145614	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	2.56	CHEMBL4601	Homo sapiens	Inhibition	%	2.56
	8145838	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	1.59	CHEMBL4601	Homo sapiens	Inhibition	%	1.59
	8145999	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	10.83	CHEMBL4601	Homo sapiens	Inhibition	%	10.83
	8146343	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	1.16	CHEMBL4601	Homo sapiens	Inhibition	%	1.16
	8146503	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	67.52	CHEMBL4601	Homo sapiens	Inhibition	%	67.52
	8146894	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-4.24	CHEMBL4601	Homo sapiens	Inhibition	%	-4.24
	8147063	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	1.12	CHEMBL4601	Homo sapiens	Inhibition	%	1.12
	8147429	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	-1.81	CHEMBL4601	Homo sapiens	Inhibition	%	-1.81
	8147582	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	4.63	CHEMBL4601	Homo sapiens	Inhibition	%	4.63
	8147993	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	2.4	CHEMBL4601	Homo sapiens	Inhibition	%	2.4
	8148151	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	70.93	CHEMBL4601	Homo sapiens	Inhibition	%	70.93
	8148489	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	11.8	CHEMBL4601	Homo sapiens	Inhibition	%	11.8
	8148628	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	4.36	CHEMBL4601	Homo sapiens	Inhibition	%	4.36
	8148852	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	4.11	CHEMBL4601	Homo sapiens	Inhibition	%	4.11
	8148990	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	3.36	CHEMBL4601	Homo sapiens	Inhibition	%	3.36
	8149373	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	2.35	CHEMBL4601	Homo sapiens	Inhibition	%	2.35
	8149507	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	6.15	CHEMBL4601	Homo sapiens	Inhibition	%	6.15
	8149829	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	17.08	CHEMBL4601	Homo sapiens	Inhibition	%	17.08
	8150178	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	1.76	CHEMBL4601	Homo sapiens	Inhibition	%	1.76
	8150338	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	43.97	CHEMBL4601	Homo sapiens	Inhibition	%	43.97
	8150682	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	1.4	CHEMBL4601	Homo sapiens	Inhibition	%	1.4
	8150847	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	0.16	CHEMBL4601	Homo sapiens	Inhibition	%	0.16
	8151071	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	3.39	CHEMBL4601	Homo sapiens	Inhibition	%	3.39
	8151234	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-2.14	CHEMBL4601	Homo sapiens	Inhibition	%	-2.14
	8151411	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	6.4	CHEMBL4601	Homo sapiens	Inhibition	%	6.4
	8151773	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	2.26	CHEMBL4601	Homo sapiens	Inhibition	%	2.26
	8151927	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	2.5	CHEMBL4601	Homo sapiens	Inhibition	%	2.5
	8152151	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	17.89	CHEMBL4601	Homo sapiens	Inhibition	%	17.89
	8152339	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	6.95	CHEMBL4601	Homo sapiens	Inhibition	%	6.95
	8152497	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	3.8	CHEMBL4601	Homo sapiens	Inhibition	%	3.8
	8152721	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	7.06	CHEMBL4601	Homo sapiens	Inhibition	%	7.06
	8152835	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	18.75	CHEMBL4601	Homo sapiens	Inhibition	%	18.75
	8153198	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	6.28	CHEMBL4601	Homo sapiens	Inhibition	%	6.28
	8153335	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	6.07	CHEMBL4601	Homo sapiens	Inhibition	%	6.07
	8153716	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	4.81	CHEMBL4601	Homo sapiens	Inhibition	%	4.81
	8153849	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	2.42	CHEMBL4601	Homo sapiens	Inhibition	%	2.42
	8154073	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	5.45	CHEMBL4601	Homo sapiens	Inhibition	%	5.45
	8154170	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	66.24	CHEMBL4601	Homo sapiens	Inhibition	%	66.24
	8154520	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	3.78	CHEMBL4601	Homo sapiens	Inhibition	%	3.78
	8154679	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	-0.91	CHEMBL4601	Homo sapiens	Inhibition	%	-0.91
	8154903	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	2.87	CHEMBL4601	Homo sapiens	Inhibition	%	2.87
	8155023	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	1.34	CHEMBL4601	Homo sapiens	Inhibition	%	1.34
	8155423	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	1.57	CHEMBL4601	Homo sapiens	Inhibition	%	1.57
	8155584	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-3.93	CHEMBL4601	Homo sapiens	Inhibition	%	-3.93
	8155762	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	-0.52	CHEMBL4601	Homo sapiens	Inhibition	%	-0.52
	8155986	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	1.65	CHEMBL4601	Homo sapiens	Inhibition	%	1.65
	8156124	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	-0.32	CHEMBL4601	Homo sapiens	Inhibition	%	-0.32
	8156336	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	3.74	CHEMBL4601	Homo sapiens	Inhibition	%	3.74
	8156560	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	4.0	CHEMBL4601	Homo sapiens	Inhibition	%	4.0
	8156710	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	18.72	CHEMBL4601	Homo sapiens	Inhibition	%	18.72
	8156853	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	4.11	CHEMBL4601	Homo sapiens	Inhibition	%	4.11
	8157077	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	4.41	CHEMBL4601	Homo sapiens	Inhibition	%	4.41
	8157197	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	3.23	CHEMBL4601	Homo sapiens	Inhibition	%	3.23
	8157562	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	3.48	CHEMBL4601	Homo sapiens	Inhibition	%	3.48
	8157692	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	8.39	CHEMBL4601	Homo sapiens	Inhibition	%	8.39
	8157916	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	1.85	CHEMBL4601	Homo sapiens	Inhibition	%	1.85
	8158077	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	-1.6	CHEMBL4601	Homo sapiens	Inhibition	%	-1.6
	8158327	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	84.98	CHEMBL4601	Homo sapiens	Inhibition	%	84.98
	8158709	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	3.04	CHEMBL4601	Homo sapiens	Inhibition	%	3.04
	8158878	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	1.78	CHEMBL4601	Homo sapiens	Inhibition	%	1.78
	8159237	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	5.25	CHEMBL4601	Homo sapiens	Inhibition	%	5.25
	8159357	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	10.34	CHEMBL4601	Homo sapiens	Inhibition	%	10.34
	8159581	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	4.76	CHEMBL4601	Homo sapiens	Inhibition	%	4.76
	8159712	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	6.34	CHEMBL4601	Homo sapiens	Inhibition	%	6.34
	8160077	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	2.26	CHEMBL4601	Homo sapiens	Inhibition	%	2.26
	8160214	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	0.26	CHEMBL4601	Homo sapiens	Inhibition	%	0.26
	8160588	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	1.95	CHEMBL4601	Homo sapiens	Inhibition	%	1.95
	8160882	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	8.16	CHEMBL4601	Homo sapiens	Inhibition	%	8.16
	8161032	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	2.66	CHEMBL4601	Homo sapiens	Inhibition	%	2.66
	8161399	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	6.27	CHEMBL4601	Homo sapiens	Inhibition	%	6.27
	8161524	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	23.47	CHEMBL4601	Homo sapiens	Inhibition	%	23.47
	8161748	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	3.64	CHEMBL4601	Homo sapiens	Inhibition	%	3.64
	8161886	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	5.36	CHEMBL4601	Homo sapiens	Inhibition	%	5.36
	8162240	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	3.7	CHEMBL4601	Homo sapiens	Inhibition	%	3.7
	8162400	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-0.99	CHEMBL4601	Homo sapiens	Inhibition	%	-0.99
	8162653	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	4.5	CHEMBL4601	Homo sapiens	Inhibition	%	4.5
	8163025	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	3.25	CHEMBL4601	Homo sapiens	Inhibition	%	3.25
	8163194	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	2.23	CHEMBL4601	Homo sapiens	Inhibition	%	2.23
	8163418	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	3.4	CHEMBL4601	Homo sapiens	Inhibition	%	3.4
	8163552	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	9.3	CHEMBL4601	Homo sapiens	Inhibition	%	9.3
	8163899	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	4.76	CHEMBL4601	Homo sapiens	Inhibition	%	4.76
	8164033	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	18.13	CHEMBL4601	Homo sapiens	Inhibition	%	18.13
	8164397	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	-2.17	CHEMBL4601	Homo sapiens	Inhibition	%	-2.17
	8164552	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	6.1	CHEMBL4601	Homo sapiens	Inhibition	%	6.1
	8164776	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	5.32	CHEMBL4601	Homo sapiens	Inhibition	%	5.32
	8164920	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	13.99	CHEMBL4601	Homo sapiens	Inhibition	%	13.99
	8165214	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	4.0	CHEMBL4601	Homo sapiens	Inhibition	%	4.0
	8165355	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	8.9	CHEMBL4601	Homo sapiens	Inhibition	%	8.9
	8165579	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	3.24	CHEMBL4601	Homo sapiens	Inhibition	%	3.24
	8165722	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	13.7	CHEMBL4601	Homo sapiens	Inhibition	%	13.7
	8166072	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	2.79	CHEMBL4601	Homo sapiens	Inhibition	%	2.79
	8166210	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	1.68	CHEMBL4601	Homo sapiens	Inhibition	%	1.68
	8166564	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	12.96	CHEMBL4601	Homo sapiens	Inhibition	%	12.96
	8166889	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	55.42	CHEMBL4601	Homo sapiens	Inhibition	%	55.42
	8166977	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	8.63	CHEMBL4601	Homo sapiens	Inhibition	%	8.63
	8167201	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	0.94	CHEMBL4601	Homo sapiens	Inhibition	%	0.94
	8167342	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	8.92	CHEMBL4601	Homo sapiens	Inhibition	%	8.92
	8167730	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	3.17	CHEMBL4601	Homo sapiens	Inhibition	%	3.17
	8167863	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	4.83	CHEMBL4601	Homo sapiens	Inhibition	%	4.83
	8168211	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	1.78	CHEMBL4601	Homo sapiens	Inhibition	%	1.78
	8168352	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	67.76	CHEMBL4601	Homo sapiens	Inhibition	%	67.76
	8168576	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	6.4	CHEMBL4601	Homo sapiens	Inhibition	%	6.4
	8168712	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	1.66	CHEMBL4601	Homo sapiens	Inhibition	%	1.66
	8169100	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	23.53	CHEMBL4601	Homo sapiens	Inhibition	%	23.53
	8169242	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	1.77	CHEMBL4601	Homo sapiens	Inhibition	%	1.77
	8169546	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	6.37	CHEMBL4601	Homo sapiens	Inhibition	%	6.37
	8169904	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	3.13	CHEMBL4601	Homo sapiens	Inhibition	%	3.13
	8170049	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	1.52	CHEMBL4601	Homo sapiens	Inhibition	%	1.52
	8170398	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	0.03	CHEMBL4601	Homo sapiens	Inhibition	%	0.03
	8170538	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	3.52	CHEMBL4601	Homo sapiens	Inhibition	%	3.52
	8170762	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	4.21	CHEMBL4601	Homo sapiens	Inhibition	%	4.21
	8170897	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	55.36	CHEMBL4601	Homo sapiens	Inhibition	%	55.36
	8171094	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	1.35	CHEMBL4601	Homo sapiens	Inhibition	%	1.35
	8171318	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	11.07	CHEMBL4601	Homo sapiens	Inhibition	%	11.07
	8171535	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	4.32	CHEMBL4601	Homo sapiens	Inhibition	%	4.32
	8171676	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	5.95	CHEMBL4601	Homo sapiens	Inhibition	%	5.95
	8172053	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	-0.23	CHEMBL4601	Homo sapiens	Inhibition	%	-0.23
	8172185	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	8.38	CHEMBL4601	Homo sapiens	Inhibition	%	8.38
	8172409	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	4.56	CHEMBL4601	Homo sapiens	Inhibition	%	4.56
	8172537	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	5.55	CHEMBL4601	Homo sapiens	Inhibition	%	5.55
	8172903	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	17.05	CHEMBL4601	Homo sapiens	Inhibition	%	17.05
	8173039	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-2.66	CHEMBL4601	Homo sapiens	Inhibition	%	-2.66
	8173428	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	6.09	CHEMBL4601	Homo sapiens	Inhibition	%	6.09
	8173569	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	2.53	CHEMBL4601	Homo sapiens	Inhibition	%	2.53
	8173793	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	4.36	CHEMBL4601	Homo sapiens	Inhibition	%	4.36
	8173880	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	7.16	CHEMBL4601	Homo sapiens	Inhibition	%	7.16
	8174236	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	11.4	CHEMBL4601	Homo sapiens	Inhibition	%	11.4
	8174384	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	2.35	CHEMBL4601	Homo sapiens	Inhibition	%	2.35
	8174608	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	0.45	CHEMBL4601	Homo sapiens	Inhibition	%	0.45
	8174730	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	1.67	CHEMBL4601	Homo sapiens	Inhibition	%	1.67
	8175097	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	4.11	CHEMBL4601	Homo sapiens	Inhibition	%	4.11
	8175233	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	3.47	CHEMBL4601	Homo sapiens	Inhibition	%	3.47
	8175457	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	6.47	CHEMBL4601	Homo sapiens	Inhibition	%	6.47
	8175489	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	3.56	CHEMBL4601	Homo sapiens	Inhibition	%	3.56
	8175713	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	6.0	CHEMBL4601	Homo sapiens	Inhibition	%	6.0
	8175876	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	10.75	CHEMBL4601	Homo sapiens	Inhibition	%	10.75
	8176029	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	19.21	CHEMBL4601	Homo sapiens	Inhibition	%	19.21
	8176253	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	5.04	CHEMBL4601	Homo sapiens	Inhibition	%	5.04
	8176402	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	5.33	CHEMBL4601	Homo sapiens	Inhibition	%	5.33
	8176758	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	8.06	CHEMBL4601	Homo sapiens	Inhibition	%	8.06
	8176888	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	2.69	CHEMBL4601	Homo sapiens	Inhibition	%	2.69
	8177254	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	29.55	CHEMBL4601	Homo sapiens	Inhibition	%	29.55
	8177392	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	0.49	CHEMBL4601	Homo sapiens	Inhibition	%	0.49
	8177616	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	6.37	CHEMBL4601	Homo sapiens	Inhibition	%	6.37
	8177780	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	23.14	CHEMBL4601	Homo sapiens	Inhibition	%	23.14
	8178144	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	10.7	CHEMBL4601	Homo sapiens	Inhibition	%	10.7
	8178232	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	5.31	CHEMBL4601	Homo sapiens	Inhibition	%	5.31
	8178456	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	5.52	CHEMBL4601	Homo sapiens	Inhibition	%	5.52
	8178583	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	50.25	CHEMBL4601	Homo sapiens	Inhibition	%	50.25
	8178956	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	3.3	CHEMBL4601	Homo sapiens	Inhibition	%	3.3
	8179079	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	3.17	CHEMBL4601	Homo sapiens	Inhibition	%	3.17
	8179303	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	5.56	CHEMBL4601	Homo sapiens	Inhibition	%	5.56
	8179447	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	1.97	CHEMBL4601	Homo sapiens	Inhibition	%	1.97
	8179808	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	4.08	CHEMBL4601	Homo sapiens	Inhibition	%	4.08
	8180065	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	4.01	CHEMBL4601	Homo sapiens	Inhibition	%	4.01
	8180219	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	52.01	CHEMBL4601	Homo sapiens	Inhibition	%	52.01
	8180599	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	5.62	CHEMBL4601	Homo sapiens	Inhibition	%	5.62
	8180747	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	0.1	CHEMBL4601	Homo sapiens	Inhibition	%	0.1
	8181104	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	95.31	CHEMBL4601	Homo sapiens	Inhibition	%	95.31
	8181235	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	8.22	CHEMBL4601	Homo sapiens	Inhibition	%	8.22
	8181459	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-2.78	CHEMBL4601	Homo sapiens	Inhibition	%	-2.78
	8181599	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	86.28	CHEMBL4601	Homo sapiens	Inhibition	%	86.28
	8181962	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	19.64	CHEMBL4601	Homo sapiens	Inhibition	%	19.64
	8182125	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	7.59	CHEMBL4601	Homo sapiens	Inhibition	%	7.59
	8182489	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	3.39	CHEMBL4601	Homo sapiens	Inhibition	%	3.39
	8182805	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	4.14	CHEMBL4601	Homo sapiens	Inhibition	%	4.14
	8182927	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	4.36	CHEMBL4601	Homo sapiens	Inhibition	%	4.36
	8183151	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	5.54	CHEMBL4601	Homo sapiens	Inhibition	%	5.54
	8183300	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	6.68	CHEMBL4601	Homo sapiens	Inhibition	%	6.68
	8183653	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	-0.58	CHEMBL4601	Homo sapiens	Inhibition	%	-0.58
	8183795	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	4.41	CHEMBL4601	Homo sapiens	Inhibition	%	4.41
	8184155	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	7.54	CHEMBL4601	Homo sapiens	Inhibition	%	7.54
	8184421	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	6.78	CHEMBL4601	Homo sapiens	Inhibition	%	6.78
	8184568	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	1.55	CHEMBL4601	Homo sapiens	Inhibition	%	1.55
	8184792	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	6.36	CHEMBL4601	Homo sapiens	Inhibition	%	6.36
	8184949	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	17.06	CHEMBL4601	Homo sapiens	Inhibition	%	17.06
	8185098	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	2.14	CHEMBL4601	Homo sapiens	Inhibition	%	2.14
	8185322	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	0.12	CHEMBL4601	Homo sapiens	Inhibition	%	0.12
	8185453	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	102.99	CHEMBL4601	Homo sapiens	Inhibition	%	102.99
	8185808	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-1.43	CHEMBL4601	Homo sapiens	Inhibition	%	-1.43
	8185947	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	2.71	CHEMBL4601	Homo sapiens	Inhibition	%	2.71
	8186171	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	6.62	CHEMBL4601	Homo sapiens	Inhibition	%	6.62
	8186312	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	9.68	CHEMBL4601	Homo sapiens	Inhibition	%	9.68
	8186476	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	20.57	CHEMBL4601	Homo sapiens	Inhibition	%	20.57
	8186700	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	6.0	CHEMBL4601	Homo sapiens	Inhibition	%	6.0
	8186839	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	0.92	CHEMBL4601	Homo sapiens	Inhibition	%	0.92
	8187161	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	22.17	CHEMBL4601	Homo sapiens	Inhibition	%	22.17
	8187509	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	7.26	CHEMBL4601	Homo sapiens	Inhibition	%	7.26
	8187657	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	40.66	CHEMBL4601	Homo sapiens	Inhibition	%	40.66
	8188010	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	12.03	CHEMBL4601	Homo sapiens	Inhibition	%	12.03
	8188153	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	2.27	CHEMBL4601	Homo sapiens	Inhibition	%	2.27
	8188377	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	5.96	CHEMBL4601	Homo sapiens	Inhibition	%	5.96
	8188512	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	6.33	CHEMBL4601	Homo sapiens	Inhibition	%	6.33
	8188786	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	7.91	CHEMBL4601	Homo sapiens	Inhibition	%	7.91
	8189158	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	1.02	CHEMBL4601	Homo sapiens	Inhibition	%	1.02
	8189314	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	67.82	CHEMBL4601	Homo sapiens	Inhibition	%	67.82
	8189687	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	3.96	CHEMBL4601	Homo sapiens	Inhibition	%	3.96
	8189819	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	6.2	CHEMBL4601	Homo sapiens	Inhibition	%	6.2
	8190043	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	10.25	CHEMBL4601	Homo sapiens	Inhibition	%	10.25
	8190175	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	5.88	CHEMBL4601	Homo sapiens	Inhibition	%	5.88
	8190539	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	5.89	CHEMBL4601	Homo sapiens	Inhibition	%	5.89
	8190676	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	46.2	CHEMBL4601	Homo sapiens	Inhibition	%	46.2
	8191064	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	5.72	CHEMBL4601	Homo sapiens	Inhibition	%	5.72
	8191202	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	4.92	CHEMBL4601	Homo sapiens	Inhibition	%	4.92
	8191426	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	5.13	CHEMBL4601	Homo sapiens	Inhibition	%	5.13
	8191522	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	72.77	CHEMBL4601	Homo sapiens	Inhibition	%	72.77
	8191868	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	7.21	CHEMBL4601	Homo sapiens	Inhibition	%	7.21
	8192017	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	2.78	CHEMBL4601	Homo sapiens	Inhibition	%	2.78
	8192241	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	3.98	CHEMBL4601	Homo sapiens	Inhibition	%	3.98
	8192370	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	0.56	CHEMBL4601	Homo sapiens	Inhibition	%	0.56
	8192738	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	4.25	CHEMBL4601	Homo sapiens	Inhibition	%	4.25
	8192874	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	26.8	CHEMBL4601	Homo sapiens	Inhibition	%	26.8
	8193146	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	33.25	CHEMBL4601	Homo sapiens	Inhibition	%	33.25
	8193515	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	4.8	CHEMBL4601	Homo sapiens	Inhibition	%	4.8
	8193672	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	3.79	CHEMBL4601	Homo sapiens	Inhibition	%	3.79
	8193896	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	5.69	CHEMBL4601	Homo sapiens	Inhibition	%	5.69
	8194045	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-1.28	CHEMBL4601	Homo sapiens	Inhibition	%	-1.28
	8194400	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	17.54	CHEMBL4601	Homo sapiens	Inhibition	%	17.54
	8194531	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	3.92	CHEMBL4601	Homo sapiens	Inhibition	%	3.92
	8194898	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	36.91	CHEMBL4601	Homo sapiens	Inhibition	%	36.91
	8195031	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	3.29	CHEMBL4601	Homo sapiens	Inhibition	%	3.29
	8195255	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	6.89	CHEMBL4601	Homo sapiens	Inhibition	%	6.89
	8195419	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	4.83	CHEMBL4601	Homo sapiens	Inhibition	%	4.83
	8195782	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	4.49	CHEMBL4601	Homo sapiens	Inhibition	%	4.49
	8195880	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	2.13	CHEMBL4601	Homo sapiens	Inhibition	%	2.13
	8196104	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	3.49	CHEMBL4601	Homo sapiens	Inhibition	%	3.49
	8196221	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	5.48	CHEMBL4601	Homo sapiens	Inhibition	%	5.48
	8196595	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	15.19	CHEMBL4601	Homo sapiens	Inhibition	%	15.19
	8196723	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	4.1	CHEMBL4601	Homo sapiens	Inhibition	%	4.1
	8197088	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	14.53	CHEMBL4601	Homo sapiens	Inhibition	%	14.53
	8197225	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	1.51	CHEMBL4601	Homo sapiens	Inhibition	%	1.51
	8197449	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	2.17	CHEMBL4601	Homo sapiens	Inhibition	%	2.17
	8197500	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	3.05	CHEMBL4601	Homo sapiens	Inhibition	%	3.05
	8197724	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	5.71	CHEMBL4601	Homo sapiens	Inhibition	%	5.71
	8197864	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	0.65	CHEMBL4601	Homo sapiens	Inhibition	%	0.65
	8198245	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	-1.54	CHEMBL4601	Homo sapiens	Inhibition	%	-1.54
	8198383	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-2.02	CHEMBL4601	Homo sapiens	Inhibition	%	-2.02
	8198737	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	65.49	CHEMBL4601	Homo sapiens	Inhibition	%	65.49
	8198868	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	4.84	CHEMBL4601	Homo sapiens	Inhibition	%	4.84
	8199092	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	4.71	CHEMBL4601	Homo sapiens	Inhibition	%	4.71
	8199240	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	4.68	CHEMBL4601	Homo sapiens	Inhibition	%	4.68
	8199598	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	6.04	CHEMBL4601	Homo sapiens	Inhibition	%	6.04
	8199761	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	6.88	CHEMBL4601	Homo sapiens	Inhibition	%	6.88
	8200123	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	5.07	CHEMBL4601	Homo sapiens	Inhibition	%	5.07
	8200451	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	7.5	CHEMBL4601	Homo sapiens	Inhibition	%	7.5
	8200566	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	5.84	CHEMBL4601	Homo sapiens	Inhibition	%	5.84
	8200940	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	63.35	CHEMBL4601	Homo sapiens	Inhibition	%	63.35
	8201070	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	2.12	CHEMBL4601	Homo sapiens	Inhibition	%	2.12
	8201294	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	7.01	CHEMBL4601	Homo sapiens	Inhibition	%	7.01
	8201429	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	2.61	CHEMBL4601	Homo sapiens	Inhibition	%	2.61
	8201786	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	24.68	CHEMBL4601	Homo sapiens	Inhibition	%	24.68
	8202065	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	4.08	CHEMBL4601	Homo sapiens	Inhibition	%	4.08
	8202205	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	7.77	CHEMBL4601	Homo sapiens	Inhibition	%	7.77
	8202596	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	4.07	CHEMBL4601	Homo sapiens	Inhibition	%	4.07
	8202721	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	5.01	CHEMBL4601	Homo sapiens	Inhibition	%	5.01
	8202945	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	7.81	CHEMBL4601	Homo sapiens	Inhibition	%	7.81
	8203075	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	5.31	CHEMBL4601	Homo sapiens	Inhibition	%	5.31
	8203430	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	13.78	CHEMBL4601	Homo sapiens	Inhibition	%	13.78
	8203576	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	6.35	CHEMBL4601	Homo sapiens	Inhibition	%	6.35
	8203934	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	7.36	CHEMBL4601	Homo sapiens	Inhibition	%	7.36
	8204100	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	18.08	CHEMBL4601	Homo sapiens	Inhibition	%	18.08
	8204324	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	67.5	CHEMBL4601	Homo sapiens	Inhibition	%	67.5
	8204461	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	52.53	CHEMBL4601	Homo sapiens	Inhibition	%	52.53
	8204790	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	40.24	CHEMBL4601	Homo sapiens	Inhibition	%	40.24
	8204905	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	5.52	CHEMBL4601	Homo sapiens	Inhibition	%	5.52
	8205129	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	30.33	CHEMBL4601	Homo sapiens	Inhibition	%	30.33
	8205278	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	6.35	CHEMBL4601	Homo sapiens	Inhibition	%	6.35
	8205638	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	0.8	CHEMBL4601	Homo sapiens	Inhibition	%	0.8
	8205777	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	5.54	CHEMBL4601	Homo sapiens	Inhibition	%	5.54
	8206133	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	81.22	CHEMBL4601	Homo sapiens	Inhibition	%	81.22
	8206409	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	5.42	CHEMBL4601	Homo sapiens	Inhibition	%	5.42
	8206552	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-1.42	CHEMBL4601	Homo sapiens	Inhibition	%	-1.42
	8206776	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	0.1	CHEMBL4601	Homo sapiens	Inhibition	%	0.1
	8206956	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	0.2	CHEMBL4601	Homo sapiens	Inhibition	%	0.2
	8207306	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	5.86	CHEMBL4601	Homo sapiens	Inhibition	%	5.86
	8207436	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	7.17	CHEMBL4601	Homo sapiens	Inhibition	%	7.17
	8207792	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	51.17	CHEMBL4601	Homo sapiens	Inhibition	%	51.17
	8207937	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	2.34	CHEMBL4601	Homo sapiens	Inhibition	%	2.34
	8208161	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	3.25	CHEMBL4601	Homo sapiens	Inhibition	%	3.25
	8208293	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	6.49	CHEMBL4601	Homo sapiens	Inhibition	%	6.49
	8208683	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	3.76	CHEMBL4601	Homo sapiens	Inhibition	%	3.76
	8208816	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	96.88	CHEMBL4601	Homo sapiens	Inhibition	%	96.88
	8209145	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	1.06	CHEMBL4601	Homo sapiens	Inhibition	%	1.06
	8209485	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	2.76	CHEMBL4601	Homo sapiens	Inhibition	%	2.76
	8209635	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	7.89	CHEMBL4601	Homo sapiens	Inhibition	%	7.89
	8209995	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	2.85	CHEMBL4601	Homo sapiens	Inhibition	%	2.85
	8210136	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	4.58	CHEMBL4601	Homo sapiens	Inhibition	%	4.58
	8210360	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	5.79	CHEMBL4601	Homo sapiens	Inhibition	%	5.79
	8210496	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-3.07	CHEMBL4601	Homo sapiens	Inhibition	%	-3.07
	8210755	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	2.2	CHEMBL4601	Homo sapiens	Inhibition	%	2.2
	8211123	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	2.66	CHEMBL4601	Homo sapiens	Inhibition	%	2.66
	8211293	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	3.36	CHEMBL4601	Homo sapiens	Inhibition	%	3.36
	8211640	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	10.62	CHEMBL4601	Homo sapiens	Inhibition	%	10.62
	8211769	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	3.18	CHEMBL4601	Homo sapiens	Inhibition	%	3.18
	8211993	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	11.05	CHEMBL4601	Homo sapiens	Inhibition	%	11.05
	8212125	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	4.43	CHEMBL4601	Homo sapiens	Inhibition	%	4.43
	8212490	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	3.22	CHEMBL4601	Homo sapiens	Inhibition	%	3.22
	8212623	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	7.25	CHEMBL4601	Homo sapiens	Inhibition	%	7.25
	8212847	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	6.64	CHEMBL4601	Homo sapiens	Inhibition	%	6.64
	8213017	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	6.55	CHEMBL4601	Homo sapiens	Inhibition	%	6.55
	8213146	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	5.31	CHEMBL4601	Homo sapiens	Inhibition	%	5.31
	8213370	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	3.69	CHEMBL4601	Homo sapiens	Inhibition	%	3.69
	8213474	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	10.8	CHEMBL4601	Homo sapiens	Inhibition	%	10.8
	8213811	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	7.02	CHEMBL4601	Homo sapiens	Inhibition	%	7.02
	8213958	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	0.27	CHEMBL4601	Homo sapiens	Inhibition	%	0.27
	8214182	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	1.67	CHEMBL4601	Homo sapiens	Inhibition	%	1.67
	8214319	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	-0.56	CHEMBL4601	Homo sapiens	Inhibition	%	-0.56
	8214677	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	48.87	CHEMBL4601	Homo sapiens	Inhibition	%	48.87
	8214829	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	0.94	CHEMBL4601	Homo sapiens	Inhibition	%	0.94
	8215080	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	6.8	CHEMBL4601	Homo sapiens	Inhibition	%	6.8
	8215304	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	4.81	CHEMBL4601	Homo sapiens	Inhibition	%	4.81
	8215457	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	4.35	CHEMBL4601	Homo sapiens	Inhibition	%	4.35
	8215621	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	3.43	CHEMBL4601	Homo sapiens	Inhibition	%	3.43
	8215845	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	4.9	CHEMBL4601	Homo sapiens	Inhibition	%	4.9
	8215964	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	4.82	CHEMBL4601	Homo sapiens	Inhibition	%	4.82
	8216307	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	3.76	CHEMBL4601	Homo sapiens	Inhibition	%	3.76
	8216443	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	4.64	CHEMBL4601	Homo sapiens	Inhibition	%	4.64
	8216667	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	5.0	CHEMBL4601	Homo sapiens	Inhibition	%	5.0
	8216805	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	2.76	CHEMBL4601	Homo sapiens	Inhibition	%	2.76
	8217163	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	7.36	CHEMBL4601	Homo sapiens	Inhibition	%	7.36
	8217337	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	-5.64	CHEMBL4601	Homo sapiens	Inhibition	%	-5.64
	8217692	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	4.42	CHEMBL4601	Homo sapiens	Inhibition	%	4.42
	8217793	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	0.06	CHEMBL4601	Homo sapiens	Inhibition	%	0.06
	8218017	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-1.29	CHEMBL4601	Homo sapiens	Inhibition	%	-1.29
	8218132	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	4.89	CHEMBL4601	Homo sapiens	Inhibition	%	4.89
	8218483	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	9.98	CHEMBL4601	Homo sapiens	Inhibition	%	9.98
	8218626	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	3.6	CHEMBL4601	Homo sapiens	Inhibition	%	3.6
	8218850	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	3.11	CHEMBL4601	Homo sapiens	Inhibition	%	3.11
	8218981	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	91.54	CHEMBL4601	Homo sapiens	Inhibition	%	91.54
	8219141	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	-5.63	CHEMBL4601	Homo sapiens	Inhibition	%	-5.63
	8219365	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	-2.62	CHEMBL4601	Homo sapiens	Inhibition	%	-2.62
	8219615	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	10.83	CHEMBL4601	Homo sapiens	Inhibition	%	10.83
	8219776	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	3.81	CHEMBL4601	Homo sapiens	Inhibition	%	3.81
	8220169	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	4.04	CHEMBL4601	Homo sapiens	Inhibition	%	4.04
	8220298	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	7.68	CHEMBL4601	Homo sapiens	Inhibition	%	7.68
	8220636	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	5.16	CHEMBL4601	Homo sapiens	Inhibition	%	5.16
	8220998	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	4.05	CHEMBL4601	Homo sapiens	Inhibition	%	4.05
	8221134	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	2.92	CHEMBL4601	Homo sapiens	Inhibition	%	2.92
	8221491	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	4.63	CHEMBL4601	Homo sapiens	Inhibition	%	4.63
	8221656	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	-0.31	CHEMBL4601	Homo sapiens	Inhibition	%	-0.31
	8222011	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	9.89	CHEMBL4601	Homo sapiens	Inhibition	%	9.89
	8222333	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	4.59	CHEMBL4601	Homo sapiens	Inhibition	%	4.59
	8222467	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	12.45	CHEMBL4601	Homo sapiens	Inhibition	%	12.45
	8222809	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	53.38	CHEMBL4601	Homo sapiens	Inhibition	%	53.38
	8223177	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	25.42	CHEMBL4601	Homo sapiens	Inhibition	%	25.42
	8223306	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	3.52	CHEMBL4601	Homo sapiens	Inhibition	%	3.52
	8223691	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	-1.66	CHEMBL4601	Homo sapiens	Inhibition	%	-1.66
	8223941	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	29.02	CHEMBL4601	Homo sapiens	Inhibition	%	29.02
	8224103	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	11.83	CHEMBL4601	Homo sapiens	Inhibition	%	11.83
	8224327	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	4.19	CHEMBL4601	Homo sapiens	Inhibition	%	4.19
	8224497	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	5.46	CHEMBL4601	Homo sapiens	Inhibition	%	5.46
	8224632	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	4.94	CHEMBL4601	Homo sapiens	Inhibition	%	4.94
	8224856	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	3.25	CHEMBL4601	Homo sapiens	Inhibition	%	3.25
	8224970	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	5.88	CHEMBL4601	Homo sapiens	Inhibition	%	5.88
	8225328	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	4.78	CHEMBL4601	Homo sapiens	Inhibition	%	4.78
	8225466	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	2.66	CHEMBL4601	Homo sapiens	Inhibition	%	2.66
	8225690	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	0.9	CHEMBL4601	Homo sapiens	Inhibition	%	0.9
	8225825	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	8.17	CHEMBL4601	Homo sapiens	Inhibition	%	8.17
	8225983	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.44	CHEMBL4601	Homo sapiens	Inhibition	%	1.44
	8226207	CHEMBL1962251	GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	4.41	CHEMBL4601	Homo sapiens	Inhibition	%	4.41
	8226332	CHEMBL1962250	GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	4.52	CHEMBL4601	Homo sapiens	Inhibition	%	4.52
inactive	9611766	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1cccc(-c2[nH]c(-c3ccnc(N)n3)cc2C(N)=O)c1C		CHEMBL1964290	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611767	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1n[nH]c2ccc(-c3cncc(OCCN)c3)cc12		CHEMBL1967887	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611768	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Nc1ncnc2onc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL213505	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611769	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL2000568	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611770	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)cc1C		CHEMBL2000335	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
active	9611771	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1		CHEMBL1974328	=	Ki	nM	1995.26	CHEMBL4601	Homo sapiens	pKi		5.7
active	9611772	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cn1cc(-c2cnn3c(N)c(-c4ccc(NC(=O)Nc5cccc(C(F)(F)F)c5)cc4)cnc23)cn1		CHEMBL1988717	=	Ki	nM	316.23	CHEMBL4601	Homo sapiens	pKi		6.5
active	9611773	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Ki	nM	12.59	CHEMBL4601	Homo sapiens	pKi		7.9
active	9611774	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	N#CCOc1ccc(Nc2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2Br)cc1		CHEMBL1987034	=	Ki	nM	199.53	CHEMBL4601	Homo sapiens	pKi		6.7
inactive	9611775	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
active	9611776	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4cccc(Cl)c4)cc[nH]c3=O)nc12		CHEMBL2005886	=	Ki	nM	1584.89	CHEMBL4601	Homo sapiens	pKi		5.8
inactive	9611777	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C(Nc1ccc2[nH]ncc2c1)c1ccc(Cl)cc1		CHEMBL1973808	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611778	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL481491	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611779	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CC(=O)Nc1c(C(N)=O)sc2ccc(Cl)c(Cl)c12		CHEMBL1973142	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611780	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1ccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)cc1		CHEMBL1972576	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611781	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611782	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4nc(N)nc(N)c34)cc2)c1		CHEMBL1973145	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
active	9611783	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1cccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982924	=	Ki	nM	1995.26	CHEMBL4601	Homo sapiens	pKi		5.7
inactive	9611784	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1992342	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611785	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CCCC(=O)Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL2005936	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611786	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	NC1CCC(Nc2nccc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1966628	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611787	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc(C(N)=O)c3)cc2)c1		CHEMBL1971141	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611788	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	NC1CCCCC1Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL1995813	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611789	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=c1[nH][nH]c2cccc(-c3ccccc3)c12		CHEMBL1989834	<	Ki	nM	25118.86	CHEMBL4601	Homo sapiens	pKi		4.6
active	9611790	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3cn[nH]c3c2)n1		CHEMBL244378	=	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611791	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CC(C)Cn1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL1965423	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611792	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1969372	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611793	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1983945	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611794	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C1NC(=S)SC1=C1C(=O)Nc2ccc(Br)cc21		CHEMBL2001920	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611795	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	c1ccc(Nc2ncnc3ccccc23)cc1		CHEMBL289959	<	Ki	nM	25118.86	CHEMBL4601	Homo sapiens	pKi		4.6
inactive	9611796	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1cc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3C(N)=O)n2)cc(OC)c1OC		CHEMBL1241473	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
active	9611797	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CS(=O)(=O)N(Cc1ccc2[nH]c(=O)c3cccn3c2c1)C1CC1		CHEMBL1978448	=	Ki	nM	1995.26	CHEMBL4601	Homo sapiens	pKi		5.7
inactive	9611798	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	OC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1993584	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611799	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CCn1c(C)c(-c2ccnc(Nc3cccc(OC)c3)n2)sc1=O		CHEMBL1986263	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611800	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CSc1c[nH]c2ncnc(NCCCO)c12		CHEMBL2000114	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611801	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CCN(CC)CC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2001257	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611802	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cccc12		CHEMBL1975647	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611803	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1ccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)cc1		CHEMBL1992536	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611804	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1968380	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611805	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C(NCc1ccccc1)Nc1ncc([N+](=O)[O-])s1		CHEMBL1964644	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611806	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C(NCc1ccc(Cl)c(Cl)c1)Nc1ccc2[nH]ncc2c1		CHEMBL1981782	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611807	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CCN1CCN(CCCC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1		CHEMBL1992740	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611808	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CNC(=O)c1cc2c(-c3ccccc3F)n[nH]c2s1		CHEMBL1977681	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611809	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	OCCNc1cc2cc(-c3cccnc3)ccc2cn1		CHEMBL1990912	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611810	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	OCCCn1cnc(-c2ccccc2)c1-c1ccncc1		CHEMBL2002373	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611811	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1cccc(Cl)c1		CHEMBL1973348	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611812	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611813	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2NCCCN)c1		CHEMBL2006188	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611814	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1967531	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611815	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CCCC(=O)Nc1nn(C(=O)CC)c2nc3ccccc3cc12		CHEMBL1970913	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611816	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(C)=O)c3c2)cc1		CHEMBL1973893	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
active	9611817	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Ki	nM	5.012	CHEMBL4601	Homo sapiens	pKi		8.3
inactive	9611818	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	NC(=O)Cn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL1985095	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611819	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611820	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C1CCCc2oc3cc(C(F)(F)F)ccc3c(=O)c21		CHEMBL2006493	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
active	9611821	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	=	Ki	nM	316.23	CHEMBL4601	Homo sapiens	pKi		6.5
inactive	9611822	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1C		CHEMBL1983449	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611823	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=c1[nH]cnc2c1oc1ccc(Cl)cc12		CHEMBL1992323	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
active	9611824	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CCc1c(-c2ccc(C(C)(C)O)cc2)[nH]c2nccnc12		CHEMBL1976420	=	Ki	nM	316.23	CHEMBL4601	Homo sapiens	pKi		6.5
inactive	9611825	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1		CHEMBL1994864	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611826	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	c1ccc2c(c1)Cc1c[nH]nc1-2		CHEMBL1989423	<	Ki	nM	25118.86	CHEMBL4601	Homo sapiens	pKi		4.6
inactive	9611827	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=c1nc(-c2cc3c(Oc4ccc(I)cc4)cncc3s2)[nH]o1		CHEMBL497151	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611828	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Brc1ccc2c(c1)-c1[nH]ncc1C2		CHEMBL1995172	<	Ki	nM	12589.25	CHEMBL4601	Homo sapiens	pKi		4.9
inactive	9611829	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1cc(O)ccc1-n1cc(C(N)=O)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL340921	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611830	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C1NCCc2[nH]c(-c3ccnc(C=Cc4ccccc4)c3)cc21		CHEMBL1997129	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611831	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	N#Cc1ccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)nc1		CHEMBL1999718	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611832	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C1Nc2ccccc2Nc2nnc(I)cc21		CHEMBL1977346	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611833	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL1971649	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611834	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Fc1ccc(-c2nc3sccn3c2-c2ccncc2)cc1		CHEMBL2000508	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611835	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CCCCNc1n[s+]([O-])nc1Nc1ccc(F)cc1		CHEMBL1971694	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611836	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CCc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2001547	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611837	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611838	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1cc(NC(=O)CCNC(=O)Nc2nc(C)c(-c3ccc(-n4cccn4)cc3)s2)no1		CHEMBL1986603	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611839	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611840	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1ccc(-c2ccc(NC(=O)Nc3cc(F)cc(F)c3)cc2)c2c(N)noc12		CHEMBL1969190	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
active	9611841	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Ki	nM	630.96	CHEMBL4601	Homo sapiens	pKi		6.2
inactive	9611842	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)n[nH]c12		CHEMBL1973937	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611843	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1cc(C=C2SC(=O)NC2=O)ccc1O		CHEMBL2003286	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
active	9611844	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccn1		CHEMBL1992306	=	Ki	nM	501.19	CHEMBL4601	Homo sapiens	pKi		6.3
inactive	9611845	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611846	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1n[nH]c2c1C(c1ccccc1I)C(C#N)=C(N)O2		CHEMBL1979318	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611847	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	NCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1989518	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
active	9611848	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1998585	=	Ki	nM	1000.0	CHEMBL4601	Homo sapiens	pKi		6.0
inactive	9611849	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2C		CHEMBL519697	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611850	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1cc(C=C(C#N)c2nc3ccccc3[nH]2)c(Br)cc1O		CHEMBL1994241	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611851	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CCN(CC)CC#Cc1ccc2c(c1)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL2007044	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611852	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C(O)c1cc(-c2cccs2)n2nccc2n1		CHEMBL1977619	<	Ki	nM	25118.86	CHEMBL4601	Homo sapiens	pKi		4.6
inactive	9611853	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
active	9611854	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1ccc(Cl)cc1		CHEMBL1998829	=	Ki	nM	1258.93	CHEMBL4601	Homo sapiens	pKi		5.9
inactive	9611855	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
active	9611856	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Ki	nM	39.81	CHEMBL4601	Homo sapiens	pKi		7.4
active	9611857	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CCN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccc(C(=O)Nc6ccccc6F)c5)nc5ccccn45)n3)cc2)CC1		CHEMBL1981725	=	Ki	nM	12.59	CHEMBL4601	Homo sapiens	pKi		7.9
inactive	9611858	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1cc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL1984363	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611859	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CC(=O)Nc1cccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)c1		CHEMBL1988608	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611860	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1ccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)cc1C		CHEMBL184847	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611861	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COCCn1cc(-c2ccncn2)c(-c2ccc(Cl)cc2)n1		CHEMBL1982866	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611862	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CN(C)c1ccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)cc1		CHEMBL1984367	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611863	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Nc1c(-c2ccccc2)c2cc(Cl)ccc2[nH]c1=O		CHEMBL462120	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611864	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccccc4)nn12)CCCC3		CHEMBL2007592	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
active	9611865	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4ccccc4F)cc3)c12		CHEMBL1965570	=	Ki	nM	501.19	CHEMBL4601	Homo sapiens	pKi		6.3
inactive	9611866	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C1CCCN1Cc1ccc2c(c1)[nH]c(=O)c1cccn12		CHEMBL539474	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611867	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	NC(COc1cncc(-c2ccc3[nH]c(=O)oc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1987679	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611868	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611869	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1cncc2cccc(S(=O)(=O)N3CCCNCC3C)c12		CHEMBL1082440	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611870	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3F)c2-c2ccncn2)CC1		CHEMBL1614705	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611871	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611872	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)s2)c1		CHEMBL1984633	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611873	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	1995.26	CHEMBL4601	Homo sapiens	pKi		5.7
inactive	9611874	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COCCN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1986970	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611875	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=c1cc(-c2ccncc2)nc(NC2CCCCC2)[nH]1		CHEMBL1958401	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611876	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	NC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL1990482	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611877	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Fc1ccc(-c2nc3cnccn3c2-c2ccnc(NCC3CC3)n2)cc1		CHEMBL1990904	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611878	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C(NCC1CCCCC1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL2005475	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611879	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)cccc12		CHEMBL1966816	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
active	9611880	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	=	Ki	nM	12.59	CHEMBL4601	Homo sapiens	pKi		7.9
inactive	9611881	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611882	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2C)c1		CHEMBL183844	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611883	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	N#Cc1cnc(NC(=O)Nc2ccc3cc(C(=O)O)ccc3c2)cn1		CHEMBL560813	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611884	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL220057	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611885	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	c1ccc(Nc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682545	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611886	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1974935	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611887	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1cc(OC2CCCC2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL2001224	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
active	9611888	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CC(CN2CCCC2)C1		CHEMBL1968791	=	Ki	nM	630.96	CHEMBL4601	Homo sapiens	pKi		6.2
inactive	9611889	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611890	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	c1ccc(COc2ccc(Nc3ncnc4ccccc34)cc2)cc1		CHEMBL1980163	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611891	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Fc1ccc(-c2nc3occn3c2-c2ccnc(NC3CCNCC3)n2)cc1		CHEMBL1971186	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611892	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C(Cc1ccc(Cl)cc1)Nc1[nH]nc2c1CCC2		CHEMBL2003482	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611893	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CC(=O)Nc1cc2ccccn2n1		CHEMBL1976872	<	Ki	nM	25118.86	CHEMBL4601	Homo sapiens	pKi		4.6
active	9611894	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Nc1nccc2cnc(-c3ccccc3)n12		CHEMBL1969156	=	Ki	nM	5011.87	CHEMBL4601	Homo sapiens	pKi		5.3
inactive	9611895	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCCC5)cnc(N)c34)cc2)c1		CHEMBL1973211	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611896	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CC(=O)N(c1ccncc1)c1c(NC(C)C(C)(C)C)c(=O)c1=O		CHEMBL2005899	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611897	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)c(NC3CCCCC3)n2c1		CHEMBL1682552	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611898	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611899	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1		CHEMBL1972125	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611900	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(Cl)c4)c3)cc12		CHEMBL1974870	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611901	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1cc(C)c(C=C2C(=O)Nc3ccccc32)[nH]1		CHEMBL2002702	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611902	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C(Nc1ccc2[nH]ncc2c1)c1cccc(F)c1		CHEMBL1461728	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611903	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611904	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	c1cc2cc(-c3ccc4cn[nH]c4c3)cnc2[nH]1		CHEMBL1976134	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611905	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1ccc(C(=O)Nc2c(C(N)=O)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL1965131	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611906	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL1970903	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611907	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1cccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)c1		CHEMBL1969523	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611908	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611909	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CC(=O)N1CCC(Nc2nccc(-c3c(-c4ccc(F)cc4)nc4occn34)n2)CC1		CHEMBL1986781	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611910	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611911	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	NCC(O)C(O)Cn1cc(I)c2c(N)ncnc21		CHEMBL1975534	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611912	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COCCOCC#Cc1cc(-c2n[nH]c3c2C(=O)c2cc(CN4CCN(C)CC4)ccc2-3)cs1		CHEMBL387971	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611913	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1cccc(NC(=O)Nc2ccc(-c3noc4ncnc(N)c34)cc2)c1		CHEMBL211378	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611914	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CN(C)c1cc2sncc2cc1NC(=O)C(=O)O		CHEMBL1997023	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611915	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccco2)C(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL2001751	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611916	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1cc(C)cc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1964687	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611917	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1ccccc1NC(=O)Nc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL1984586	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611918	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1c(O)ccc2c1CCCC2=NNC(=O)Cc1cccc2ccccc12		CHEMBL1972659	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611919	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1ccc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)cc1Cl		CHEMBL272453	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611920	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Nc1nnc2ccc(-c3ccccc3)cn12		CHEMBL1987143	<	Ki	nM	25118.86	CHEMBL4601	Homo sapiens	pKi		4.6
inactive	9611921	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1ccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)cc1		CHEMBL2005828	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611922	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(C)c2)c1		CHEMBL1969049	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611923	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CCOC(=O)c1ccc2[nH]c3c(c2c1)CCNC3=O		CHEMBL2005528	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611924	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)c1		CHEMBL185569	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611925	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	c1cc2[nH]ncc2cc1-c1cn(CC2CCOCC2)nn1		CHEMBL1969843	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
active	9611926	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	=	Ki	nM	630.96	CHEMBL4601	Homo sapiens	pKi		6.2
inactive	9611927	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1cc(-c2ccc3[nH]nc(C(=O)Nc4ccccc4)c3c2)ccc1O		CHEMBL2007002	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611928	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CN1CCC(NC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)CC1		CHEMBL1987007	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611929	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
active	9611930	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Clc1cc(-c2c[nH]c3ncccc23)cc(NCc2ccccc2)n1		CHEMBL1969588	=	Ki	nM	630.96	CHEMBL4601	Homo sapiens	pKi		6.2
inactive	9611931	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1cc(C=C2SC(=S)NC2=O)ccc1O		CHEMBL1973098	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9611932	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(=O)CC)c3c2)cc1		CHEMBL1972221	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615497	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CCCCn1c(NC(=O)c2ccc(C#N)cc2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL484390	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615498	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=c1c(NCc2cccc(C(F)(F)F)c2)c(Nc2ccncc2)c1=O		CHEMBL1979252	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615499	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
active	9615500	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1c(F)cccc1F		CHEMBL1996979	=	Ki	nM	79.43	CHEMBL4601	Homo sapiens	pKi		7.1
inactive	9615501	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CCc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1968406	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615502	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1cccc(C=C2SC(=Nc3ccccc3)NC2=O)c1		CHEMBL1972937	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615503	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccc(F)cc3)cc12		CHEMBL1986499	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615504	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1C1CCOc2c(F)cccc21		CHEMBL2000393	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615505	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Brc1cnc2[nH]cc(-c3ccccc3)c2c1		CHEMBL1992634	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615506	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1242373	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615507	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1998545	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
active	9615508	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Fc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL316264	=	Ki	nM	1995.26	CHEMBL4601	Homo sapiens	pKi		5.7
inactive	9615509	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1ccc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1988075	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615510	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Nc1ncnc(Nc2cc(CNC(=O)C(F)(F)F)c(O)c(-c3ccc(Cl)cc3)c2)n1		CHEMBL2001239	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615511	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615512	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Nc1ncnc2scc(C(=O)Nc3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1988594	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615513	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Nc1ncnc2c1c(I)nn2C1OC(CO)C(O)C1O		CHEMBL2001288	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
active	9615514	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	Ki	nM	316.23	CHEMBL4601	Homo sapiens	pKi		6.5
inactive	9615515	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C(NN=Cc1ccc(O)cc1O)Nc1cccc2nsnc12		CHEMBL1999811	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615516	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CSc1ccc2nc3c(c(Cl)c2c1)CCNC3=O		CHEMBL1985074	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615517	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	NCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL2000481	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615518	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Nc1nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc2n1CC1CC1		CHEMBL1982874	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615519	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CN(C)CC(=O)NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1991725	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615520	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615521	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3[nH]ncc3c2)n1		CHEMBL396523	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615522	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1cc(C)cc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1970203	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615523	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C(c1cc(Cc2n[nH]c(=O)c3c2CCCC3)ccc1F)N1CCN(c2ncccn2)CC1		CHEMBL1986530	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615524	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	c1cnc2[nH]cc(-c3ccnc(NC4CCCCC4)n3)c2c1		CHEMBL385478	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615525	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCCC4)cc3OC)nc2N1C1CCCC1		CHEMBL2005375	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615526	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Clc1ccc(-c2n[nH]cc2-c2ccncn2)cc1Cl		CHEMBL1984191	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615527	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Oc1cccc(Nc2ncnc3scc(Cl)c23)c1		CHEMBL1982992	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
active	9615528	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(N3CCN(C(C)=O)CC3)ccc2OC)ncc1Br		CHEMBL1971029	=	Ki	nM	398.11	CHEMBL4601	Homo sapiens	pKi		6.4
inactive	9615529	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1F		CHEMBL1981079	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615530	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CCN(CC)CCCNc1cccc(-c2nc3c(C(N)=O)cccc3[nH]2)n1		CHEMBL1972276	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615531	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCc4cccc(F)c4)cc2NC3=O)ccc1O		CHEMBL2000832	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615532	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=c1c(NCc2ccc(Cl)cc2)c(Nc2ccncc2)c1=O		CHEMBL1980489	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615533	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL394790	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615534	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615535	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1nc2c(sc3c(Br)ccc(Cl)c32)c(=O)o1		CHEMBL1974702	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
active	9615536	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1ccc(-c2cc3nccn3c(Nc3ccccc3C(N)=O)n2)cc1OC		CHEMBL1998112	=	Ki	nM	31.62	CHEMBL4601	Homo sapiens	pKi		7.5
inactive	9615537	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1996111	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615538	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CC(C)n1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)cc21		CHEMBL1969126	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615539	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1nccn2c(-c3ccnc(NCC4(O)CC4)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1965589	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615540	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Nc1ncnc2sc(Br)c(-c3ccc(NC(=O)Cc4cccc(Cl)c4)cc3)c12		CHEMBL1980896	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615541	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615542	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	NC(=O)c1cc2c(Oc3cccc(F)c3)cncc2s1		CHEMBL1964777	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615543	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)O)s3)c2cc1OC		CHEMBL474432	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615544	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1ccc2c(c1)NC(=O)c1ccccc1N2		CHEMBL1999714	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615545	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)C(=O)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1971149	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615546	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C(Cc1ccccc1Cl)Nc1ccc2cn[nH]c2c1		CHEMBL1987533	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615547	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CC(C)(O)CNc1nccc(-c2c(-c3ccc(F)cc3F)nc3c(CC4CC4)nccn23)n1		CHEMBL1994040	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615548	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	c1cc2c(s1)CCc1cn[nH]c1-2		CHEMBL2001539	<	Ki	nM	25118.86	CHEMBL4601	Homo sapiens	pKi		4.6
inactive	9615549	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	NC(COc1cncc(-c2ccc3c(c2)CC(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL1967302	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
active	9615550	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	=	Ki	nM	12.59	CHEMBL4601	Homo sapiens	pKi		7.9
inactive	9615551	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615552	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCCCN4CCOCC4)cc2-3)cn1		CHEMBL398951	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615553	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1cc2cnc3c(c2cc1OC)C(=O)NC3=O		CHEMBL1982506	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615554	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1		CHEMBL1968127	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615555	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1cc(C)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1975233	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615556	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL1985406	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615557	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cn1nc(C(F)(F)F)c2c(=O)c3cc(Cl)ccc3n(O)c21		CHEMBL207400	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615558	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	NCCC(C(=O)Nc1ccc2[nH]ncc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL1998121	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615559	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1ccccc1NC(=O)Nc1ccc2c(c1)CCc1sc3ncnc(N)c3c1-2		CHEMBL1982135	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615560	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CC4CC4)nccn23)n1		CHEMBL1991800	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615561	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Nc1ncnc2c1sc1ncnc(N)c12		CHEMBL1976090	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
active	9615562	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4c(c3)OCO4)csc12		CHEMBL1993243	=	Ki	nM	125.89	CHEMBL4601	Homo sapiens	pKi		6.9
inactive	9615563	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1nn(-c2ccccc2)c2c1c(=O)c1cc(Cl)ccc1n2O		CHEMBL379835	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615564	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1997597	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615565	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	S=c1[nH]nc2c3c4c(sc3n3c(=S)[nH]nc3n12)CCC4		CHEMBL1969537	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615566	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1976093	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615567	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cn1cc(C(CN)c2cncc(C=Cc3ccncc3)c2)c2ccccc21		CHEMBL1979357	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615568	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CCCCOc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1996817	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615569	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1cccs1		CHEMBL1975256	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
active	9615570	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cnn(C)c5)cnn4c3N)cc2)c1		CHEMBL508928	=	Ki	nM	501.19	CHEMBL4601	Homo sapiens	pKi		6.3
inactive	9615571	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1cccc(-c2cc3c(=O)[nH]c4ccccc4n3c2)c1		CHEMBL1991356	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615572	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615573	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL2004892	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615574	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL468280	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615575	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	NC(=O)c1cc2c(Oc3ccc(Br)cc3)cncc2s1		CHEMBL116070	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615576	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1cc(C)c2oc(Nc3ccc(-c4cccc(C(N)=O)c4N)cc3F)nc2c1		CHEMBL1990884	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615577	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615578	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL256835	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615579	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	NC(=O)c1cc(-c2cccc(N)c2)cc2cccnc12		CHEMBL1970314	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615580	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	OCCCn1cnc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL2004871	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615581	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncn3)cc2)c1		CHEMBL2004872	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615582	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C1Nc2ccccc2Nc2ccccc21		CHEMBL1727312	<	Ki	nM	12589.25	CHEMBL4601	Homo sapiens	pKi		4.9
inactive	9615583	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1980142	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615584	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL41783	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615585	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1cccc2c1Nc1cc(Nc3ccncc3)ccc1C(=O)N2		CHEMBL2006276	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615586	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)noc12		CHEMBL271381	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615587	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1		CHEMBL262433	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615588	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1ccc(C(=O)Nc2c(C#N)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL2006785	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
active	9615589	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Ki	nM	7.943	CHEMBL4601	Homo sapiens	pKi		8.1
inactive	9615590	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1nn(C)c2sc(C(N)=O)cc12		CHEMBL1986588	<	Ki	nM	25118.86	CHEMBL4601	Homo sapiens	pKi		4.6
inactive	9615591	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C(NNC(=S)Nc1ccc(Cl)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1966722	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615592	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCNC(C)=O)cc2NC3=O)ccc1O		CHEMBL1975500	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615593	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1		CHEMBL394619	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615594	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C(O)c1c2c(nc3ccccc13)C(=C1CCCC1)CC2		CHEMBL1996831	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615595	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc1)CCN2		CHEMBL411903	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615596	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615597	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Oc1ccc(Nc2[nH]nc(-c3ccc(O)cc3)c2-c2ccc(O)cc2)cc1		CHEMBL1969042	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615598	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL1989646	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615599	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1cc(C=C(C#N)c2nc3cc(C)ccc3[nH]2)c(Br)cc1O		CHEMBL2000345	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615600	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615601	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1nccn2c(-c3ccnc(NCCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1978200	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615602	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1cc(C=C2SC(=Nc3ccccc3)NC2=O)ccc1O		CHEMBL1970522	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615603	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	C(=Cc1cncc(OC2CCNC2)c1)c1ccncc1		CHEMBL1966087	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615604	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1375418	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615605	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL2007064	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
active	9615606	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cncc21		CHEMBL1964692	=	Ki	nM	794.33	CHEMBL4601	Homo sapiens	pKi		6.1
inactive	9615607	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C(NC(CO)Cc1ccc(Cl)cc1)c1ccc(-c2ccncc2)cc1		CHEMBL1996931	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615608	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	FC(F)(F)c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C(F)(F)F)c1		CHEMBL1964413	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
active	9615609	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL1981047	=	Ki	nM	398.11	CHEMBL4601	Homo sapiens	pKi		6.4
inactive	9615610	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccc(Cl)c(Cl)c4)c3)cc12		CHEMBL1991063	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615611	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL1973483	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615612	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCC(O)C1		CHEMBL1997340	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615613	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1cccc(Nc2ncnc3ccccc23)c1		CHEMBL117697	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615614	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615615	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1ccc(-c2ccc(NC(=O)Nc3ccc(F)c(C)c3)cc2)c2c(N)noc12		CHEMBL1979093	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615616	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=c1[nH]c2sccc2c2nc(-c3ccncc3)nn12		CHEMBL1968151	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615617	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cn1cc(-c2ccncn2)c(-c2ccc(F)cc2)n1		CHEMBL1989474	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615618	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccccc4)c3)cc12		CHEMBL2002726	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615619	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C(Nc1cnccn1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL2003817	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615620	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C(Nc1nc2ccccc2n1CCCO)c1cccc([N+](=O)[O-])c1		CHEMBL210887	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
active	9615621	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	=	Ki	nM	50.12	CHEMBL4601	Homo sapiens	pKi		7.3
inactive	9615622	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615623	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(OC(F)(F)F)c4)c3)cc12		CHEMBL1965836	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615624	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12		CHEMBL583144	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615625	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	NC(=O)c1cc2c(-c3ccc(F)cc3)cncc2s1		CHEMBL1974310	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
active	9615626	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	=	Ki	nM	15.85	CHEMBL4601	Homo sapiens	pKi		7.8
inactive	9615627	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Nc1ncnc2sc3c(c12)-c1ccc(NC(=O)Nc2ccccc2)cc1CC3		CHEMBL1994693	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
active	9615628	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Nc1ncc(C=CC(=O)NCCCn2ccnc2)c2scc(-c3ccc(Br)cc3)c12		CHEMBL1994938	=	Ki	nM	15.85	CHEMBL4601	Homo sapiens	pKi		7.8
inactive	9615629	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615630	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1977223	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615631	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	NCCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL1966279	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615632	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CC(C)(C)C(=O)Oc1ccc2c(c1)nc(NC(=O)c1cccc([N+](=O)[O-])c1)n2CCCO		CHEMBL1236126	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615633	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C(NNC(=S)Nc1ccc(F)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1975138	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
active	9615634	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	c1ccc(CNc2cc(-c3c[nH]c4ncccc34)ncn2)cc1		CHEMBL2002346	=	Ki	nM	794.33	CHEMBL4601	Homo sapiens	pKi		6.1
inactive	9615635	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CC(C)Cn1c(N)nc2c(F)cc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2004419	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615636	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615637	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1cc2nnc(SCc3cn4ccccc4n3)n2c2ccccc12		CHEMBL1980704	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615638	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	NC(=O)c1sc2ccc(Cl)c(Cl)c2c1NC(=O)c1ccc(Cl)cc1		CHEMBL2003271	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615639	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Nc1cc2nc(-c3ccccc3)cn2cn1		CHEMBL1972365	<	Ki	nM	25118.86	CHEMBL4601	Homo sapiens	pKi		4.6
inactive	9615640	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CC(C)(C)c1n[nH]c2c1C(c1ccccc1F)C(C#N)=C(N)O2		CHEMBL2004447	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
active	9615641	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Ki	nM	630.96	CHEMBL4601	Homo sapiens	pKi		6.2
inactive	9615642	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	OCCNc1cc2cc(-c3ccsc3)ccc2cn1		CHEMBL1973860	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615643	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C(Nc1ccc2cn[nH]c2c1)c1ccc(Cl)cc1		CHEMBL1972489	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615644	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL260135	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615645	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Brc1ccc2[nH]nc(-c3ccccc3)c2c1		CHEMBL1994074	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615646	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	NC(=O)c1cccc2cn[nH]c12		CHEMBL451401	<	Ki	nM	25118.86	CHEMBL4601	Homo sapiens	pKi		4.6
inactive	9615647	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=c1[nH]cc(I)c2nc(-c3cccc(Cl)c3)cn12		CHEMBL1982610	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615648	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1cccc(C2(c3cccc(C)c3)CC2C(=O)Nc2ccncc2)c1		CHEMBL1999496	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615649	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CN(C)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1986328	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615650	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
active	9615651	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1090356	=	Ki	nM	100.0	CHEMBL4601	Homo sapiens	pKi		7.0
inactive	9615652	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(C(F)(F)F)cc12		CHEMBL1976455	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
active	9615653	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1		CHEMBL1983923	=	Ki	nM	1258.93	CHEMBL4601	Homo sapiens	pKi		5.9
inactive	9615654	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=c1c(NCc2ccccc2F)c(Nc2ccncc2)c1=O		CHEMBL1982361	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615655	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CCOC(=O)C1=c2sc(=Cc3ccco3)c(=O)n2C(N)=C(C#N)C1c1ccco1		CHEMBL1999112	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615656	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C(Nc1ccc(-c2cccc3sncc23)cc1)Nc1ccc(F)c(C(F)(F)F)c1		CHEMBL2000801	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615657	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682546	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615658	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1991395	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615659	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CN1CCN(c2cccc(Nc3nccc(-c4c(C(N)=O)nc5ccccn45)n3)c2)CC1		CHEMBL1971245	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
active	9615660	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	=	Ki	nM	15.85	CHEMBL4601	Homo sapiens	pKi		7.8
inactive	9615661	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615662	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C(NCc1ccccc1)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL1972142	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615663	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CC(C)Nc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682553	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
active	9615664	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C1NN=Cc2c[nH]c3cc(NC(=O)C4CC4c4ccccc4)cc1c23		CHEMBL1969502	=	Ki	nM	501.19	CHEMBL4601	Homo sapiens	pKi		6.3
inactive	9615665	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1cccc(-c2c(-c3ccncc3)nc(NCC(N)Cc3ccccc3)n(C)c2=O)c1		CHEMBL1971430	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
active	9615666	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cccc(F)c1		CHEMBL2003638	=	Ki	nM	1995.26	CHEMBL4601	Homo sapiens	pKi		5.7
inactive	9615667	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL1983963	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
active	9615668	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1ccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)cc1		CHEMBL1997764	=	Ki	nM	794.33	CHEMBL4601	Homo sapiens	pKi		6.1
inactive	9615669	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=c1[nH]cnc2ccc(Br)cc12		CHEMBL562488	<	Ki	nM	25118.86	CHEMBL4601	Homo sapiens	pKi		4.6
inactive	9615670	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	N#Cc1ccc2nc(N)n(-c3nc(-c4ccccc4)cs3)c2c1		CHEMBL1996066	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615671	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Oc1ccc(-c2n[nH]c(Nc3cccc(Cl)c3)c2-c2ccc(O)cc2)cc1		CHEMBL1985092	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615672	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1ccccc1		CHEMBL2004692	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615673	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CNc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL1981410	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615674	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=c1[nH]c2sc3c(c2c2nc(-c4cccnc4)nn12)CCCC3		CHEMBL1970806	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615675	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1ccc(C=C2C(=O)ON=C2c2ccc(Br)cc2)cc1OC		CHEMBL1991434	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615676	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CN(C)c1cccc2c(S(=O)(=O)N(CCN)c3cncc(-c4ccc5cnccc5c4)c3)cccc12		CHEMBL1967544	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615677	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1nc(COc2ccccc2Cl)sc1-c1ccnc(N)n1		CHEMBL1375640	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615678	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL1979970	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615679	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615680	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCN4CCOCC4)cc2-3)cn1		CHEMBL249282	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615681	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1996587	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615682	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CS(=O)(=O)NCCOc1cncc(-c2ccc3cnccc3c2)c1		CHEMBL1964804	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615683	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1O		CHEMBL2000354	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615684	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1cccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1965507	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615685	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CN1CCN(CCCNc2cccc(-c3nc4c(C(N)=O)cccc4[nH]3)n2)CC1		CHEMBL2006237	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615686	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615687	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CCCC(=O)Nc1n[nH]c2nc3ccccc3cc12		CHEMBL1967564	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615688	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	OCCCNc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL2000071	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615689	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615690	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1ccc2c(NC(=O)Nc3cc(C(F)(F)F)ccn3)ccnc2c1		CHEMBL1979176	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
active	9615691	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Nc1nccn2c(C3CC(CN4CCCC4)C3)nc(-c3cccc(OCc4ccccc4)c3)c12		CHEMBL1991138	=	Ki	nM	794.33	CHEMBL4601	Homo sapiens	pKi		6.1
inactive	9615692	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1F		CHEMBL1969755	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615693	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1979516	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615694	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C(O)c1ccc(N2C(=O)c3ccccc3C2=O)cc1O		CHEMBL1972820	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615695	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615696	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CN1CCC(C(=O)n2nc(N)c3cc(-c4cn(Cc5ccccc5)nn4)ccc32)CC1		CHEMBL1978014	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615697	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CC(C)OC1=NNC(=O)C1=Cc1c[nH]c2ccccc12		CHEMBL1989029	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615698	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C(Nc1cnccn1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1994538	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615699	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CN(C)CC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1965631	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615700	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1ccccc1NC(=O)Nc1ccc(NC(=O)c2csc3ncnc(N)c23)cc1		CHEMBL1980144	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
active	9615701	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1964444	=	Ki	nM	398.11	CHEMBL4601	Homo sapiens	pKi		6.4
inactive	9615702	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2OC)c1		CHEMBL1991188	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615703	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Clc1csc2ncnc(Nc3ccccc3)c12		CHEMBL1986139	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615704	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)cccc12		CHEMBL1980540	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615705	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1C#N		CHEMBL377408	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615706	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN(C)C)cnc(N)c34)cc2)c1		CHEMBL1979883	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615707	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL231209	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615708	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c12		CHEMBL1976220	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615709	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
active	9615710	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CN1CCN(C2CCC(n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1997617	=	Ki	nM	3.162	CHEMBL4601	Homo sapiens	pKi		8.5
inactive	9615711	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CCCCn1c(NC(=O)c2cccc(C#N)c2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL1969301	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615712	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C(C)(C)C		CHEMBL1986186	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615713	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17370	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615714	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1n[nH]c2c1C(c1ccccc1Cl)C(C#N)=C(N)O2		CHEMBL1970189	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615715	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371206	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615716	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Nc1ncnc2c1c(I)nn2C1CCC(O)CC1		CHEMBL1996791	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
active	9615717	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1ccc2c(NC(=O)Nc3cccc(Br)n3)ccnc2c1		CHEMBL1983932	=	Ki	nM	15.85	CHEMBL4601	Homo sapiens	pKi		7.8
inactive	9615718	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615719	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C(NC(CO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1974288	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615720	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615721	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1cc(OCC2CCC(C(=O)O)C2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL1991285	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615722	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615723	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1nn(C)c2sc(C(N)=O)c(N)c12		CHEMBL1996837	<	Ki	nM	25118.86	CHEMBL4601	Homo sapiens	pKi		4.6
active	9615724	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1		CHEMBL243088	=	Ki	nM	794.33	CHEMBL4601	Homo sapiens	pKi		6.1
inactive	9615725	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615726	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC		CHEMBL1190711	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
active	9615727	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl		CHEMBL1993661	=	Ki	nM	79.43	CHEMBL4601	Homo sapiens	pKi		7.1
active	9615728	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1cccc(F)c1F		CHEMBL1974416	=	Ki	nM	1995.26	CHEMBL4601	Homo sapiens	pKi		5.7
inactive	9615729	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2		CHEMBL1980391	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615730	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	CC(C)Cc1cc(-c2ccc3[nH]nc(N)c3c2)on1		CHEMBL1966343	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615731	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL404367	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
inactive	9615732	CHEMBL1963803	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK6	F	O=C(c1cccc(-c2cnc3[nH]ccc3c2)c1)N1CCOCC1		CHEMBL1997872	<	Ki	nM	2511.89	CHEMBL4601	Homo sapiens	pKi		5.6
	10838555	CHEMBL2014128	Inhibition of BRK at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	1.0	CHEMBL4601	Homo sapiens	INH	%	1.0
	10839673	CHEMBL2015833	Inhibition of BRK assessed as residual activity at 1 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	21.0	CHEMBL4601	Homo sapiens	Activity	%	21.0
	10840500	CHEMBL2015925	Inhibition of BRK assessed as residual activity at 10 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	5.0	CHEMBL4601	Homo sapiens	Activity	%	5.0
	10886639	CHEMBL2034082	Inhibition of PTK6 at 1 uM	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)Nc2cnc3[nH]nc(OC)c3c2)c1F		CHEMBL1822067	=	Inhibition	%	83.0	CHEMBL4601	Homo sapiens	INH	%	83.0
	10886640	CHEMBL2034082	Inhibition of PTK6 at 1 uM	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)Nc2cnc3cc(-c4ccccc4)nn3c2)c1F		CHEMBL2030242	=	Inhibition	%	47.0	CHEMBL4601	Homo sapiens	INH	%	47.0
	10921346	CHEMBL2046170	Inhibition of BRK at 1 uM	B	CCN1C(=O)CCCc2c1ccc(Nc1ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n1)c2OC		CHEMBL2042829	=	Inhibition	%	100.0	CHEMBL4601	Homo sapiens	INH	%	100.0
	10921347	CHEMBL2046167	Inhibition of BRK at 0.1 uM	B	CCN1C(=O)CCCc2c1ccc(Nc1ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n1)c2OC		CHEMBL2042829	=	Inhibition	%	88.0	CHEMBL4601	Homo sapiens	INH	%	88.0
	10981544	CHEMBL2067602	Inhibition of human BRK at 1 uM	B	COc1c(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc2c1CC[C@@H](N1CCOCC1)CC2		CHEMBL2064666	>=	Inhibition	%	90.0	CHEMBL4601	Homo sapiens	INH	%	90.0
	10981559	CHEMBL2067587	Inhibition of human BRK	B	COc1c(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc2c1CC[C@@H](N1CCOCC1)CC2		CHEMBL2064666	=	IC50	nM	73.0	CHEMBL4601	Homo sapiens	IC50	nM	73.0
	12046248	CHEMBL2156485	Inhibition of Brk at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	14.2	CHEMBL4601	Homo sapiens	INH	%	14.2
	12074619	CHEMBL2161016	Inhibition of Brk at 1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	<	Inhibition	%	50.0	CHEMBL4601	Homo sapiens	INH	%	50.0
	12116242	CHEMBL2172946	Inhibition of BRK	B	Cn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(C(F)(F)F)c2)c2c(N)ncnc21		CHEMBL2171124	=	IC50	nM	412.0	CHEMBL4601	Homo sapiens	IC50	nM	412.0
Active	12155948	CHEMBL2185147	Inhibition of PTK6 assessed as residual activity at 1000 nM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041		Inhibition	%		CHEMBL4601	Homo sapiens	INH		
	12170840	CHEMBL2212707	Inhibition of BRK assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	103.0	CHEMBL4601	Homo sapiens	Activity	%	103.0
	12172141	CHEMBL2214396	Inhibition of BRK assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	101.0	CHEMBL4601	Homo sapiens	Activity	%	101.0
	12173721	CHEMBL2211635	Inhibition of BRK assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL4601	Homo sapiens	Activity	%	100.0
	12183822	CHEMBL2214438	Inhibition of PTK6	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL4601	Homo sapiens	pIC50		5.0
	12224467	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	109.0	CHEMBL4601	Homo sapiens	Residual Activity	%	109.0
	12224468	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	106.0	CHEMBL4601	Homo sapiens	Residual Activity	%	106.0
	12224469	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	94.0	CHEMBL4601	Homo sapiens	Residual Activity	%	94.0
	12224470	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	106.0	CHEMBL4601	Homo sapiens	Residual Activity	%	106.0
	12224471	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	69.0	CHEMBL4601	Homo sapiens	Residual Activity	%	69.0
	12224472	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	98.0	CHEMBL4601	Homo sapiens	Residual Activity	%	98.0
	12224473	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	97.0	CHEMBL4601	Homo sapiens	Residual Activity	%	97.0
	12224474	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	33.0	CHEMBL4601	Homo sapiens	Residual Activity	%	33.0
	12224475	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	109.0	CHEMBL4601	Homo sapiens	Residual Activity	%	109.0
	12224476	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	78.0	CHEMBL4601	Homo sapiens	Residual Activity	%	78.0
	12224477	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	99.0	CHEMBL4601	Homo sapiens	Residual Activity	%	99.0
	12224478	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	99.0	CHEMBL4601	Homo sapiens	Residual Activity	%	99.0
	12224479	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	80.0	CHEMBL4601	Homo sapiens	Residual Activity	%	80.0
	12224480	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	5.0	CHEMBL4601	Homo sapiens	Residual Activity	%	5.0
	12224481	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	74.0	CHEMBL4601	Homo sapiens	Residual Activity	%	74.0
	12224482	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	99.0	CHEMBL4601	Homo sapiens	Residual Activity	%	99.0
	12224483	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	109.0	CHEMBL4601	Homo sapiens	Residual Activity	%	109.0
	12224484	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	110.0	CHEMBL4601	Homo sapiens	Residual Activity	%	110.0
	12224485	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	108.0	CHEMBL4601	Homo sapiens	Residual Activity	%	108.0
	12224486	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	93.0	CHEMBL4601	Homo sapiens	Residual Activity	%	93.0
	12224487	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	101.0	CHEMBL4601	Homo sapiens	Residual Activity	%	101.0
	12224488	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	89.0	CHEMBL4601	Homo sapiens	Residual Activity	%	89.0
	12224489	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	113.0	CHEMBL4601	Homo sapiens	Residual Activity	%	113.0
	12224490	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	21.0	CHEMBL4601	Homo sapiens	Residual Activity	%	21.0
	12224491	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	109.0	CHEMBL4601	Homo sapiens	Residual Activity	%	109.0
	12224492	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	18.0	CHEMBL4601	Homo sapiens	Residual Activity	%	18.0
	12224493	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	90.0	CHEMBL4601	Homo sapiens	Residual Activity	%	90.0
	12224494	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	18.0	CHEMBL4601	Homo sapiens	Residual Activity	%	18.0
	12224495	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	98.0	CHEMBL4601	Homo sapiens	Residual Activity	%	98.0
	12224496	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	101.0	CHEMBL4601	Homo sapiens	Residual Activity	%	101.0
	12224497	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	93.0	CHEMBL4601	Homo sapiens	Residual Activity	%	93.0
	12224498	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	2.0	CHEMBL4601	Homo sapiens	Residual Activity	%	2.0
	12224499	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	110.0	CHEMBL4601	Homo sapiens	Residual Activity	%	110.0
	12224500	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	110.0	CHEMBL4601	Homo sapiens	Residual Activity	%	110.0
	12224501	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	109.0	CHEMBL4601	Homo sapiens	Residual Activity	%	109.0
	12224502	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	103.0	CHEMBL4601	Homo sapiens	Residual Activity	%	103.0
	12224503	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	78.0	CHEMBL4601	Homo sapiens	Residual Activity	%	78.0
	12224504	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	101.0	CHEMBL4601	Homo sapiens	Residual Activity	%	101.0
	12224505	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	111.0	CHEMBL4601	Homo sapiens	Residual Activity	%	111.0
	12224506	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	107.0	CHEMBL4601	Homo sapiens	Residual Activity	%	107.0
	12224507	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	118.0	CHEMBL4601	Homo sapiens	Residual Activity	%	118.0
	12224508	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	108.0	CHEMBL4601	Homo sapiens	Residual Activity	%	108.0
	12224509	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	29.0	CHEMBL4601	Homo sapiens	Residual Activity	%	29.0
	12224510	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	85.0	CHEMBL4601	Homo sapiens	Residual Activity	%	85.0
	12224511	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	22.0	CHEMBL4601	Homo sapiens	Residual Activity	%	22.0
	12224512	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	95.0	CHEMBL4601	Homo sapiens	Residual Activity	%	95.0
	12224513	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	108.0	CHEMBL4601	Homo sapiens	Residual Activity	%	108.0
	12224514	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	103.0	CHEMBL4601	Homo sapiens	Residual Activity	%	103.0
	12224515	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	107.0	CHEMBL4601	Homo sapiens	Residual Activity	%	107.0
	12224516	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	113.0	CHEMBL4601	Homo sapiens	Residual Activity	%	113.0
	12224517	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	98.0	CHEMBL4601	Homo sapiens	Residual Activity	%	98.0
	12224518	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	0.0	CHEMBL4601	Homo sapiens	Residual Activity	%	0.0
	12224519	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	66.0	CHEMBL4601	Homo sapiens	Residual Activity	%	66.0
	12224520	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	101.0	CHEMBL4601	Homo sapiens	Residual Activity	%	101.0
	12224521	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	115.0	CHEMBL4601	Homo sapiens	Residual Activity	%	115.0
	12224522	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	107.0	CHEMBL4601	Homo sapiens	Residual Activity	%	107.0
	12224523	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	35.0	CHEMBL4601	Homo sapiens	Residual Activity	%	35.0
	12224524	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	112.0	CHEMBL4601	Homo sapiens	Residual Activity	%	112.0
	12224525	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	112.0	CHEMBL4601	Homo sapiens	Residual Activity	%	112.0
	12224526	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	101.0	CHEMBL4601	Homo sapiens	Residual Activity	%	101.0
	12224527	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	84.0	CHEMBL4601	Homo sapiens	Residual Activity	%	84.0
	12224528	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	98.0	CHEMBL4601	Homo sapiens	Residual Activity	%	98.0
	12224529	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	102.0	CHEMBL4601	Homo sapiens	Residual Activity	%	102.0
	12224530	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	101.0	CHEMBL4601	Homo sapiens	Residual Activity	%	101.0
	12224531	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	110.0	CHEMBL4601	Homo sapiens	Residual Activity	%	110.0
	12224532	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	112.0	CHEMBL4601	Homo sapiens	Residual Activity	%	112.0
	12224533	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	109.0	CHEMBL4601	Homo sapiens	Residual Activity	%	109.0
	12224534	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	108.0	CHEMBL4601	Homo sapiens	Residual Activity	%	108.0
	12224535	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	99.0	CHEMBL4601	Homo sapiens	Residual Activity	%	99.0
	12224536	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	7.0	CHEMBL4601	Homo sapiens	Residual Activity	%	7.0
	12224537	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	103.0	CHEMBL4601	Homo sapiens	Residual Activity	%	103.0
	12224538	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	40.0	CHEMBL4601	Homo sapiens	Residual Activity	%	40.0
	12224539	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	110.0	CHEMBL4601	Homo sapiens	Residual Activity	%	110.0
	12224540	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	30.0	CHEMBL4601	Homo sapiens	Residual Activity	%	30.0
	12224541	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	92.0	CHEMBL4601	Homo sapiens	Residual Activity	%	92.0
	12224542	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	102.0	CHEMBL4601	Homo sapiens	Residual Activity	%	102.0
	12224543	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	110.0	CHEMBL4601	Homo sapiens	Residual Activity	%	110.0
	12224544	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	65.0	CHEMBL4601	Homo sapiens	Residual Activity	%	65.0
	12224545	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	108.0	CHEMBL4601	Homo sapiens	Residual Activity	%	108.0
	12224546	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	38.0	CHEMBL4601	Homo sapiens	Residual Activity	%	38.0
	12224547	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	104.0	CHEMBL4601	Homo sapiens	Residual Activity	%	104.0
	12224548	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	106.0	CHEMBL4601	Homo sapiens	Residual Activity	%	106.0
	12224549	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	105.0	CHEMBL4601	Homo sapiens	Residual Activity	%	105.0
	12224550	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	97.0	CHEMBL4601	Homo sapiens	Residual Activity	%	97.0
	12224551	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	98.0	CHEMBL4601	Homo sapiens	Residual Activity	%	98.0
	12224552	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	104.0	CHEMBL4601	Homo sapiens	Residual Activity	%	104.0
	12224553	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	108.0	CHEMBL4601	Homo sapiens	Residual Activity	%	108.0
	12224554	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	59.0	CHEMBL4601	Homo sapiens	Residual Activity	%	59.0
	12224555	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	109.0	CHEMBL4601	Homo sapiens	Residual Activity	%	109.0
	12224556	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	91.0	CHEMBL4601	Homo sapiens	Residual Activity	%	91.0
	12224557	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	104.0	CHEMBL4601	Homo sapiens	Residual Activity	%	104.0
	12224558	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	95.0	CHEMBL4601	Homo sapiens	Residual Activity	%	95.0
	12224559	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	40.0	CHEMBL4601	Homo sapiens	Residual Activity	%	40.0
	12224560	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	60.0	CHEMBL4601	Homo sapiens	Residual Activity	%	60.0
	12224561	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	59.0	CHEMBL4601	Homo sapiens	Residual Activity	%	59.0
	12224562	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	105.0	CHEMBL4601	Homo sapiens	Residual Activity	%	105.0
	12224563	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	107.0	CHEMBL4601	Homo sapiens	Residual Activity	%	107.0
	12224564	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	107.0	CHEMBL4601	Homo sapiens	Residual Activity	%	107.0
	12224565	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	111.0	CHEMBL4601	Homo sapiens	Residual Activity	%	111.0
	12224566	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	97.0	CHEMBL4601	Homo sapiens	Residual Activity	%	97.0
	12224567	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	81.0	CHEMBL4601	Homo sapiens	Residual Activity	%	81.0
	12224568	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	19.0	CHEMBL4601	Homo sapiens	Residual Activity	%	19.0
	12224569	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	105.0	CHEMBL4601	Homo sapiens	Residual Activity	%	105.0
	12224570	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	100.0	CHEMBL4601	Homo sapiens	Residual Activity	%	100.0
	12224571	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	111.0	CHEMBL4601	Homo sapiens	Residual Activity	%	111.0
	12224572	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	89.0	CHEMBL4601	Homo sapiens	Residual Activity	%	89.0
	12224573	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	106.0	CHEMBL4601	Homo sapiens	Residual Activity	%	106.0
	12224574	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	97.0	CHEMBL4601	Homo sapiens	Residual Activity	%	97.0
	12224575	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	104.0	CHEMBL4601	Homo sapiens	Residual Activity	%	104.0
	12224576	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	95.0	CHEMBL4601	Homo sapiens	Residual Activity	%	95.0
	12224577	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	36.0	CHEMBL4601	Homo sapiens	Residual Activity	%	36.0
	12224578	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	59.0	CHEMBL4601	Homo sapiens	Residual Activity	%	59.0
	12224579	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	105.0	CHEMBL4601	Homo sapiens	Residual Activity	%	105.0
	12224580	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	97.0	CHEMBL4601	Homo sapiens	Residual Activity	%	97.0
	12224581	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	102.0	CHEMBL4601	Homo sapiens	Residual Activity	%	102.0
	12224582	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	96.0	CHEMBL4601	Homo sapiens	Residual Activity	%	96.0
	12224583	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	77.0	CHEMBL4601	Homo sapiens	Residual Activity	%	77.0
	12224584	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	100.0	CHEMBL4601	Homo sapiens	Residual Activity	%	100.0
	12224585	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	88.0	CHEMBL4601	Homo sapiens	Residual Activity	%	88.0
	12224586	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	109.0	CHEMBL4601	Homo sapiens	Residual Activity	%	109.0
	12224587	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	31.0	CHEMBL4601	Homo sapiens	Residual Activity	%	31.0
	12224588	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	94.0	CHEMBL4601	Homo sapiens	Residual Activity	%	94.0
	12224589	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	105.0	CHEMBL4601	Homo sapiens	Residual Activity	%	105.0
	12224590	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	105.0	CHEMBL4601	Homo sapiens	Residual Activity	%	105.0
	12224591	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	56.0	CHEMBL4601	Homo sapiens	Residual Activity	%	56.0
	12224592	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	105.0	CHEMBL4601	Homo sapiens	Residual Activity	%	105.0
	12224593	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	109.0	CHEMBL4601	Homo sapiens	Residual Activity	%	109.0
	12224594	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	107.0	CHEMBL4601	Homo sapiens	Residual Activity	%	107.0
	12224595	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	37.0	CHEMBL4601	Homo sapiens	Residual Activity	%	37.0
	12224596	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	49.0	CHEMBL4601	Homo sapiens	Residual Activity	%	49.0
	12224597	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	104.0	CHEMBL4601	Homo sapiens	Residual Activity	%	104.0
	12224598	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	24.0	CHEMBL4601	Homo sapiens	Residual Activity	%	24.0
	12224599	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	95.0	CHEMBL4601	Homo sapiens	Residual Activity	%	95.0
	12224600	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	103.0	CHEMBL4601	Homo sapiens	Residual Activity	%	103.0
	12224601	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	0.0	CHEMBL4601	Homo sapiens	Residual Activity	%	0.0
	12224602	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	96.0	CHEMBL4601	Homo sapiens	Residual Activity	%	96.0
	12224603	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	112.0	CHEMBL4601	Homo sapiens	Residual Activity	%	112.0
	12224604	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	54.0	CHEMBL4601	Homo sapiens	Residual Activity	%	54.0
	12224605	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	90.0	CHEMBL4601	Homo sapiens	Residual Activity	%	90.0
	12224606	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	103.0	CHEMBL4601	Homo sapiens	Residual Activity	%	103.0
	12224607	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	105.0	CHEMBL4601	Homo sapiens	Residual Activity	%	105.0
	12224608	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	105.0	CHEMBL4601	Homo sapiens	Residual Activity	%	105.0
	12224609	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	110.0	CHEMBL4601	Homo sapiens	Residual Activity	%	110.0
	12224610	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	53.0	CHEMBL4601	Homo sapiens	Residual Activity	%	53.0
	12224611	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	109.0	CHEMBL4601	Homo sapiens	Residual Activity	%	109.0
	12224612	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	110.0	CHEMBL4601	Homo sapiens	Residual Activity	%	110.0
	12224613	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	99.0	CHEMBL4601	Homo sapiens	Residual Activity	%	99.0
	12224614	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	60.0	CHEMBL4601	Homo sapiens	Residual Activity	%	60.0
	12224615	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	51.0	CHEMBL4601	Homo sapiens	Residual Activity	%	51.0
	12224616	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	110.0	CHEMBL4601	Homo sapiens	Residual Activity	%	110.0
	12224617	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	102.0	CHEMBL4601	Homo sapiens	Residual Activity	%	102.0
	12224618	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	99.0	CHEMBL4601	Homo sapiens	Residual Activity	%	99.0
	12224619	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	97.0	CHEMBL4601	Homo sapiens	Residual Activity	%	97.0
	12224620	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	112.0	CHEMBL4601	Homo sapiens	Residual Activity	%	112.0
	12224621	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	104.0	CHEMBL4601	Homo sapiens	Residual Activity	%	104.0
	12224622	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	95.0	CHEMBL4601	Homo sapiens	Residual Activity	%	95.0
	12224623	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	49.0	CHEMBL4601	Homo sapiens	Residual Activity	%	49.0
	12224624	CHEMBL2218956	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	106.0	CHEMBL4601	Homo sapiens	Residual Activity	%	106.0
	12224625	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	110.0	CHEMBL4601	Homo sapiens	Residual Activity	%	110.0
	12224626	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	68.0	CHEMBL4601	Homo sapiens	Residual Activity	%	68.0
	12224627	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	94.0	CHEMBL4601	Homo sapiens	Residual Activity	%	94.0
	12224628	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	95.0	CHEMBL4601	Homo sapiens	Residual Activity	%	95.0
	12224629	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	53.0	CHEMBL4601	Homo sapiens	Residual Activity	%	53.0
	12224630	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	96.0	CHEMBL4601	Homo sapiens	Residual Activity	%	96.0
	12224631	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	101.0	CHEMBL4601	Homo sapiens	Residual Activity	%	101.0
	12224632	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	3.0	CHEMBL4601	Homo sapiens	Residual Activity	%	3.0
	12224633	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	98.0	CHEMBL4601	Homo sapiens	Residual Activity	%	98.0
	12224634	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	55.0	CHEMBL4601	Homo sapiens	Residual Activity	%	55.0
	12224635	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	97.0	CHEMBL4601	Homo sapiens	Residual Activity	%	97.0
	12224636	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	107.0	CHEMBL4601	Homo sapiens	Residual Activity	%	107.0
	12224637	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	60.0	CHEMBL4601	Homo sapiens	Residual Activity	%	60.0
	12224638	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	-1.0	CHEMBL4601	Homo sapiens	Residual Activity	%	-1.0
	12224639	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	14.0	CHEMBL4601	Homo sapiens	Residual Activity	%	14.0
	12224640	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	109.0	CHEMBL4601	Homo sapiens	Residual Activity	%	109.0
	12224641	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	94.0	CHEMBL4601	Homo sapiens	Residual Activity	%	94.0
	12224642	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	101.0	CHEMBL4601	Homo sapiens	Residual Activity	%	101.0
	12224643	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	114.0	CHEMBL4601	Homo sapiens	Residual Activity	%	114.0
	12224644	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	107.0	CHEMBL4601	Homo sapiens	Residual Activity	%	107.0
	12224645	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	107.0	CHEMBL4601	Homo sapiens	Residual Activity	%	107.0
	12224646	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	48.0	CHEMBL4601	Homo sapiens	Residual Activity	%	48.0
	12224647	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	105.0	CHEMBL4601	Homo sapiens	Residual Activity	%	105.0
	12224648	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	1.0	CHEMBL4601	Homo sapiens	Residual Activity	%	1.0
	12224649	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	107.0	CHEMBL4601	Homo sapiens	Residual Activity	%	107.0
	12224650	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	2.0	CHEMBL4601	Homo sapiens	Residual Activity	%	2.0
	12224651	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	45.0	CHEMBL4601	Homo sapiens	Residual Activity	%	45.0
	12224652	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	1.0	CHEMBL4601	Homo sapiens	Residual Activity	%	1.0
	12224653	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	98.0	CHEMBL4601	Homo sapiens	Residual Activity	%	98.0
	12224654	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	89.0	CHEMBL4601	Homo sapiens	Residual Activity	%	89.0
	12224655	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	37.0	CHEMBL4601	Homo sapiens	Residual Activity	%	37.0
	12224656	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	-1.0	CHEMBL4601	Homo sapiens	Residual Activity	%	-1.0
	12224657	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	79.0	CHEMBL4601	Homo sapiens	Residual Activity	%	79.0
	12224658	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	105.0	CHEMBL4601	Homo sapiens	Residual Activity	%	105.0
	12224659	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	101.0	CHEMBL4601	Homo sapiens	Residual Activity	%	101.0
	12224660	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	97.0	CHEMBL4601	Homo sapiens	Residual Activity	%	97.0
	12224661	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	25.0	CHEMBL4601	Homo sapiens	Residual Activity	%	25.0
	12224662	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	102.0	CHEMBL4601	Homo sapiens	Residual Activity	%	102.0
	12224663	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	102.0	CHEMBL4601	Homo sapiens	Residual Activity	%	102.0
	12224664	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	107.0	CHEMBL4601	Homo sapiens	Residual Activity	%	107.0
	12224665	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	108.0	CHEMBL4601	Homo sapiens	Residual Activity	%	108.0
	12224666	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	107.0	CHEMBL4601	Homo sapiens	Residual Activity	%	107.0
	12224667	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	36.0	CHEMBL4601	Homo sapiens	Residual Activity	%	36.0
	12224668	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	40.0	CHEMBL4601	Homo sapiens	Residual Activity	%	40.0
	12224669	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	11.0	CHEMBL4601	Homo sapiens	Residual Activity	%	11.0
	12224670	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	75.0	CHEMBL4601	Homo sapiens	Residual Activity	%	75.0
	12224671	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	106.0	CHEMBL4601	Homo sapiens	Residual Activity	%	106.0
	12224672	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	104.0	CHEMBL4601	Homo sapiens	Residual Activity	%	104.0
	12224673	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	90.0	CHEMBL4601	Homo sapiens	Residual Activity	%	90.0
	12224674	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	107.0	CHEMBL4601	Homo sapiens	Residual Activity	%	107.0
	12224675	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	82.0	CHEMBL4601	Homo sapiens	Residual Activity	%	82.0
	12224676	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	-1.0	CHEMBL4601	Homo sapiens	Residual Activity	%	-1.0
	12224677	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	34.0	CHEMBL4601	Homo sapiens	Residual Activity	%	34.0
	12224678	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	95.0	CHEMBL4601	Homo sapiens	Residual Activity	%	95.0
	12224679	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	110.0	CHEMBL4601	Homo sapiens	Residual Activity	%	110.0
	12224680	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	103.0	CHEMBL4601	Homo sapiens	Residual Activity	%	103.0
	12224681	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	10.0	CHEMBL4601	Homo sapiens	Residual Activity	%	10.0
	12224682	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	95.0	CHEMBL4601	Homo sapiens	Residual Activity	%	95.0
	12224683	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	101.0	CHEMBL4601	Homo sapiens	Residual Activity	%	101.0
	12227049	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	101.0	CHEMBL4601	Homo sapiens	Residual Activity	%	101.0
	12227050	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	65.0	CHEMBL4601	Homo sapiens	Residual Activity	%	65.0
	12227051	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	93.0	CHEMBL4601	Homo sapiens	Residual Activity	%	93.0
	12227052	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	103.0	CHEMBL4601	Homo sapiens	Residual Activity	%	103.0
	12227053	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	103.0	CHEMBL4601	Homo sapiens	Residual Activity	%	103.0
	12227054	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	105.0	CHEMBL4601	Homo sapiens	Residual Activity	%	105.0
	12227055	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	97.0	CHEMBL4601	Homo sapiens	Residual Activity	%	97.0
	12227056	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	106.0	CHEMBL4601	Homo sapiens	Residual Activity	%	106.0
	12227057	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	99.0	CHEMBL4601	Homo sapiens	Residual Activity	%	99.0
	12227058	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	103.0	CHEMBL4601	Homo sapiens	Residual Activity	%	103.0
	12227059	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	4.0	CHEMBL4601	Homo sapiens	Residual Activity	%	4.0
	12227060	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	101.0	CHEMBL4601	Homo sapiens	Residual Activity	%	101.0
	12227061	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	46.0	CHEMBL4601	Homo sapiens	Residual Activity	%	46.0
	12227062	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	89.0	CHEMBL4601	Homo sapiens	Residual Activity	%	89.0
	12227063	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	18.0	CHEMBL4601	Homo sapiens	Residual Activity	%	18.0
	12227064	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	34.0	CHEMBL4601	Homo sapiens	Residual Activity	%	34.0
	12227065	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	72.0	CHEMBL4601	Homo sapiens	Residual Activity	%	72.0
	12227066	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	104.0	CHEMBL4601	Homo sapiens	Residual Activity	%	104.0
	12227067	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	11.0	CHEMBL4601	Homo sapiens	Residual Activity	%	11.0
	12227068	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	102.0	CHEMBL4601	Homo sapiens	Residual Activity	%	102.0
	12227069	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	6.0	CHEMBL4601	Homo sapiens	Residual Activity	%	6.0
	12227070	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	100.0	CHEMBL4601	Homo sapiens	Residual Activity	%	100.0
	12227071	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	74.0	CHEMBL4601	Homo sapiens	Residual Activity	%	74.0
	12227072	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	100.0	CHEMBL4601	Homo sapiens	Residual Activity	%	100.0
	12227073	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	89.0	CHEMBL4601	Homo sapiens	Residual Activity	%	89.0
	12227074	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	94.0	CHEMBL4601	Homo sapiens	Residual Activity	%	94.0
	12227075	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	96.0	CHEMBL4601	Homo sapiens	Residual Activity	%	96.0
	12227076	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	89.0	CHEMBL4601	Homo sapiens	Residual Activity	%	89.0
	12227077	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	7.0	CHEMBL4601	Homo sapiens	Residual Activity	%	7.0
	12227078	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	96.0	CHEMBL4601	Homo sapiens	Residual Activity	%	96.0
	12227079	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	23.0	CHEMBL4601	Homo sapiens	Residual Activity	%	23.0
	12227080	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	104.0	CHEMBL4601	Homo sapiens	Residual Activity	%	104.0
	12227081	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	78.0	CHEMBL4601	Homo sapiens	Residual Activity	%	78.0
	12227082	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	4.0	CHEMBL4601	Homo sapiens	Residual Activity	%	4.0
	12227083	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	50.0	CHEMBL4601	Homo sapiens	Residual Activity	%	50.0
	12227084	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	7.0	CHEMBL4601	Homo sapiens	Residual Activity	%	7.0
	12227085	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	104.0	CHEMBL4601	Homo sapiens	Residual Activity	%	104.0
	12227086	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	103.0	CHEMBL4601	Homo sapiens	Residual Activity	%	103.0
	12227087	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	106.0	CHEMBL4601	Homo sapiens	Residual Activity	%	106.0
	12227088	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	108.0	CHEMBL4601	Homo sapiens	Residual Activity	%	108.0
	12227089	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	87.0	CHEMBL4601	Homo sapiens	Residual Activity	%	87.0
	12227090	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	53.0	CHEMBL4601	Homo sapiens	Residual Activity	%	53.0
	12227091	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	1.0	CHEMBL4601	Homo sapiens	Residual Activity	%	1.0
	12227092	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	105.0	CHEMBL4601	Homo sapiens	Residual Activity	%	105.0
	12227093	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	101.0	CHEMBL4601	Homo sapiens	Residual Activity	%	101.0
	12227094	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	107.0	CHEMBL4601	Homo sapiens	Residual Activity	%	107.0
	12227095	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	82.0	CHEMBL4601	Homo sapiens	Residual Activity	%	82.0
	12227096	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	102.0	CHEMBL4601	Homo sapiens	Residual Activity	%	102.0
	12227097	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	80.0	CHEMBL4601	Homo sapiens	Residual Activity	%	80.0
	12227098	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	96.0	CHEMBL4601	Homo sapiens	Residual Activity	%	96.0
	12227099	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	72.0	CHEMBL4601	Homo sapiens	Residual Activity	%	72.0
	12227100	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	31.0	CHEMBL4601	Homo sapiens	Residual Activity	%	31.0
	12227101	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	43.0	CHEMBL4601	Homo sapiens	Residual Activity	%	43.0
	12227102	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	94.0	CHEMBL4601	Homo sapiens	Residual Activity	%	94.0
	12227103	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	54.0	CHEMBL4601	Homo sapiens	Residual Activity	%	54.0
	12227104	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	103.0	CHEMBL4601	Homo sapiens	Residual Activity	%	103.0
	12227105	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	95.0	CHEMBL4601	Homo sapiens	Residual Activity	%	95.0
	12227106	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	26.0	CHEMBL4601	Homo sapiens	Residual Activity	%	26.0
	12227107	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	88.0	CHEMBL4601	Homo sapiens	Residual Activity	%	88.0
	12227108	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	30.0	CHEMBL4601	Homo sapiens	Residual Activity	%	30.0
	12227109	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	69.0	CHEMBL4601	Homo sapiens	Residual Activity	%	69.0
	12227110	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	29.0	CHEMBL4601	Homo sapiens	Residual Activity	%	29.0
	12227111	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	34.0	CHEMBL4601	Homo sapiens	Residual Activity	%	34.0
	12227112	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	100.0	CHEMBL4601	Homo sapiens	Residual Activity	%	100.0
	12227113	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	96.0	CHEMBL4601	Homo sapiens	Residual Activity	%	96.0
	12227114	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	53.0	CHEMBL4601	Homo sapiens	Residual Activity	%	53.0
	12227115	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	108.0	CHEMBL4601	Homo sapiens	Residual Activity	%	108.0
	12227116	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	92.0	CHEMBL4601	Homo sapiens	Residual Activity	%	92.0
	12227117	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	102.0	CHEMBL4601	Homo sapiens	Residual Activity	%	102.0
	12227118	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	46.0	CHEMBL4601	Homo sapiens	Residual Activity	%	46.0
	12227119	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	8.0	CHEMBL4601	Homo sapiens	Residual Activity	%	8.0
	12227120	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	101.0	CHEMBL4601	Homo sapiens	Residual Activity	%	101.0
	12227121	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	17.0	CHEMBL4601	Homo sapiens	Residual Activity	%	17.0
	12227122	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	95.0	CHEMBL4601	Homo sapiens	Residual Activity	%	95.0
	12227123	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	101.0	CHEMBL4601	Homo sapiens	Residual Activity	%	101.0
	12227124	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	0.0	CHEMBL4601	Homo sapiens	Residual Activity	%	0.0
	12227125	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	83.0	CHEMBL4601	Homo sapiens	Residual Activity	%	83.0
	12227126	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	95.0	CHEMBL4601	Homo sapiens	Residual Activity	%	95.0
	12227127	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	11.0	CHEMBL4601	Homo sapiens	Residual Activity	%	11.0
	12227128	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	102.0	CHEMBL4601	Homo sapiens	Residual Activity	%	102.0
	12227129	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	115.0	CHEMBL4601	Homo sapiens	Residual Activity	%	115.0
	12227130	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	114.0	CHEMBL4601	Homo sapiens	Residual Activity	%	114.0
	12227131	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	98.0	CHEMBL4601	Homo sapiens	Residual Activity	%	98.0
	12227132	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	105.0	CHEMBL4601	Homo sapiens	Residual Activity	%	105.0
	12227133	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	7.0	CHEMBL4601	Homo sapiens	Residual Activity	%	7.0
	12227134	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	102.0	CHEMBL4601	Homo sapiens	Residual Activity	%	102.0
	12227135	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	115.0	CHEMBL4601	Homo sapiens	Residual Activity	%	115.0
	12227136	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	77.0	CHEMBL4601	Homo sapiens	Residual Activity	%	77.0
	12227137	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	37.0	CHEMBL4601	Homo sapiens	Residual Activity	%	37.0
	12227138	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	19.0	CHEMBL4601	Homo sapiens	Residual Activity	%	19.0
	12227139	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	108.0	CHEMBL4601	Homo sapiens	Residual Activity	%	108.0
	12227140	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	71.0	CHEMBL4601	Homo sapiens	Residual Activity	%	71.0
	12227141	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	101.0	CHEMBL4601	Homo sapiens	Residual Activity	%	101.0
	12227142	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	96.0	CHEMBL4601	Homo sapiens	Residual Activity	%	96.0
	12227143	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	110.0	CHEMBL4601	Homo sapiens	Residual Activity	%	110.0
	12227144	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	113.0	CHEMBL4601	Homo sapiens	Residual Activity	%	113.0
	12227145	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	79.0	CHEMBL4601	Homo sapiens	Residual Activity	%	79.0
	12227146	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	5.0	CHEMBL4601	Homo sapiens	Residual Activity	%	5.0
	12227147	CHEMBL2218957	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	101.0	CHEMBL4601	Homo sapiens	Residual Activity	%	101.0
	12626711	CHEMBL2316986	Inhibition of BRK (unknown origin) at 1 uM	B	COc1cc(Nc2ncc(Cl)c(-c3cccc(CC#N)c3)n2)ccc1N1CCN(C)CC1		CHEMBL2312140	>=	Inhibition	%	80.0	CHEMBL4601	Homo sapiens	INH	%	80.0
	12673093	CHEMBL2345632	Inhibition of recombinant BRK (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336379	=	Activity	%	44.0	CHEMBL4601	Homo sapiens	Activity	%	44.0
	12673094	CHEMBL2345632	Inhibition of recombinant BRK (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336377	=	Activity	%	50.0	CHEMBL4601	Homo sapiens	Activity	%	50.0
	12693252	CHEMBL2343937	Inhibition of BRK (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	10000.0	CHEMBL4601	Homo sapiens	IC50	nM	10000.0
	12728890	CHEMBL2349973	Inhibition of BRK (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	94.0	CHEMBL4601	Homo sapiens	Activity	%	94.0
	12730032	CHEMBL2353907	Inhibition of BRK (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	99.0	CHEMBL4601	Homo sapiens	Activity	%	99.0
	12730925	CHEMBL2349852	Inhibition of BRK (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	73.0	CHEMBL4601	Homo sapiens	Activity	%	73.0
	12731169	CHEMBL2349973	Inhibition of BRK (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	99.0	CHEMBL4601	Homo sapiens	Activity	%	99.0
	13374366	CHEMBL2406310	Inhibition of PTK6 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	6.0	CHEMBL4601	Homo sapiens	INH	%	6.0
	13439933	CHEMBL2429476	Competitive binding affinity to PTK6 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL4601	Homo sapiens	INH	%	50.0
	13445443	CHEMBL2429476	Competitive binding affinity to PTK6 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	78.0	CHEMBL4601	Homo sapiens	INH	%	78.0
	13448498	CHEMBL2429476	Competitive binding affinity to PTK6 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL4601	Homo sapiens	INH	%	50.0
	13448634	CHEMBL2429476	Competitive binding affinity to PTK6 (unknown origin) at 10 uM in presence of ATP relative to control	B	O=C([C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1)N1CCOCC1		CHEMBL2425649	<	Inhibition	%	50.0	CHEMBL4601	Homo sapiens	INH	%	50.0
	13451429	CHEMBL2429476	Competitive binding affinity to PTK6 (unknown origin) at 10 uM in presence of ATP relative to control	B	N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425652	<	Inhibition	%	50.0	CHEMBL4601	Homo sapiens	INH	%	50.0
	13454614	CHEMBL2429476	Competitive binding affinity to PTK6 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL4601	Homo sapiens	INH	%	50.0
	13507643	CHEMBL2444017	Inhibition of BRK (unknown origin)	B	CN(C)c1ccc(Oc2cc(O)cc(O)c2-c2cc(C(=O)NC3CCN(C4CCC5(CC4)OCCO5)CC3)no2)cc1		CHEMBL2443026	>	IC50	nM	10.0	CHEMBL4601	Homo sapiens	IC50	nM	10.0
	13507644	CHEMBL2444017	Inhibition of BRK (unknown origin)	B	CC(C)Nc1ccc(Oc2cc(O)cc(O)c2-c2cc(C(=O)NC3CCN(C)CC3)no2)cc1		CHEMBL2443139	>	IC50	nM	10.0	CHEMBL4601	Homo sapiens	IC50	nM	10.0
	13507645	CHEMBL2444017	Inhibition of BRK (unknown origin)	B	CN1CCC(NC(=O)c2cc(-c3c(O)cc(O)cc3Oc3ccc(N(C)C)cc3)on2)CC1		CHEMBL2443138	>	IC50	nM	10.0	CHEMBL4601	Homo sapiens	IC50	nM	10.0
	13507646	CHEMBL2444017	Inhibition of BRK (unknown origin)	B	CN1CCC(NC(=O)c2cc(-c3c(O)cc(O)cc3Oc3ccc([N+](=O)[O-])cc3)on2)CC1		CHEMBL2443044	>	IC50	nM	10.0	CHEMBL4601	Homo sapiens	IC50	nM	10.0
	13836287	CHEMBL3090855	Inhibition of BRK (unknown origin) after 90 mins by TR-FRET/IMAP fluorescence polarization assay	B	CNS(=O)(=O)Nc1cccc(Cc2c(C)c3cc(Cl)c(OC(=O)N(C)C)cc3oc2=O)c1		CHEMBL3086065	>	IC50	nM	50000.0	CHEMBL4601	Homo sapiens	IC50	uM	50.0
	13872201	CHEMBL3102388	Inhibition of human BRK assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	102.0	CHEMBL4601	Homo sapiens	Activity	%	102.0
Not Active	13906186	CHEMBL3117248	Inhibition of PTK6 in human MDA-MB-231 cells assessed as effect on total protein level at 1 to 20 uM after 72 hrs by Western blot analysis	B	CC1=CC[C@H]2[C@H](CC[C@]2(C)O)C(C)(C)[C@@H]1CC[C@H]1[C@]2(C)CC[C@H](OC(=O)c3ccc(Cl)c(Cl)c3)C(C)(C)O[C@H]2CC[C@@]1(C)O		CHEMBL3113311		Activity			CHEMBL4601	Homo sapiens	Activity		
Dose-dependent effect	13906187	CHEMBL3117249	Inhibition of PTK6 phosphorylation in human MDA-MB-231 cells after 72 hrs by Western blot analysis	B	CC1=CC[C@H]2[C@H](CC[C@]2(C)O)C(C)(C)[C@@H]1CC[C@H]1[C@]2(C)CC[C@H](OC(=O)c3ccc(Cl)c(Cl)c3)C(C)(C)O[C@H]2CC[C@@]1(C)O		CHEMBL3113311		Inhibition	%		CHEMBL4601	Homo sapiens	INH		
Dose-dependent effect	13906188	CHEMBL3117250	Inhibition of PTK6 (unknown origin) phosphorylation using Z'-LYTE-Tyr 1 peptide substrate after 1 hr by fluorescence assay	B	CC1=CC[C@H]2[C@H](CC[C@]2(C)O)C(C)(C)[C@@H]1CC[C@H]1[C@]2(C)CC[C@H](OC(=O)c3ccc(Cl)c(Cl)c3)C(C)(C)O[C@H]2CC[C@@]1(C)O		CHEMBL3113311		Inhibition	%		CHEMBL4601	Homo sapiens	INH		
Active	13906204	CHEMBL3117247	Inhibition of PTK6 phosphorylation in human MDA-MB-231 cells at 20 uM after 72 hrs by Western blot analysis	B	CC1=CC[C@H]2[C@H](CC[C@]2(C)O)C(C)(C)[C@@H]1CC[C@H]1[C@]2(C)CC[C@H](OC(=O)c3ccccc3)C(C)(C)O[C@H]2CC[C@@]1(C)O		CHEMBL3113101		Inhibition	%		CHEMBL4601	Homo sapiens	INH		
	13907001	CHEMBL3117250	Inhibition of PTK6 (unknown origin) phosphorylation using Z'-LYTE-Tyr 1 peptide substrate after 1 hr by fluorescence assay	B	CC1=CC[C@H]2[C@H](CC[C@]2(C)O)C(C)(C)[C@@H]1CC[C@H]1[C@]2(C)CC[C@H](OC(=O)c3ccc(Cl)c(Cl)c3)C(C)(C)O[C@H]2CC[C@@]1(C)O		CHEMBL3113311	=	IC50	nM	5300.0	CHEMBL4601	Homo sapiens	IC50	uM	5.3
	13907058	CHEMBL3117250	Inhibition of PTK6 (unknown origin) phosphorylation using Z'-LYTE-Tyr 1 peptide substrate after 1 hr by fluorescence assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1250.0	CHEMBL4601	Homo sapiens	IC50	uM	1.25
	13953219	CHEMBL3132653	Inhibition of human BRK assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125728	=	Activity	%	112.0	CHEMBL4601	Homo sapiens	Activity	%	112.0
	13953227	CHEMBL3132653	Inhibition of human BRK assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125727	=	Activity	%	110.0	CHEMBL4601	Homo sapiens	Activity	%	110.0
	13954640	CHEMBL3132653	Inhibition of human BRK assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125726	=	Activity	%	102.0	CHEMBL4601	Homo sapiens	Activity	%	102.0
Active	13973385	CHEMBL3134648	Inhibition of BRK in human T47D cells assessed as phosphorylation of STAT3 at >100 nM by Western blot analysis	B	Oc1cccc(Nc2ccnc3[nH]c4ccccc4c23)c1		CHEMBL3133821		Inhibition	%		CHEMBL4601	Homo sapiens	INH		
	13973398	CHEMBL3134836	Inhibition of human recombinant GST-fused Brk expressed in baculovirus Sf9 insect cells using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting	B	CC(=O)c1ccc2[nH]c3nccc(Nc4cccc(Cl)c4)c3c2c1		CHEMBL3133819	=	IC50	nM	13.0	CHEMBL4601	Homo sapiens	IC50	nM	13.0
	13973399	CHEMBL3134836	Inhibition of human recombinant GST-fused Brk expressed in baculovirus Sf9 insect cells using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting	B	CC(=O)c1ccc2[nH]c3nccc(Nc4cccc(O)c4)c3c2c1	Outside typical range	CHEMBL3133816	>	IC50	nM	1000000.0	CHEMBL4601	Homo sapiens	IC50	nM	1000000.0
	13973400	CHEMBL3134836	Inhibition of human recombinant GST-fused Brk expressed in baculovirus Sf9 insect cells using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting	B	CC(=O)c1ccc2[nH]c3nccc(Nc4cccc([N+](=O)[O-])c4)c3c2c1		CHEMBL3133817	=	IC50	nM	21.0	CHEMBL4601	Homo sapiens	IC50	nM	21.0
	13973401	CHEMBL3134836	Inhibition of human recombinant GST-fused Brk expressed in baculovirus Sf9 insect cells using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting	B	CC(=O)c1ccc2[nH]c3nccc(Nc4cccc(N)c4)c3c2c1		CHEMBL3133818	=	IC50	nM	7.6	CHEMBL4601	Homo sapiens	IC50	nM	7.6
	13973417	CHEMBL3134836	Inhibition of human recombinant GST-fused Brk expressed in baculovirus Sf9 insect cells using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting	B	Cc1ccccc1Nc1ccnc2[nH]c3ccccc3c12	Outside typical range	CHEMBL3133820	>	IC50	nM	1000000.0	CHEMBL4601	Homo sapiens	IC50	nM	1000000.0
	13973418	CHEMBL3134836	Inhibition of human recombinant GST-fused Brk expressed in baculovirus Sf9 insect cells using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting	B	Oc1cccc(Nc2ccnc3[nH]c4ccccc4c23)c1		CHEMBL3133821	=	IC50	nM	3.2	CHEMBL4601	Homo sapiens	IC50	nM	3.2
	13973419	CHEMBL3134836	Inhibition of human recombinant GST-fused Brk expressed in baculovirus Sf9 insect cells using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting	B	Clc1cccc(Nc2ccnc3[nH]c4ccccc4c23)c1		CHEMBL3133822	=	IC50	nM	4.7	CHEMBL4601	Homo sapiens	IC50	nM	4.7
	13973420	CHEMBL3134836	Inhibition of human recombinant GST-fused Brk expressed in baculovirus Sf9 insect cells using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting	B	Clc1ccc(Nc2ccnc3[nH]c4ccccc4c23)cc1	Outside typical range	CHEMBL3133823	>	IC50	nM	1000000.0	CHEMBL4601	Homo sapiens	IC50	nM	1000000.0
	13973421	CHEMBL3134836	Inhibition of human recombinant GST-fused Brk expressed in baculovirus Sf9 insect cells using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting	B	O=S(=O)(c1ccc2[nH]c3nccc(Nc4cccc(O)c4)c3c2c1)N1CCOCC1	Outside typical range	CHEMBL3133824	>	IC50	nM	1000000.0	CHEMBL4601	Homo sapiens	IC50	nM	1000000.0
	13973422	CHEMBL3134836	Inhibition of human recombinant GST-fused Brk expressed in baculovirus Sf9 insect cells using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting	B	COc1cccc(Nc2ccnc3[nH]c4ccc(S(=O)(=O)N5CCOCC5)cc4c23)c1		CHEMBL3133825	=	IC50	nM	5.7	CHEMBL4601	Homo sapiens	IC50	nM	5.7
	13973423	CHEMBL3134836	Inhibition of human recombinant GST-fused Brk expressed in baculovirus Sf9 insect cells using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting	B	CCOc1cccc(Nc2ccnc3[nH]c4ccc(S(=O)(=O)N5CCOCC5)cc4c23)c1		CHEMBL3133826	=	IC50	nM	410.0	CHEMBL4601	Homo sapiens	IC50	nM	410.0
	13973424	CHEMBL3134836	Inhibition of human recombinant GST-fused Brk expressed in baculovirus Sf9 insect cells using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting	B	O=S(=O)(c1ccc2[nH]c3nccc(Nc4cccc(OCc5ccccc5)c4)c3c2c1)N1CCOCC1		CHEMBL3133827	=	IC50	nM	55.0	CHEMBL4601	Homo sapiens	IC50	nM	55.0
	13973425	CHEMBL3134836	Inhibition of human recombinant GST-fused Brk expressed in baculovirus Sf9 insect cells using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting	B	COc1cccc(Nc2ccnc3[nH]c4ccc(S(=O)(=O)N5CCNCC5)cc4c23)c1		CHEMBL3133828	=	IC50	nM	4.8	CHEMBL4601	Homo sapiens	IC50	nM	4.8
	13973426	CHEMBL3134836	Inhibition of human recombinant GST-fused Brk expressed in baculovirus Sf9 insect cells using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting	B	CCOc1cccc(Nc2ccnc3[nH]c4ccc(S(=O)(=O)N5CCNCC5)cc4c23)c1		CHEMBL3133829	=	IC50	nM	26.0	CHEMBL4601	Homo sapiens	IC50	nM	26.0
	13973427	CHEMBL3134836	Inhibition of human recombinant GST-fused Brk expressed in baculovirus Sf9 insect cells using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting	B	COc1cccc(Nc2ccnc3[nH]c4ccc(S(=O)(=O)N5CCN(CCO)CC5)cc4c23)c1		CHEMBL3133830	=	IC50	nM	9.2	CHEMBL4601	Homo sapiens	IC50	nM	9.2
	13973428	CHEMBL3134836	Inhibition of human recombinant GST-fused Brk expressed in baculovirus Sf9 insect cells using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting	B	CCOc1cccc(Nc2ccnc3[nH]c4ccc(S(=O)(=O)N5CCN(CCO)CC5)cc4c23)c1		CHEMBL3133831	=	IC50	nM	479.0	CHEMBL4601	Homo sapiens	IC50	nM	479.0
	13973429	CHEMBL3134836	Inhibition of human recombinant GST-fused Brk expressed in baculovirus Sf9 insect cells using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting	B	O=S(=O)(c1ccc2[nH]c3nccc(Nc4cccc(O)c4)c3c2c1)N1CCN(CCO)CC1	Outside typical range	CHEMBL3133832	>	IC50	nM	1000000.0	CHEMBL4601	Homo sapiens	IC50	nM	1000000.0
	13973430	CHEMBL3134836	Inhibition of human recombinant GST-fused Brk expressed in baculovirus Sf9 insect cells using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting	B	Oc1cccc(Nc2ccnc3[nH]c4ccc(Br)cc4c23)c1	Outside typical range	CHEMBL3133833	>	IC50	nM	1000000.0	CHEMBL4601	Homo sapiens	IC50	nM	1000000.0
	13973431	CHEMBL3134836	Inhibition of human recombinant GST-fused Brk expressed in baculovirus Sf9 insect cells using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting	B	COc1cccc(Nc2ccnc3[nH]c4ccc(Br)cc4c23)c1		CHEMBL3133834	=	IC50	nM	186.0	CHEMBL4601	Homo sapiens	IC50	nM	186.0
	13973432	CHEMBL3134836	Inhibition of human recombinant GST-fused Brk expressed in baculovirus Sf9 insect cells using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting	B	Clc1cccc(Nc2ccnc3[nH]c4ccc(Br)cc4c23)c1		CHEMBL3133814	=	IC50	nM	13.0	CHEMBL4601	Homo sapiens	IC50	nM	13.0
	13973433	CHEMBL3134836	Inhibition of human recombinant GST-fused Brk expressed in baculovirus Sf9 insect cells using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting	B	O=[N+]([O-])c1cccc(Nc2ccnc3[nH]c4ccc(Br)cc4c23)c1		CHEMBL3133815	=	IC50	nM	4.1	CHEMBL4601	Homo sapiens	IC50	nM	4.1
	14585308	CHEMBL3241824	Inhibition of human PTK6 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	57.5	CHEMBL4601	Homo sapiens	Activity	%	57.5
	14593757	CHEMBL3241182	Inhibition of Brk (unknown origin) using [gamma-33P]-ATP after 60 mins by scintillation counting	B	Oc1cccc(Nc2ccnc3[nH]c4ccccc4c23)c1		CHEMBL3133821	=	IC50	nM	3.15	CHEMBL4601	Homo sapiens	IC50	nM	3.15
	14593758	CHEMBL3241182	Inhibition of Brk (unknown origin) using [gamma-33P]-ATP after 60 mins by scintillation counting	B	COc1cc(Nc2ccnc3[nH]c4ccccc4c23)ccc1Br		CHEMBL3238103	=	IC50	nM	4.41	CHEMBL4601	Homo sapiens	IC50	nM	4.41
	14593759	CHEMBL3241182	Inhibition of Brk (unknown origin) using [gamma-33P]-ATP after 60 mins by scintillation counting	B	Clc1cccc(Nc2ccnc3[nH]c4ccccc4c23)c1		CHEMBL3133822	=	IC50	nM	4.75	CHEMBL4601	Homo sapiens	IC50	nM	4.75
	14593760	CHEMBL3241182	Inhibition of Brk (unknown origin) using [gamma-33P]-ATP after 60 mins by scintillation counting	B	O=[N+]([O-])c1cccc(Nc2ccnc3[nH]c4ccccc4c23)c1		CHEMBL3238097	=	IC50	nM	5.65	CHEMBL4601	Homo sapiens	IC50	nM	5.65
	14593791	CHEMBL3241182	Inhibition of Brk (unknown origin) using [gamma-33P]-ATP after 60 mins by scintillation counting	B	c1ccc(COc2cccc(Nc3ccnc4[nH]c5ccccc5c34)c2)cc1		CHEMBL3238096	=	IC50	nM	40.7	CHEMBL4601	Homo sapiens	IC50	nM	40.7
	14593792	CHEMBL3241182	Inhibition of Brk (unknown origin) using [gamma-33P]-ATP after 60 mins by scintillation counting	B	C1=CCc2cc(Nc3ccnc4[nH]c5ccccc5c34)ccc2C1		CHEMBL3238091	=	IC50	nM	43.5	CHEMBL4601	Homo sapiens	IC50	nM	43.5
	14593793	CHEMBL3241182	Inhibition of Brk (unknown origin) using [gamma-33P]-ATP after 60 mins by scintillation counting	B	Clc1cc(Cl)cc(Nc2ccnc3[nH]c4ccccc4c23)c1		CHEMBL3238102	=	IC50	nM	53.4	CHEMBL4601	Homo sapiens	IC50	nM	53.4
	14593794	CHEMBL3241182	Inhibition of Brk (unknown origin) using [gamma-33P]-ATP after 60 mins by scintillation counting	B	FC(F)(F)c1cccc(Nc2ccnc3[nH]c4ccccc4c23)c1		CHEMBL3238092	=	IC50	nM	59.4	CHEMBL4601	Homo sapiens	IC50	nM	59.4
	14593795	CHEMBL3241182	Inhibition of Brk (unknown origin) using [gamma-33P]-ATP after 60 mins by scintillation counting	B	Clc1cc(Nc2ccnc3[nH]c4ccccc4c23)ccc1OCc1ccccc1		CHEMBL3238101	=	IC50	nM	64.5	CHEMBL4601	Homo sapiens	IC50	nM	64.5
	14593796	CHEMBL3241182	Inhibition of Brk (unknown origin) using [gamma-33P]-ATP after 60 mins by scintillation counting	B	Fc1ccc(Nc2ccnc3[nH]c4ccccc4c23)cc1Cl		CHEMBL3238100	=	IC50	nM	69.5	CHEMBL4601	Homo sapiens	IC50	nM	69.5
	14593797	CHEMBL3241182	Inhibition of Brk (unknown origin) using [gamma-33P]-ATP after 60 mins by scintillation counting	B	Cc1ccc(Nc2ccnc3[nH]c4ccccc4c23)cc1Cl		CHEMBL3238099	=	IC50	nM	75.6	CHEMBL4601	Homo sapiens	IC50	nM	75.6
	14593799	CHEMBL3241182	Inhibition of Brk (unknown origin) using [gamma-33P]-ATP after 60 mins by scintillation counting	B	CCOc1cc(Nc2ccnc3[nH]c4ccccc4c23)ccc1Br		CHEMBL3238104	=	IC50	nM	154.0	CHEMBL4601	Homo sapiens	IC50	nM	154.0
	14593800	CHEMBL3241182	Inhibition of Brk (unknown origin) using [gamma-33P]-ATP after 60 mins by scintillation counting	B	CCOc1cccc(Nc2ccnc3[nH]c4ccccc4c23)c1		CHEMBL3238095	=	IC50	nM	155.0	CHEMBL4601	Homo sapiens	IC50	nM	155.0
	14593801	CHEMBL3241182	Inhibition of Brk (unknown origin) using [gamma-33P]-ATP after 60 mins by scintillation counting	B	COc1ccc(Nc2ccnc3[nH]c4ccccc4c23)cc1		CHEMBL3238098	=	IC50	nM	190.0	CHEMBL4601	Homo sapiens	IC50	nM	190.0
Not Active	14593830	CHEMBL3241182	Inhibition of Brk (unknown origin) using [gamma-33P]-ATP after 60 mins by scintillation counting	B	Cc1ccccc1Nc1ccnc2[nH]c3ccccc3c12		CHEMBL3133820		IC50			CHEMBL4601	Homo sapiens	IC50		
Not Active	14593831	CHEMBL3241182	Inhibition of Brk (unknown origin) using [gamma-33P]-ATP after 60 mins by scintillation counting	B	CSc1cccc(Nc2ccnc3[nH]c4ccccc4c23)c1		CHEMBL3238093		IC50			CHEMBL4601	Homo sapiens	IC50		
Not Active	14596518	CHEMBL3241182	Inhibition of Brk (unknown origin) using [gamma-33P]-ATP after 60 mins by scintillation counting	B	COc1cccc(Nc2ccnc3[nH]c4ccccc4c23)c1		CHEMBL3238094		IC50			CHEMBL4601	Homo sapiens	IC50		
Not Active	14596519	CHEMBL3241182	Inhibition of Brk (unknown origin) using [gamma-33P]-ATP after 60 mins by scintillation counting	B	Clc1ccc(Nc2ccnc3[nH]c4ccccc4c23)cc1		CHEMBL3133823		IC50			CHEMBL4601	Homo sapiens	IC50		
	14663217	CHEMBL3268848	Inhibition of BRK (unknown origin) at 1 uM relative to control	B	CCOC(=O)c1sc(-c2ccncc2)nc1O		CHEMBL3261228	=	Inhibition	%	94.0	CHEMBL4601	Homo sapiens	INH	%	94.0
	14663218	CHEMBL3268848	Inhibition of BRK (unknown origin) at 1 uM relative to control	B	NC(=O)c1sc(-c2ccnc(N)n2)nc1-c1ccc(Cl)cc1Cl		CHEMBL3261514	=	Inhibition	%	68.0	CHEMBL4601	Homo sapiens	INH	%	68.0
	14663219	CHEMBL3268848	Inhibition of BRK (unknown origin) at 1 uM relative to control	B	COc1ccc(-c2nc(-c3ccnc(N)n3)sc2C(N)=O)c(Cl)c1		CHEMBL3261517	=	Inhibition	%	80.0	CHEMBL4601	Homo sapiens	INH	%	80.0
	14751173	CHEMBL3301286	Inhibition of BRK (unknown origin)	B	CC(C)(C)CNC(=O)CC1CNC(=O)c2cc(-c3ccsc3)cn21		CHEMBL3298400	>	IC50	nM	10000.0	CHEMBL4601	Homo sapiens	IC50	uM	10.0
	14751174	CHEMBL3301286	Inhibition of BRK (unknown origin)	B	CN1CCN(C[C@@H](NC(=O)C[C@H]2CNC(=O)c3cc(-c4cccc(Cl)c4)cn32)C2CCCCC2)CC1		CHEMBL3297762	>	IC50	nM	10000.0	CHEMBL4601	Homo sapiens	IC50	uM	10.0
	15007976	CHEMBL3367751	Inhibition of human BRK at 1 uM by radiometric Assay	B	NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)Cc4ccccc4)cc23)c1		CHEMBL3330255	=	Inhibition	%	-7.0	CHEMBL4601	Homo sapiens	INH	%	-7.0
	15007977	CHEMBL3367751	Inhibition of human BRK at 1 uM by radiometric Assay	B	COC(C(=O)Nc1ccc2[nH]nc(-c3cccc(S(N)(=O)=O)c3)c2c1)c1ccccc1		CHEMBL3330401	=	Inhibition	%	0.0	CHEMBL4601	Homo sapiens	INH	%	0.0
	15007978	CHEMBL3367751	Inhibition of human BRK at 1 uM by radiometric Assay	B	NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)C(c4ccsc4)N4CCCC4)cc23)c1		CHEMBL3330410	=	Inhibition	%	-2.0	CHEMBL4601	Homo sapiens	INH	%	-2.0
	15014109	CHEMBL3361864	Inhibition of BRK (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	5.5	CHEMBL4601	Homo sapiens	INH	%	5.5
	15036738	CHEMBL3381063	Inhibition of BRK (unknown origin)	B	Nc1nc2c3c(F)cccc3nc(Cc3ccc4c(c3)OCO4)n2n1		CHEMBL3309990	>	IC50	nM	10000.0	CHEMBL4601	Homo sapiens	IC50	uM	10.0
	15036739	CHEMBL3381063	Inhibition of BRK (unknown origin)	B	Nc1ccc2c(c1)nc(Cc1ccc3c(c1)OCO3)n1nc(N)nc21		CHEMBL3309995	>	IC50	nM	10000.0	CHEMBL4601	Homo sapiens	IC50	uM	10.0
	15036740	CHEMBL3381063	Inhibition of BRK (unknown origin)	B	OCCCNc1ccc2c(c1)nc(-c1ccc3c(c1)OCO3)n1ncnc21		CHEMBL3309997	>	IC50	nM	10000.0	CHEMBL4601	Homo sapiens	IC50	uM	10.0
	15036741	CHEMBL3381063	Inhibition of BRK (unknown origin)	B	Nc1nc2c3ccc(NCCO)cc3nc(Cc3ccc4c(c3)OCO4)n2n1		CHEMBL3309998	>	IC50	nM	10000.0	CHEMBL4601	Homo sapiens	IC50	uM	10.0
	15036742	CHEMBL3381063	Inhibition of BRK (unknown origin)	B	CN1CCN(c2cc(F)c3c(c2)nc(Cc2ccc4c(c2)OCO4)n2nc(N)nc32)CC1		CHEMBL3310151	>	IC50	nM	10000.0	CHEMBL4601	Homo sapiens	IC50	uM	10.0
	15072599	CHEMBL3382659	Inhibition of BRK (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	109.0	CHEMBL4601	Homo sapiens	Activity	%	109.0
	15105066	CHEMBL3381839	Inhibition of PTK6 (unknown origin) expressed in HEK293 cells assessed as decrease in tyrosine phosphorylation by chemiluminescence assay	B	COc1cc(I)cc(/C=N/c2ccc3[nH]c(=O)[nH]c3c2)c1O		CHEMBL3335234	=	IC50	nM	58100.0	CHEMBL4601	Homo sapiens	IC50	uM	58.1
	15105067	CHEMBL3381839	Inhibition of PTK6 (unknown origin) expressed in HEK293 cells assessed as decrease in tyrosine phosphorylation by chemiluminescence assay	B	COc1cc(Cl)cc(/C=N/c2ccc3[nH]c(=O)[nH]c3c2)c1O		CHEMBL3335233	=	IC50	nM	74040.0	CHEMBL4601	Homo sapiens	IC50	uM	74.04
Not Determined	15105068	CHEMBL3381839	Inhibition of PTK6 (unknown origin) expressed in HEK293 cells assessed as decrease in tyrosine phosphorylation by chemiluminescence assay	B	COc1cccc(/C=N/c2ccc3[nH]c(=O)[nH]c3c2)c1O		CHEMBL3335232		IC50			CHEMBL4601	Homo sapiens	IC50		
	15105069	CHEMBL3381839	Inhibition of PTK6 (unknown origin) expressed in HEK293 cells assessed as decrease in tyrosine phosphorylation by chemiluminescence assay	B	O=c1[nH]c2ccc(/N=C/c3cc(Cl)ccc3O)cc2[nH]1		CHEMBL3335231	>	IC50	nM	100000.0	CHEMBL4601	Homo sapiens	IC50	uM	100.0
Not Determined	15105070	CHEMBL3381839	Inhibition of PTK6 (unknown origin) expressed in HEK293 cells assessed as decrease in tyrosine phosphorylation by chemiluminescence assay	B	COc1cc(Br)cc(/C=N/c2ccc3[nH]c(=O)[nH]c3c2)c1OC		CHEMBL3335230		IC50			CHEMBL4601	Homo sapiens	IC50		
	15105071	CHEMBL3381839	Inhibition of PTK6 (unknown origin) expressed in HEK293 cells assessed as decrease in tyrosine phosphorylation by chemiluminescence assay	B	COc1cc(Br)cc(/C=N/c2ccc3[nH]c(=O)[nH]c3c2)c1O		CHEMBL3335229	=	IC50	nM	52440.0	CHEMBL4601	Homo sapiens	IC50	uM	52.44
	15105072	CHEMBL3381839	Inhibition of PTK6 (unknown origin) expressed in HEK293 cells assessed as decrease in tyrosine phosphorylation by chemiluminescence assay	B	COc1ccc(Br)cc1/C=N/c1ccc2[nH]c(=O)[nH]c2c1		CHEMBL3335228	>	IC50	nM	100000.0	CHEMBL4601	Homo sapiens	IC50	uM	100.0
	15105073	CHEMBL3381839	Inhibition of PTK6 (unknown origin) expressed in HEK293 cells assessed as decrease in tyrosine phosphorylation by chemiluminescence assay	B	O=c1[nH]c2ccc(/N=C/c3ccccc3O)cc2[nH]1		CHEMBL3335227	>	IC50	nM	100000.0	CHEMBL4601	Homo sapiens	IC50	uM	100.0
Not Determined	15105074	CHEMBL3381839	Inhibition of PTK6 (unknown origin) expressed in HEK293 cells assessed as decrease in tyrosine phosphorylation by chemiluminescence assay	B	O=c1[nH]c2ccc(/N=C/c3ccccc3)cc2[nH]1		CHEMBL3335226		IC50			CHEMBL4601	Homo sapiens	IC50		
	15105075	CHEMBL3381839	Inhibition of PTK6 (unknown origin) expressed in HEK293 cells assessed as decrease in tyrosine phosphorylation by chemiluminescence assay	B	O=c1[nH]c2ccc(/N=C/c3cc(Br)ccc3O)cc2[nH]1		CHEMBL3335225	>	IC50	nM	100000.0	CHEMBL4601	Homo sapiens	IC50	uM	100.0
	15105076	CHEMBL3381838	Inhibition of GST-tagged PTK6 (unknown origin) assessed as phosphorylated tyrosines after 20 mins by ELISA	B	CCOc1cc(Br)c(Br)c(/C=N/c2ccc3scnc3c2)c1O		CHEMBL3335254	=	IC50	nM	1170.0	CHEMBL4601	Homo sapiens	IC50	uM	1.17
	15105077	CHEMBL3381838	Inhibition of GST-tagged PTK6 (unknown origin) assessed as phosphorylated tyrosines after 20 mins by ELISA	B	CCOc1cc(Br)c(Br)c(/C=N/c2ccc3[nH]cnc3c2)c1O		CHEMBL3335253	=	IC50	nM	130.0	CHEMBL4601	Homo sapiens	IC50	uM	0.13
	15105078	CHEMBL3381838	Inhibition of GST-tagged PTK6 (unknown origin) assessed as phosphorylated tyrosines after 20 mins by ELISA	B	CCOc1cc(Br)c(Br)c(/C=N/c2ccc3[nH]ccc3c2)c1O		CHEMBL3335252	=	IC50	nM	360.0	CHEMBL4601	Homo sapiens	IC50	uM	0.36
	15105079	CHEMBL3381838	Inhibition of GST-tagged PTK6 (unknown origin) assessed as phosphorylated tyrosines after 20 mins by ELISA	B	COc1cc(Br)c(Br)c(/C=N/c2ccc3scnc3c2)c1O		CHEMBL3335251	=	IC50	nM	1300.0	CHEMBL4601	Homo sapiens	IC50	uM	1.3
	15105080	CHEMBL3381838	Inhibition of GST-tagged PTK6 (unknown origin) assessed as phosphorylated tyrosines after 20 mins by ELISA	B	COc1cc(Br)c(Br)c(/C=N/c2ccc3[nH]cnc3c2)c1O		CHEMBL3335250	=	IC50	nM	200.0	CHEMBL4601	Homo sapiens	IC50	uM	0.2
	15105081	CHEMBL3381838	Inhibition of GST-tagged PTK6 (unknown origin) assessed as phosphorylated tyrosines after 20 mins by ELISA	B	COc1cc(Br)c(Br)c(/C=N/c2ccc3[nH]ccc3c2)c1O		CHEMBL3335249	=	IC50	nM	270.0	CHEMBL4601	Homo sapiens	IC50	uM	0.27
	15105082	CHEMBL3381838	Inhibition of GST-tagged PTK6 (unknown origin) assessed as phosphorylated tyrosines after 20 mins by ELISA	B	CCOc1cc(Br)c(Br)c(CNc2ccc3[nH]c(=O)[nH]c3c2)c1O		CHEMBL3335248	=	IC50	nM	4790.0	CHEMBL4601	Homo sapiens	IC50	uM	4.79
	15105083	CHEMBL3381838	Inhibition of GST-tagged PTK6 (unknown origin) assessed as phosphorylated tyrosines after 20 mins by ELISA	B	COc1cc(Br)c(Br)c(CNc2ccc3[nH]c(=O)[nH]c3c2)c1O		CHEMBL3335247	>	IC50	nM	10000.0	CHEMBL4601	Homo sapiens	IC50	uM	10.0
	15105084	CHEMBL3381838	Inhibition of GST-tagged PTK6 (unknown origin) assessed as phosphorylated tyrosines after 20 mins by ELISA	B	CCOc1cc(Cl)c(Cl)c(/C=N/c2ccc3[nH]c(=O)[nH]c3c2)c1O		CHEMBL3335246	=	IC50	nM	1290.0	CHEMBL4601	Homo sapiens	IC50	uM	1.29
	15105085	CHEMBL3381838	Inhibition of GST-tagged PTK6 (unknown origin) assessed as phosphorylated tyrosines after 20 mins by ELISA	B	CCOc1cc(Br)c(Br)c(/C=N/c2ccc3[nH]c(=O)[nH]c3c2)c1O		CHEMBL3335245	=	IC50	nM	520.0	CHEMBL4601	Homo sapiens	IC50	uM	0.52
	15105086	CHEMBL3381838	Inhibition of GST-tagged PTK6 (unknown origin) assessed as phosphorylated tyrosines after 20 mins by ELISA	B	COc1cc(Br)c(Br)c(/C=N/c2ccc3[nH]c(=O)[nH]c3c2)c1O		CHEMBL3335244	=	IC50	nM	120.0	CHEMBL4601	Homo sapiens	IC50	uM	0.12
	15105087	CHEMBL3381838	Inhibition of GST-tagged PTK6 (unknown origin) assessed as phosphorylated tyrosines after 20 mins by ELISA	B	O=c1[nH]c2ccc(/N=C/c3c(O)c(Br)cc(Br)c3Br)cc2[nH]1		CHEMBL3335243	=	IC50	nM	410.0	CHEMBL4601	Homo sapiens	IC50	uM	0.41
	15105088	CHEMBL3381838	Inhibition of GST-tagged PTK6 (unknown origin) assessed as phosphorylated tyrosines after 20 mins by ELISA	B	N#C/C(=C\c1c[nH]c2ccccc12)C(=O)c1ccc(O)c(O)c1		CHEMBL68534	=	IC50	nM	2320.0	CHEMBL4601	Homo sapiens	IC50	uM	2.32
	15105089	CHEMBL3381838	Inhibition of GST-tagged PTK6 (unknown origin) assessed as phosphorylated tyrosines after 20 mins by ELISA	B	COc1ccc(Br)c(/C=N/c2ccc3[nH]c(=O)[nH]c3c2)c1O		CHEMBL3335242	=	IC50	nM	3900.0	CHEMBL4601	Homo sapiens	IC50	uM	3.9
	15105090	CHEMBL3381838	Inhibition of GST-tagged PTK6 (unknown origin) assessed as phosphorylated tyrosines after 20 mins by ELISA	B	O=c1[nH]c2ccc(/N=C/c3c(O)cccc3Br)cc2[nH]1		CHEMBL3335241	=	IC50	nM	1350.0	CHEMBL4601	Homo sapiens	IC50	uM	1.35
	15105091	CHEMBL3381838	Inhibition of GST-tagged PTK6 (unknown origin) assessed as phosphorylated tyrosines after 20 mins by ELISA	B	COc1ccc(/C=N/c2ccc3[nH]c(=O)[nH]c3c2)c(O)c1		CHEMBL3335240	>	IC50	nM	10000.0	CHEMBL4601	Homo sapiens	IC50	uM	10.0
	15105092	CHEMBL3381838	Inhibition of GST-tagged PTK6 (unknown origin) assessed as phosphorylated tyrosines after 20 mins by ELISA	B	O=c1[nH]c2ccc(/N=C/c3ccc(O)cc3O)cc2[nH]1		CHEMBL3335239	>	IC50	nM	10000.0	CHEMBL4601	Homo sapiens	IC50	uM	10.0
	15105093	CHEMBL3381838	Inhibition of GST-tagged PTK6 (unknown origin) assessed as phosphorylated tyrosines after 20 mins by ELISA	B	O=c1[nH]c2ccc(/N=C/c3cc(Br)cc(Br)c3O)cc2[nH]1		CHEMBL3335238	=	IC50	nM	5600.0	CHEMBL4601	Homo sapiens	IC50	uM	5.6
	15105094	CHEMBL3381838	Inhibition of GST-tagged PTK6 (unknown origin) assessed as phosphorylated tyrosines after 20 mins by ELISA	B	CCOc1cc(Cl)cc(/C=N/c2ccc3[nH]c(=O)[nH]c3c2)c1O		CHEMBL3335237	=	IC50	nM	1990.0	CHEMBL4601	Homo sapiens	IC50	uM	1.99
	15105095	CHEMBL3381838	Inhibition of GST-tagged PTK6 (unknown origin) assessed as phosphorylated tyrosines after 20 mins by ELISA	B	CCOc1cccc(/C=N/c2ccc3[nH]c(=O)[nH]c3c2)c1O		CHEMBL3335236	>	IC50	nM	10000.0	CHEMBL4601	Homo sapiens	IC50	uM	10.0
	15105096	CHEMBL3381838	Inhibition of GST-tagged PTK6 (unknown origin) assessed as phosphorylated tyrosines after 20 mins by ELISA	B	CCOc1cc(Br)cc(/C=N/c2ccc3[nH]c(=O)[nH]c3c2)c1O		CHEMBL3335235	=	IC50	nM	5830.0	CHEMBL4601	Homo sapiens	IC50	uM	5.83
	15105097	CHEMBL3381838	Inhibition of GST-tagged PTK6 (unknown origin) assessed as phosphorylated tyrosines after 20 mins by ELISA	B	COc1cc(I)cc(/C=N/c2ccc3[nH]c(=O)[nH]c3c2)c1O		CHEMBL3335234	=	IC50	nM	4980.0	CHEMBL4601	Homo sapiens	IC50	uM	4.98
	15105098	CHEMBL3381838	Inhibition of GST-tagged PTK6 (unknown origin) assessed as phosphorylated tyrosines after 20 mins by ELISA	B	COc1cc(Cl)cc(/C=N/c2ccc3[nH]c(=O)[nH]c3c2)c1O		CHEMBL3335233	=	IC50	nM	1680.0	CHEMBL4601	Homo sapiens	IC50	uM	1.68
	15105099	CHEMBL3381838	Inhibition of GST-tagged PTK6 (unknown origin) assessed as phosphorylated tyrosines after 20 mins by ELISA	B	COc1cccc(/C=N/c2ccc3[nH]c(=O)[nH]c3c2)c1O		CHEMBL3335232	>	IC50	nM	10000.0	CHEMBL4601	Homo sapiens	IC50	uM	10.0
	15105100	CHEMBL3381838	Inhibition of GST-tagged PTK6 (unknown origin) assessed as phosphorylated tyrosines after 20 mins by ELISA	B	O=c1[nH]c2ccc(/N=C/c3cc(Cl)ccc3O)cc2[nH]1		CHEMBL3335231	=	IC50	nM	1410.0	CHEMBL4601	Homo sapiens	IC50	uM	1.41
	15105101	CHEMBL3381838	Inhibition of GST-tagged PTK6 (unknown origin) assessed as phosphorylated tyrosines after 20 mins by ELISA	B	COc1cc(Br)cc(/C=N/c2ccc3[nH]c(=O)[nH]c3c2)c1OC		CHEMBL3335230	>	IC50	nM	10000.0	CHEMBL4601	Homo sapiens	IC50	uM	10.0
	15105102	CHEMBL3381838	Inhibition of GST-tagged PTK6 (unknown origin) assessed as phosphorylated tyrosines after 20 mins by ELISA	B	COc1cc(Br)cc(/C=N/c2ccc3[nH]c(=O)[nH]c3c2)c1O		CHEMBL3335229	=	IC50	nM	4730.0	CHEMBL4601	Homo sapiens	IC50	uM	4.73
	15105103	CHEMBL3381838	Inhibition of GST-tagged PTK6 (unknown origin) assessed as phosphorylated tyrosines after 20 mins by ELISA	B	COc1ccc(Br)cc1/C=N/c1ccc2[nH]c(=O)[nH]c2c1		CHEMBL3335228	=	IC50	nM	17110.0	CHEMBL4601	Homo sapiens	IC50	uM	17.11
	15105104	CHEMBL3381838	Inhibition of GST-tagged PTK6 (unknown origin) assessed as phosphorylated tyrosines after 20 mins by ELISA	B	O=c1[nH]c2ccc(/N=C/c3ccccc3O)cc2[nH]1		CHEMBL3335227	=	IC50	nM	2000.0	CHEMBL4601	Homo sapiens	IC50	uM	2.0
	15105105	CHEMBL3381838	Inhibition of GST-tagged PTK6 (unknown origin) assessed as phosphorylated tyrosines after 20 mins by ELISA	B	O=c1[nH]c2ccc(/N=C/c3ccccc3)cc2[nH]1		CHEMBL3335226	>	IC50	nM	10000.0	CHEMBL4601	Homo sapiens	IC50	uM	10.0
	15105106	CHEMBL3381838	Inhibition of GST-tagged PTK6 (unknown origin) assessed as phosphorylated tyrosines after 20 mins by ELISA	B	O=c1[nH]c2ccc(/N=C/c3cc(Br)ccc3O)cc2[nH]1		CHEMBL3335225	=	IC50	nM	1900.0	CHEMBL4601	Homo sapiens	IC50	uM	1.9
	15105107	CHEMBL3381839	Inhibition of PTK6 (unknown origin) expressed in HEK293 cells assessed as decrease in tyrosine phosphorylation by chemiluminescence assay	B	CCOc1cc(Br)cc(/C=N/c2ccc3[nH]c(=O)[nH]c3c2)c1O		CHEMBL3335235	=	IC50	nM	23510.0	CHEMBL4601	Homo sapiens	IC50	uM	23.51
Not Determined	15105108	CHEMBL3381839	Inhibition of PTK6 (unknown origin) expressed in HEK293 cells assessed as decrease in tyrosine phosphorylation by chemiluminescence assay	B	CCOc1cccc(/C=N/c2ccc3[nH]c(=O)[nH]c3c2)c1O		CHEMBL3335236		IC50			CHEMBL4601	Homo sapiens	IC50		
	15105109	CHEMBL3381839	Inhibition of PTK6 (unknown origin) expressed in HEK293 cells assessed as decrease in tyrosine phosphorylation by chemiluminescence assay	B	CCOc1cc(Cl)cc(/C=N/c2ccc3[nH]c(=O)[nH]c3c2)c1O		CHEMBL3335237	=	IC50	nM	51250.0	CHEMBL4601	Homo sapiens	IC50	uM	51.25
	15105110	CHEMBL3381839	Inhibition of PTK6 (unknown origin) expressed in HEK293 cells assessed as decrease in tyrosine phosphorylation by chemiluminescence assay	B	O=c1[nH]c2ccc(/N=C/c3cc(Br)cc(Br)c3O)cc2[nH]1		CHEMBL3335238	=	IC50	nM	48960.0	CHEMBL4601	Homo sapiens	IC50	uM	48.96
Not Determined	15105111	CHEMBL3381839	Inhibition of PTK6 (unknown origin) expressed in HEK293 cells assessed as decrease in tyrosine phosphorylation by chemiluminescence assay	B	O=c1[nH]c2ccc(/N=C/c3ccc(O)cc3O)cc2[nH]1		CHEMBL3335239		IC50			CHEMBL4601	Homo sapiens	IC50		
Not Determined	15105112	CHEMBL3381839	Inhibition of PTK6 (unknown origin) expressed in HEK293 cells assessed as decrease in tyrosine phosphorylation by chemiluminescence assay	B	COc1ccc(/C=N/c2ccc3[nH]c(=O)[nH]c3c2)c(O)c1		CHEMBL3335240		IC50			CHEMBL4601	Homo sapiens	IC50		
	15105113	CHEMBL3381839	Inhibition of PTK6 (unknown origin) expressed in HEK293 cells assessed as decrease in tyrosine phosphorylation by chemiluminescence assay	B	O=c1[nH]c2ccc(/N=C/c3c(O)cccc3Br)cc2[nH]1		CHEMBL3335241	=	IC50	nM	24490.0	CHEMBL4601	Homo sapiens	IC50	uM	24.49
	15105114	CHEMBL3381839	Inhibition of PTK6 (unknown origin) expressed in HEK293 cells assessed as decrease in tyrosine phosphorylation by chemiluminescence assay	B	COc1ccc(Br)c(/C=N/c2ccc3[nH]c(=O)[nH]c3c2)c1O		CHEMBL3335242	=	IC50	nM	16630.0	CHEMBL4601	Homo sapiens	IC50	uM	16.63
	15105115	CHEMBL3381839	Inhibition of PTK6 (unknown origin) expressed in HEK293 cells assessed as decrease in tyrosine phosphorylation by chemiluminescence assay	B	N#C/C(=C\c1c[nH]c2ccccc12)C(=O)c1ccc(O)c(O)c1		CHEMBL68534	=	IC50	nM	53240.0	CHEMBL4601	Homo sapiens	IC50	uM	53.24
	15105116	CHEMBL3381839	Inhibition of PTK6 (unknown origin) expressed in HEK293 cells assessed as decrease in tyrosine phosphorylation by chemiluminescence assay	B	O=c1[nH]c2ccc(/N=C/c3c(O)c(Br)cc(Br)c3Br)cc2[nH]1		CHEMBL3335243	=	IC50	nM	11750.0	CHEMBL4601	Homo sapiens	IC50	uM	11.75
	15105117	CHEMBL3381839	Inhibition of PTK6 (unknown origin) expressed in HEK293 cells assessed as decrease in tyrosine phosphorylation by chemiluminescence assay	B	COc1cc(Br)c(Br)c(/C=N/c2ccc3[nH]c(=O)[nH]c3c2)c1O		CHEMBL3335244	=	IC50	nM	1460.0	CHEMBL4601	Homo sapiens	IC50	uM	1.46
	15105118	CHEMBL3381839	Inhibition of PTK6 (unknown origin) expressed in HEK293 cells assessed as decrease in tyrosine phosphorylation by chemiluminescence assay	B	CCOc1cc(Br)c(Br)c(/C=N/c2ccc3[nH]c(=O)[nH]c3c2)c1O		CHEMBL3335245	=	IC50	nM	1600.0	CHEMBL4601	Homo sapiens	IC50	uM	1.6
	15105119	CHEMBL3381839	Inhibition of PTK6 (unknown origin) expressed in HEK293 cells assessed as decrease in tyrosine phosphorylation by chemiluminescence assay	B	CCOc1cc(Cl)c(Cl)c(/C=N/c2ccc3[nH]c(=O)[nH]c3c2)c1O		CHEMBL3335246	=	IC50	nM	3480.0	CHEMBL4601	Homo sapiens	IC50	uM	3.48
Not Determined	15105120	CHEMBL3381839	Inhibition of PTK6 (unknown origin) expressed in HEK293 cells assessed as decrease in tyrosine phosphorylation by chemiluminescence assay	B	COc1cc(Br)c(Br)c(CNc2ccc3[nH]c(=O)[nH]c3c2)c1O		CHEMBL3335247		IC50			CHEMBL4601	Homo sapiens	IC50		
	15105121	CHEMBL3381839	Inhibition of PTK6 (unknown origin) expressed in HEK293 cells assessed as decrease in tyrosine phosphorylation by chemiluminescence assay	B	COc1cc(Br)c(Br)c(/C=N/c2ccc3[nH]ccc3c2)c1O		CHEMBL3335249	=	IC50	nM	3490.0	CHEMBL4601	Homo sapiens	IC50	uM	3.49
	15105122	CHEMBL3381839	Inhibition of PTK6 (unknown origin) expressed in HEK293 cells assessed as decrease in tyrosine phosphorylation by chemiluminescence assay	B	COc1cc(Br)c(Br)c(/C=N/c2ccc3[nH]cnc3c2)c1O		CHEMBL3335250	=	IC50	nM	5520.0	CHEMBL4601	Homo sapiens	IC50	uM	5.52
	15105123	CHEMBL3381839	Inhibition of PTK6 (unknown origin) expressed in HEK293 cells assessed as decrease in tyrosine phosphorylation by chemiluminescence assay	B	COc1cc(Br)c(Br)c(/C=N/c2ccc3scnc3c2)c1O		CHEMBL3335251	=	IC50	nM	4610.0	CHEMBL4601	Homo sapiens	IC50	uM	4.61
	15105124	CHEMBL3381839	Inhibition of PTK6 (unknown origin) expressed in HEK293 cells assessed as decrease in tyrosine phosphorylation by chemiluminescence assay	B	CCOc1cc(Br)c(Br)c(/C=N/c2ccc3[nH]ccc3c2)c1O		CHEMBL3335252	=	IC50	nM	7580.0	CHEMBL4601	Homo sapiens	IC50	uM	7.58
	15105125	CHEMBL3381839	Inhibition of PTK6 (unknown origin) expressed in HEK293 cells assessed as decrease in tyrosine phosphorylation by chemiluminescence assay	B	CCOc1cc(Br)c(Br)c(/C=N/c2ccc3[nH]cnc3c2)c1O		CHEMBL3335253	=	IC50	nM	4710.0	CHEMBL4601	Homo sapiens	IC50	uM	4.71
	15105126	CHEMBL3381839	Inhibition of PTK6 (unknown origin) expressed in HEK293 cells assessed as decrease in tyrosine phosphorylation by chemiluminescence assay	B	CCOc1cc(Br)c(Br)c(/C=N/c2ccc3scnc3c2)c1O		CHEMBL3335254	=	IC50	nM	2540.0	CHEMBL4601	Homo sapiens	IC50	uM	2.54
Dose-dependent effect	15105127	CHEMBL3381839	Inhibition of PTK6 (unknown origin) expressed in HEK293 cells assessed as decrease in tyrosine phosphorylation by chemiluminescence assay	B	COc1cc(Br)c(Br)c(/C=N/c2ccc3[nH]c(=O)[nH]c3c2)c1O		CHEMBL3335244		Inhibition	%		CHEMBL4601	Homo sapiens	INH		
Dose-dependent effect	15105128	CHEMBL3381839	Inhibition of PTK6 (unknown origin) expressed in HEK293 cells assessed as decrease in tyrosine phosphorylation by chemiluminescence assay	B	CCOc1cc(Br)c(Br)c(/C=N/c2ccc3[nH]c(=O)[nH]c3c2)c1O		CHEMBL3335245		Inhibition	%		CHEMBL4601	Homo sapiens	INH		
Dose-dependent effect	15105129	CHEMBL3381840	Inhibition of PTK6 (unknown origin) expressed in HEK293 cells assessed as decrease in paxillin phosphorylation by chemiluminescence assay	B	COc1cc(Br)c(Br)c(/C=N/c2ccc3[nH]c(=O)[nH]c3c2)c1O		CHEMBL3335244		Inhibition	%		CHEMBL4601	Homo sapiens	INH		
Dose-dependent effect	15105130	CHEMBL3381840	Inhibition of PTK6 (unknown origin) expressed in HEK293 cells assessed as decrease in paxillin phosphorylation by chemiluminescence assay	B	CCOc1cc(Br)c(Br)c(/C=N/c2ccc3[nH]c(=O)[nH]c3c2)c1O		CHEMBL3335245		Inhibition	%		CHEMBL4601	Homo sapiens	INH		
Dose-dependent effect	15105131	CHEMBL3381841	Inhibition of PTK6 (unknown origin) expressed in HEK293 cells assessed as decrease in STAT3 phosphorylation by chemiluminescence assay	B	COc1cc(Br)c(Br)c(/C=N/c2ccc3[nH]c(=O)[nH]c3c2)c1O		CHEMBL3335244		Inhibition	%		CHEMBL4601	Homo sapiens	INH		
Dose-dependent effect	15105132	CHEMBL3381841	Inhibition of PTK6 (unknown origin) expressed in HEK293 cells assessed as decrease in STAT3 phosphorylation by chemiluminescence assay	B	CCOc1cc(Br)c(Br)c(/C=N/c2ccc3[nH]c(=O)[nH]c3c2)c1O		CHEMBL3335245		Inhibition	%		CHEMBL4601	Homo sapiens	INH		
	15656302	CHEMBL3598816	Inhibition of PTK6 (unknown origin) at 0.1 uM	B	CN1CCc2cc(-c3cnc4[nH]cc(C(=O)c5ccccc5Cl)c4c3)ccc2C1		CHEMBL3597011	>	Inhibition	%	95.0	CHEMBL4601	Homo sapiens	INH	%	95.0
	15685874	CHEMBL3607950	Inhibition of human BRK	B	NC(=O)c1cc(F)cc2c1C(=O)N(C1CCN(C3CCC(F)(F)CC3)CC1)C2		CHEMBL3606021	>	IC50	nM	10000.0	CHEMBL4601	Homo sapiens	IC50	uM	10.0
	15756098	CHEMBL3632168	Inhibition of BRK (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	100.04	CHEMBL4601	Homo sapiens	INH	%	100.04
	15757693	CHEMBL3632168	Inhibition of BRK (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	95.67	CHEMBL4601	Homo sapiens	INH	%	95.67
	15758001	CHEMBL3632168	Inhibition of BRK (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	84.39	CHEMBL4601	Homo sapiens	INH	%	84.39
	16370663	CHEMBL3734196	Inhibition of Brk (unknown origin)	B	CCCS(=O)(=O)Nc1ccc(Cl)c(C(=O)Nc2ccc(NC(C)=O)nc2)c1F		CHEMBL3732214	<=	IC50	nM	10000.0	CHEMBL4601	Homo sapiens	IC50	uM	10.0
	16425323	CHEMBL3751372	Inhibition of Brk (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	3.5	CHEMBL4601	Homo sapiens	INH	%	3.5
	16431741	CHEMBL3748633	Inhibition of human BRK using poly[Glu:Tyr] (4:1) as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL4601	Homo sapiens	IC50	uM	10.0
	16495342	CHEMBL3776889	Inhibition of N-terminal His6-tagged recombinant human BRK expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-6.0	CHEMBL4601	Homo sapiens	Activity	%	-6.0
	16508111	CHEMBL3776889	Inhibition of N-terminal His6-tagged recombinant human BRK expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	3.0	CHEMBL4601	Homo sapiens	Activity	%	3.0
	16509088	CHEMBL3776889	Inhibition of N-terminal His6-tagged recombinant human BRK expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	1.0	CHEMBL4601	Homo sapiens	Activity	%	1.0
	16578321	CHEMBL3804375	Inhibition of partial length wild type human BRK expressed in bacterial system assessed as enzyme activity at 1 uM relative to control	B	CN(C)S(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F		CHEMBL3798256	=	Activity	%	14.0	CHEMBL4601	Homo sapiens	Activity	%	14.0
	16586980	CHEMBL3807417	Inhibition of BRK (unknown origin) in presence of gamma33-ATP	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	=	IC50	nM	195.0	CHEMBL4601	Homo sapiens	IC50	uM	0.195
	16611836	CHEMBL3816641	Inhibition of human BRK (1 to 451 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Activity	%	-12.0	CHEMBL4601	Homo sapiens	Activity	%	-12.0
	16613779	CHEMBL3817215	Inhibition of human BRK at 1 uM using poly[Glu:Tyr] (4:1) as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	26.0	CHEMBL4601	Homo sapiens	INH	%	26.0
	16618271	CHEMBL3817013	Inhibition of full length recombinant human His-tagged cytoplasmic BRK expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL4601	Homo sapiens	INH	%	50.0
	16621480	CHEMBL3820473	Inhibition of BRK (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN1C(=O)COc2c1cnc1ccc(Sc3nnc4c(F)cc(-c5cnn(C)c5)cn34)cc21		CHEMBL3818247	>	IC50	nM	30000.0	CHEMBL4601	Homo sapiens	IC50	nM	30000.0
	16622195	CHEMBL3820473	Inhibition of BRK (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	247.0	CHEMBL4601	Homo sapiens	IC50	nM	247.0
	16627488	CHEMBL3820213	Inhibition of full length recombinant human N-terminal His6-tagged BRK expressed in baculovirus infected Sf21 cells at 1 uM by radiometric assay relative to control	B	Cc1cc(-c2cnn3c(NCC4CCOCC4)nc(Oc4ccccc4)nc23)ccc1C(=O)NC1CC1		CHEMBL3819210	=	Inhibition	%	4.0	CHEMBL4601	Homo sapiens	INH	%	4.0
	16627489	CHEMBL3820213	Inhibition of full length recombinant human N-terminal His6-tagged BRK expressed in baculovirus infected Sf21 cells at 1 uM by radiometric assay relative to control	B	O=C(N[C@@H](c1ccccn1)C1CC1)c1ccc2[nH]nc(-c3ccc(N4C5CCC4CC(O)C5)cc3)c2c1	Outside typical range	CHEMBL3818239	=	Inhibition	%	-12.0	CHEMBL4601	Homo sapiens	INH	%	-12.0
	16638359	CHEMBL3825646	Inhibition of human full length N-terminal GST-tagged BRK expressed in baculovirus expression system at 1 uM	B	CC(C)(C)S(=O)(=O)c1ccc2nccc(Nc3n[nH]c4ccc(F)cc34)c2c1		CHEMBL3823499	=	Inhibition	%	30.0	CHEMBL4601	Homo sapiens	INH	%	30.0
	16654247	CHEMBL3829894	Inhibition of human BRK (1 to 451 residues) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay	B	Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1		CHEMBL1077604	=	Activity	%	93.0	CHEMBL4601	Homo sapiens	Activity	%	93.0
	16837464	CHEMBL3876126	Inhibition of human recombinant full length His-tagged PTK6 cytoplasmic domain expressed in baculovirus expression system	B	CC1(C)C(=O)N([C@H]2CCc3c(O)cccc32)c2nc(Nc3ccccc3)ncc21		CHEMBL3884319	=	IC50	nM	10000.0	CHEMBL4601	Homo sapiens	IC50	nM	10000.0
342617	17720008	CHEMBL3887545	HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 M ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	3.3	CHEMBL4601	Homo sapiens	IC50	nM	3.3
342638	17720029	CHEMBL3887545	HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 M ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)N[C@H]1CC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1		CHEMBL3647967	=	IC50	nM	3.3	CHEMBL4601	Homo sapiens	IC50	nM	3.3
385009	17758431	CHEMBL3888251	In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	3.3	CHEMBL4601	Homo sapiens	IC50	nM	3.3
385030	17758452	CHEMBL3888251	In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)N[C@H]1CC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1		CHEMBL3647967	=	IC50	nM	3.3	CHEMBL4601	Homo sapiens	IC50	nM	3.3
421754	17784813	CHEMBL3888884	"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 l reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 l of ATP solution (in H2O), 20 l of assay buffer (see below), 5 l of test sample in 10% DMSO, 10 l of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 M Na-orthovanadate, 1.2 mM DTT, 50 g/ml PEG20000, 1 M [-33P]-ATP (approx. 810^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 g/ml Phosphatidylserine and 1 g/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 g/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 M cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30 C. for 80 minutes. The reaction was stopped with 50 l of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 l 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac)."	B	Nc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1c(Cl)cc(Cl)cc1Cl		CHEMBL2011291	=	IC50	nM	61.0	CHEMBL4601	Homo sapiens	IC50	nM	61.0
421770	17784829	CHEMBL3888884	"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 l reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 l of ATP solution (in H2O), 20 l of assay buffer (see below), 5 l of test sample in 10% DMSO, 10 l of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 M Na-orthovanadate, 1.2 mM DTT, 50 g/ml PEG20000, 1 M [-33P]-ATP (approx. 810^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 g/ml Phosphatidylserine and 1 g/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 g/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 M cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30 C. for 80 minutes. The reaction was stopped with 50 l of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 l 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac)."	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	IC50	nM	980.0	CHEMBL4601	Homo sapiens	IC50	nM	980.0
Inactive	17932876	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932877	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932878	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932879	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932880	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932881	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932882	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932883	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Active	17932884	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	1237.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	1237.0
Inactive	17932885	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Active	17932886	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	=	Kd	nM	1939.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	1939.0
Inactive	17932887	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932888	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932889	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932890	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932891	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932892	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932893	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932894	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932895	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932896	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932897	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932898	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932899	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Active	17932900	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	=	Kd	nM	983.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	983.0
Inactive	17932901	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932902	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932903	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932904	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932905	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932906	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932907	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Active	17932908	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	=	Kd	nM	8187.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	8187.0
Inactive	17932909	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Active	17932910	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	=	Kd	nM	2098.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	2098.0
Inactive	17932911	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932912	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Active	17932913	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	=	Kd	nM	180.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	180.0
Inactive	17932914	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932915	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932916	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932917	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17932918	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	14295.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	14295.0
Inactive	17932919	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932920	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932921	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932922	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932923	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Active	17932924	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	59.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	59.0
Active	17932925	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	=	Kd	nM	61.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	61.0
Inactive	17932926	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932927	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932928	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Active	17932929	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	Kd	nM	31.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	31.0
Inactive	17932930	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932931	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932932	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932933	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Active	17932934	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Kd	nM	1219.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	1219.0
Inactive	17932935	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932936	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932937	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932938	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932939	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932940	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932941	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932942	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932943	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932944	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932945	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932946	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932947	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932948	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932949	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932950	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932951	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932952	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932953	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932954	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932955	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Active	17932956	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	Kd	nM	1763.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	1763.0
Inactive	17932957	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932958	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Active	17932959	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	=	Kd	nM	1414.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	1414.0
Inactive	17932960	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932961	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932962	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932963	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932964	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932965	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932966	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932967	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932968	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932969	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Active	17932970	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	546.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	546.0
Inactive	17932971	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932972	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Active	17932973	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	Kd	nM	2042.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	2042.0
Active	17932974	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	=	Kd	nM	2202.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	2202.0
Inactive	17932975	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932976	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Active	17932977	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	441.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	441.0
Inactive	17932978	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Active	17932979	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	=	Kd	nM	1411.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	1411.0
Inactive	17932980	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932981	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932982	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932983	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932984	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932985	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932986	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932987	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932988	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932989	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932990	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932991	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932992	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932993	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932994	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932995	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932996	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932997	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932998	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17932999	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933000	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933001	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933002	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933003	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933004	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933005	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933006	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Active	17933007	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	188.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	188.0
Inactive	17933008	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933009	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933010	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933011	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933012	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933013	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933014	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933015	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933016	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933017	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933018	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933019	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933020	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933021	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933022	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933023	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933024	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933025	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933026	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933027	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933028	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933029	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933030	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933031	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933032	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933033	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933034	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933035	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933036	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933037	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17933038	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	=	Kd	nM	566.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	566.0
Inactive	17933039	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933040	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933041	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933042	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933043	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933044	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933045	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933046	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933047	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933048	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933049	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933050	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933051	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933052	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933053	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933054	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933055	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933056	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933057	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933058	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933059	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Active	17933060	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	=	Kd	nM	841.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	841.0
Inactive	17933061	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933062	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933063	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933064	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933065	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933066	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933067	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933068	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933069	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933070	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933071	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933072	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Active	17933073	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Kd	nM	787.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	787.0
Uncertain	17933074	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	=	Kd	nM	173.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	173.0
Inactive	17933075	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933076	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933077	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Active	17933078	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	=	Kd	nM	1368.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	1368.0
Inactive	17933079	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933080	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933081	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933082	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933083	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933084	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933085	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933086	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933087	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933088	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933089	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933090	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933091	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933092	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933093	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933094	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933095	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933096	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933097	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933098	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933099	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933100	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933101	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933102	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933103	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933104	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933105	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933106	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933107	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933108	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933109	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933110	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Active	17933111	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	=	Kd	nM	53.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	53.0
Inactive	17933112	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933113	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17933114	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	=	Kd	nM	25.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	25.0
Inactive	17933115	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17933116	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
Active	17933117	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	=	Kd	nM	172.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	172.0
Inactive	17933118	CHEMBL3991857	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL4601	Homo sapiens	Kd apparent	nM	30000.0
	18012402	CHEMBL4004222	Inhibition of recombinant full length human N-terminal GST-tagged BRK (2 to 451 residues) expressed in baculovirus expression system	B	COc1cc2ncccc2cc1NC(=O)c1csc2cncnc12		CHEMBL3822972	>	IC50	nM	50000.0	CHEMBL4601	Homo sapiens	IC50	uM	50.0
	18114464	CHEMBL4025030	Inhibition of wild-type human partial length BRK (L166 to T451 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	96.0	CHEMBL4601	Homo sapiens	Activity	%	96.0
	18147080	CHEMBL4032522	Inhibition of BRK (unknown origin) at 100 nM relative to control	B	Nc1nccc(-c2c[nH]c3ncc(-c4ccc(F)cc4)cc23)n1		CHEMBL4095226	=	Inhibition	%	-5.9	CHEMBL4601	Homo sapiens	INH	%	-5.9
	18147081	CHEMBL4032522	Inhibition of BRK (unknown origin) at 100 nM relative to control	B	COc1ccnc2[nH]cc(-c3ccnc(N)n3)c12		CHEMBL270686	=	Inhibition	%	10.6	CHEMBL4601	Homo sapiens	INH	%	10.6
	18147116	CHEMBL4032542	Inhibition of BRK (unknown origin) at 500 nM relative to control	B	Nc1nccc(-c2c[nH]c3ncc(-c4ccc(F)cc4)cc23)n1		CHEMBL4095226	=	Inhibition	%	20.4	CHEMBL4601	Homo sapiens	INH	%	20.4
	18147117	CHEMBL4032542	Inhibition of BRK (unknown origin) at 500 nM relative to control	B	COc1ccnc2[nH]cc(-c3ccnc(N)n3)c12		CHEMBL270686	=	Inhibition	%	9.5	CHEMBL4601	Homo sapiens	INH	%	9.5
	18203554	CHEMBL4043841	Inhibition of wild-type human partial length BRK (L166 to T451 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL4601	Homo sapiens	Activity	%	100.0
	18232194	CHEMBL4050312	Inhibition of human BRK assessed as residual activity at 1 uM in presence of 33P-ATP by filter-binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	51.0	CHEMBL4601	Homo sapiens	Activity	%	51.0
	18248619	CHEMBL4053902	Inhibition of PTK6 (unknown origin) at 1 uM relative to control	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn4c5c(cccc35)CCC4)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4104658	=	Inhibition	%	83.0	CHEMBL4601	Homo sapiens	INH	%	83.0
	18253741	CHEMBL4055155	Inhibition of wild-type human partial length BRK (L166 to T451 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	100.0	CHEMBL4601	Homo sapiens	Activity	%	100.0
	18253742	CHEMBL4055155	Inhibition of wild-type human partial length BRK (L166 to T451 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	96.0	CHEMBL4601	Homo sapiens	Activity	%	96.0
	18268083	CHEMBL4057968	Inhibition of PTK6 (unknown origin)	B	CC(C)C(=O)N1CCC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1		CHEMBL4069387	=	IC50	nM	350.0	CHEMBL4601	Homo sapiens	IC50	nM	350.0
	18268084	CHEMBL4057968	Inhibition of PTK6 (unknown origin)	B	CC(C)C(=O)N1CCO[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1		CHEMBL4075954	=	IC50	nM	173.0	CHEMBL4601	Homo sapiens	IC50	nM	173.0
	18268085	CHEMBL4057968	Inhibition of PTK6 (unknown origin)	B	COCC(=O)N1CCC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1		CHEMBL4076024	=	IC50	nM	60.0	CHEMBL4601	Homo sapiens	IC50	nM	60.0
	18268086	CHEMBL4057968	Inhibition of PTK6 (unknown origin)	B	COCC(=O)N1CCO[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1		CHEMBL4062498	=	IC50	nM	77.0	CHEMBL4601	Homo sapiens	IC50	nM	77.0
	18268087	CHEMBL4057968	Inhibition of PTK6 (unknown origin)	B	Nc1nccn2c([C@@H]3CCCN(C4CCOCC4)C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c12		CHEMBL4077588	=	IC50	nM	48.0	CHEMBL4601	Homo sapiens	IC50	nM	48.0
	18268088	CHEMBL4057968	Inhibition of PTK6 (unknown origin)	B	Nc1nccn2c([C@H]3CN(C4CCOCC4)CCO3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c12		CHEMBL4060757	=	IC50	nM	113.0	CHEMBL4601	Homo sapiens	IC50	nM	113.0
	18269008	CHEMBL4058138	Inhibition of recombinant human full length N-terminal His6-tagged BRK expressed in baculovirus Sf21 insect cells preincubated for 5 mins followed by substrate addition after 30 to 60 mins in presence of ATP by fluorescence assay	B	C=CS(=O)(=O)N1CCC[C@@H]1Cn1cc(-c2ccc3c(c2)OCO3)c2c(N)ncnc21		CHEMBL4095253	=	IC50	nM	220.2	CHEMBL4601	Homo sapiens	IC50	nM	220.2
	18282041	CHEMBL4119996	Inhibition of recombinant full length His-tagged human Brk cytoplasmic domain expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	7.8	CHEMBL4601	Homo sapiens	INH	%	7.8
	18282360	CHEMBL4119996	Inhibition of recombinant full length His-tagged human Brk cytoplasmic domain expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	5.8	CHEMBL4601	Homo sapiens	INH	%	5.8
	18431340	CHEMBL4155792	Inhibition of PTK6 (unknown origin) at 1 uM relative to control	B	Cn1ncc2c(Oc3ccc4c(c3)nc(Nc3ccc(OC(F)(F)F)cc3)n4C)ncnc21		CHEMBL4170025	=	Inhibition	%	-6.7	CHEMBL4601	Homo sapiens	INH	%	-6.7
	18440096	CHEMBL4156920	Binding affinity to wild-type human partial length BRK (L166 to T451 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	92.0	CHEMBL4601	Homo sapiens	Activity	%	92.0
	18449934	CHEMBL4178168	Inhibition of human BRK (1 to 451 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	74.0	CHEMBL4601	Homo sapiens	Activity	%	74.0
	18484536	CHEMBL4185699	Binding affinity to wild-type human partial length BRK (L166 to T451 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	100.0	CHEMBL4601	Homo sapiens	Activity	%	100.0
	18485085	CHEMBL4185699	Binding affinity to wild-type human partial length BRK (L166 to T451 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	99.0	CHEMBL4601	Homo sapiens	Activity	%	99.0
	18507883	CHEMBL4190884	Inhibition of recombinant full-length human BRK at 1 uM using poly(Glu,Tyr) 4:1 as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	102.0	CHEMBL4601	Homo sapiens	INH	%	102.0
	18508006	CHEMBL4191241	Inhibition of recombinant full-length human BRK at 10 uM using poly(Glu,Tyr) 4:1 as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	102.0	CHEMBL4601	Homo sapiens	INH	%	102.0
	18653749	CHEMBL4230029	Inhibition of BRK (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	97.0	CHEMBL4601	Homo sapiens	INH	%	97.0
	18653750	CHEMBL4230029	Inhibition of BRK (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	86.0	CHEMBL4601	Homo sapiens	INH	%	86.0
	18654950	CHEMBL4230599	Binding affinity to wild-type human partial length BRK (L166 to T451 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	81.0	CHEMBL4601	Homo sapiens	Activity	%	81.0
	18694023	CHEMBL4253476	Inhibition of recombinant human full length His-tagged PTK6 expressed in baculovirus expression system at 0.1 uM by TR-FRET assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	14.0	CHEMBL4601	Homo sapiens	INH	%	14.0
	18694105	CHEMBL4253558	Inhibition of recombinant human full length His-tagged PTK6 expressed in baculovirus expression system at 1 uM by TR-FRET assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	34.0	CHEMBL4601	Homo sapiens	INH	%	34.0
	18737801	CHEMBL4261438	Inhibition of recombinant full length human BRK using poly(Glu, Tyr) 4:1 as substrate after 40 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	CCn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(OC(F)(F)F)c2)c2c(N)ncnc21		CHEMBL4281823	=	IC50	nM	111.0	CHEMBL4601	Homo sapiens	IC50	nM	111.0
	18751062	CHEMBL4263743	Inhibition of BRK (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	24.0	CHEMBL4601	Homo sapiens	INH	%	24.0
	18751715	CHEMBL4264188	Binding affinity to wild-type human partial length BRK (L166 to T451 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	95.0	CHEMBL4601	Homo sapiens	Activity	%	95.0
	18761493	CHEMBL4266531	Inhibition of recombinant human N-terminal His6-tagged full length BRK expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1	Outside typical range	CHEMBL4279192	=	Inhibition	%	-18.0	CHEMBL4601	Homo sapiens	INH	%	-18.0
	18761749	CHEMBL4266531	Inhibition of recombinant human N-terminal His6-tagged full length BRK expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1		CHEMBL4278882	=	Inhibition	%	-3.0	CHEMBL4601	Homo sapiens	INH	%	-3.0
	18761912	CHEMBL4266531	Inhibition of recombinant human N-terminal His6-tagged full length BRK expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1		CHEMBL4290222	=	Inhibition	%	-6.0	CHEMBL4601	Homo sapiens	INH	%	-6.0
	18778952	CHEMBL4269642	Inhibition of human BRK using poly[Glu:Tyr] (4:1) as substrate at 1 uM by [gamma-33P]-ATP based assay relative to control	B	COc1cc2nccc(Nc3n[nH]c(C)c3C)c2cc1S(=O)(=O)C(C)(C)C		CHEMBL4293287	>	Inhibition	%	90.0	CHEMBL4601	Homo sapiens	INH	%	90.0
	18857859	CHEMBL4307705	Binding affinity to wild-type human partial length BRK (L166 to T451 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	100.0	CHEMBL4601	Homo sapiens	Activity	%	100.0
	18892763	CHEMBL4314659	Inhibition of full-length recombinant human BRK assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	100.5	CHEMBL4601	Homo sapiens	Activity	%	100.5
	18937733	CHEMBL4327596	Inhibition of human BRK assessed as residual activity at 1 uM using poly[Glu:Tyr](4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	100.01	CHEMBL4601	Homo sapiens	Activity	%	100.01
	18937734	CHEMBL4327596	Inhibition of human BRK assessed as residual activity at 1 uM using poly[Glu:Tyr](4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	95.24	CHEMBL4601	Homo sapiens	Activity	%	95.24
	18938437	CHEMBL4327957	Inhibition of human BRK assessed as residual activity at 100 uM using poly[Glu:Tyr](4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL4601	Homo sapiens	Activity	%	65.0
	18938810	CHEMBL4328321	Inhibition of human BRK using poly[Glu:Tyr](4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	277.0	CHEMBL4601	Homo sapiens	IC50	10'-7M	2.77
	18958778	CHEMBL4333297	Binding affinity to wild-type human partial length BRK (L166 to T451 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	83.0	CHEMBL4601	Homo sapiens	Activity	%	83.0
	18964089	CHEMBL4334979	Inhibition of recombinant full length human BRK assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	103.0	CHEMBL4601	Homo sapiens	Activity	%	103.0
	18964090	CHEMBL4334979	Inhibition of recombinant full length human BRK assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	106.0	CHEMBL4601	Homo sapiens	Activity	%	106.0
	18971797	CHEMBL4336807	Inhibition of recombinant full length human BRK assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	21.0	CHEMBL4601	Homo sapiens	Activity	%	21.0
	19021458	CHEMBL4347681	Inhibition of recombinant human BRK at 20 nM using Ulight-TK peptide as substrate measured after 90 mins by LANCE assay relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	19.0	CHEMBL4601	Homo sapiens	INH	%	19.0
	19021459	CHEMBL4347682	Inhibition of recombinant human BRK at 200 nM using Ulight-TK peptide as substrate measured after 90 mins by LANCE assay relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	14.0	CHEMBL4601	Homo sapiens	INH	%	14.0
Not Active	19039884	CHEMBL4351759	Inhibition of full-length recombinant human BRK at 10 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL4601	Homo sapiens	INH		
Active	19041022	CHEMBL4352283	Inhibition of human BRK at 10 uM using poly[Glu:Tyr](4:1) as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL4601	Homo sapiens	INH		
	19059476	CHEMBL4357777	Binding affinity to wild-type human partial length BRK (L166 to T451 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL4601	Homo sapiens	Activity	%	100.0
	19090049	CHEMBL4365623	Inhibition of wild-type human partial length BRK (L166 to T451 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	98.0	CHEMBL4601	Homo sapiens	Activity	%	98.0
	19091825	CHEMBL4366299	Inhibition of human BRK at 100 nM using poly[Glu:Tyr](4:1) as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1	Outside typical range	CHEMBL4528675	=	Inhibition	%	-12.22	CHEMBL4601	Homo sapiens	INH	%	-12.22
	19098120	CHEMBL4367950	Inhibition of BRK (unknown origin) at 1 uM relative to control	B	CCn1nc(C#Cc2c(C)ccc3c(Nc4ccc(Cl)cc4)nccc23)c2c(N)ncnc21		CHEMBL4593051	>	Inhibition	%	85.0	CHEMBL4601	Homo sapiens	INH	%	85.0
Active	19114756	CHEMBL4371391	Binding affinity to wild-type human partial length BRK (L166 to T451 residues) expressed in bacterial expression system assessed as residual binding level at 5 umol/L by Kinomescan method	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL4536115		Activity			CHEMBL4601	Homo sapiens	Activity		
Active	19114781	CHEMBL4371391	Binding affinity to wild-type human partial length BRK (L166 to T451 residues) expressed in bacterial expression system assessed as residual binding level at 5 umol/L by Kinomescan method	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCC(C)CC1		CHEMBL4447225		Activity			CHEMBL4601	Homo sapiens	Activity		
	19144625	CHEMBL4377641	Inhibition of full-length recombinant human BRK at 1 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1	Outside typical range	CHEMBL4548580	=	Inhibition	%	-13.0	CHEMBL4601	Homo sapiens	INH	%	-13.0
	19146831	CHEMBL4378961	Inhibition of full-length recombinant human BRK at 10 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1		CHEMBL4459587	=	Inhibition	%	-6.0	CHEMBL4601	Homo sapiens	INH	%	-6.0
	19147753	CHEMBL4379149	Inhibition of recombinant full length human BRK using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL4601	Homo sapiens	IC50	uM	10.0
	19159304	CHEMBL4382408	Binding affinity to wild-type human partial length BRK (L166 to T451 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	0.4	CHEMBL4601	Homo sapiens	Activity	%	0.4
	19180971	CHEMBL4387181	Inhibition of recombinant full length human His-tagged BRK expressed in baculovirus expression system at 0.1 uM using tyrosine-1 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	5.0	CHEMBL4601	Homo sapiens	INH	%	5.0
	19181197	CHEMBL4387181	Inhibition of recombinant full length human His-tagged BRK expressed in baculovirus expression system at 0.1 uM using tyrosine-1 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	6.5	CHEMBL4601	Homo sapiens	INH	%	6.5
	19191703	CHEMBL4389127	Inhibition of wild-type human partial length BRK (L166 to T451 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	100.0	CHEMBL4601	Homo sapiens	INH	%	100.0
	19191790	CHEMBL4389604	Inhibition of wild-type human partial length BRK (L166 to T451 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	99.0	CHEMBL4601	Homo sapiens	INH	%	99.0
	19199992	CHEMBL4391230	Binding affinity to wild-type human partial length BRK (L166 to T451 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	90.0	CHEMBL4601	Homo sapiens	Activity	%	90.0
	19266322	CHEMBL4405272	Inhibition of wild-type human partial length BRK (L166 to T451 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL4601	Homo sapiens	INH	%	50.0
	19275940	CHEMBL4407943	Inhibition of recombinant full length human BRK at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	22.0	CHEMBL4601	Homo sapiens	INH	%	22.0
	19294884	CHEMBL4412224	Inhibition of BRK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	CC(=O)Oc1ccccc1/C=C/c1nc2ccccc2c(=O)[nH]1		CHEMBL4442304	=	Inhibition	%	30.0	CHEMBL4601	Homo sapiens	INH	%	30.0
	19294885	CHEMBL4412224	Inhibition of BRK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	CC(=O)Oc1cccc(/C=C/c2nc3ccccc3c(=O)[nH]2)c1		CHEMBL4453032	=	Inhibition	%	36.0	CHEMBL4601	Homo sapiens	INH	%	36.0
	19294886	CHEMBL4412224	Inhibition of BRK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	CC(=O)Oc1ccc(/C=C/c2nc3ccccc3c(=O)[nH]2)c(OC(C)=O)c1		CHEMBL4517514	=	Inhibition	%	0.0	CHEMBL4601	Homo sapiens	INH	%	0.0
	19294887	CHEMBL4412224	Inhibition of BRK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1ccccc1/C=C/c1nc2ccccc2c(=O)[nH]1		CHEMBL1090672	=	Inhibition	%	44.0	CHEMBL4601	Homo sapiens	INH	%	44.0
	19294888	CHEMBL4412224	Inhibition of BRK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1cccc(/C=C/c2nc3ccccc3c(=O)[nH]2)c1		CHEMBL1092204	=	Inhibition	%	0.0	CHEMBL4601	Homo sapiens	INH	%	0.0
	19294889	CHEMBL4412224	Inhibition of BRK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1ccc(/C=C/c2nc3ccccc3c(=O)[nH]2)cc1		CHEMBL1092207	=	Inhibition	%	28.0	CHEMBL4601	Homo sapiens	INH	%	28.0
	19294890	CHEMBL4412224	Inhibition of BRK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	CCOc1ccccc1/C=C/c1nc2ccccc2c(=O)[nH]1		CHEMBL4459848	=	Inhibition	%	51.0	CHEMBL4601	Homo sapiens	INH	%	51.0
	19294891	CHEMBL4412224	Inhibition of BRK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	CCOc1ccc(/C=C/c2nc3ccccc3c(=O)[nH]2)cc1		CHEMBL4583163	=	Inhibition	%	0.0	CHEMBL4601	Homo sapiens	INH	%	0.0
	19294892	CHEMBL4412224	Inhibition of BRK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	CCCCOc1ccc(/C=C/c2nc3ccccc3c(=O)[nH]2)cc1		CHEMBL4559299	=	Inhibition	%	60.0	CHEMBL4601	Homo sapiens	INH	%	60.0
	19294893	CHEMBL4412224	Inhibition of BRK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	O=c1[nH]c(/C=C/c2cccc3c2OCO3)nc2ccccc12		CHEMBL4468697	=	Inhibition	%	31.0	CHEMBL4601	Homo sapiens	INH	%	31.0
	19294894	CHEMBL4412224	Inhibition of BRK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	O=c1[nH]c(/C=C/c2ccc3c(c2)OCO3)nc2ccccc12		CHEMBL4470620	=	Inhibition	%	44.0	CHEMBL4601	Homo sapiens	INH	%	44.0
	19294895	CHEMBL4412224	Inhibition of BRK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	O=c1[nH]c(/C=C/c2c(Br)ccc3c2OCO3)nc2ccccc12		CHEMBL4518551	=	Inhibition	%	51.0	CHEMBL4601	Homo sapiens	INH	%	51.0
	19294896	CHEMBL4412224	Inhibition of BRK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	O=c1[nH]c(/C=C/c2cc3c(cc2Br)OCO3)nc2ccccc12		CHEMBL4576121	=	Inhibition	%	0.0	CHEMBL4601	Homo sapiens	INH	%	0.0
	19294897	CHEMBL4412224	Inhibition of BRK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	O=c1[nH]c(/C=C/c2cccc([N+](=O)[O-])c2)nc2ccccc12		CHEMBL4445408	=	Inhibition	%	43.0	CHEMBL4601	Homo sapiens	INH	%	43.0
	19294898	CHEMBL4412224	Inhibition of BRK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	O=c1[nH]c(/C=C/c2ccc([N+](=O)[O-])cc2)nc2ccccc12		CHEMBL4539405	=	Inhibition	%	18.0	CHEMBL4601	Homo sapiens	INH	%	18.0
	19294899	CHEMBL4412224	Inhibition of BRK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	CC(=O)Oc1ccccc1/C=C/c1nc(Nc2ccccc2I)c2ccccc2n1		CHEMBL4455338	=	Inhibition	%	0.0	CHEMBL4601	Homo sapiens	INH	%	0.0
	19294900	CHEMBL4412224	Inhibition of BRK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1ccc(OC)c(Nc2nc(/C=C/c3ccccc3OC(C)=O)nc3ccccc23)c1		CHEMBL4458986	=	Inhibition	%	12.0	CHEMBL4601	Homo sapiens	INH	%	12.0
	19294901	CHEMBL4412224	Inhibition of BRK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1ccccc1/C=C/c1nc(Nc2ccccc2Cl)c2ccccc2n1		CHEMBL4550950	=	Inhibition	%	15.0	CHEMBL4601	Homo sapiens	INH	%	15.0
	19294902	CHEMBL4412224	Inhibition of BRK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1ccccc1/C=C/c1nc(Nc2ccc(O)cc2)c2ccccc2n1		CHEMBL4472770	=	Inhibition	%	19.0	CHEMBL4601	Homo sapiens	INH	%	19.0
	19294903	CHEMBL4412224	Inhibition of BRK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1ccccc1/C=C/c1nc(Nc2cccc(O)c2)c2ccccc2n1		CHEMBL4459984	=	Inhibition	%	0.0	CHEMBL4601	Homo sapiens	INH	%	0.0
	19294904	CHEMBL4412224	Inhibition of BRK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1ccccc1/C=C/c1nc(Nc2ccc3c(c2)OCO3)c2ccccc2n1		CHEMBL4476482	=	Inhibition	%	0.0	CHEMBL4601	Homo sapiens	INH	%	0.0
	19294905	CHEMBL4412224	Inhibition of BRK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1ccccc1/C=C/c1nc(NCc2ccc3c(c2)OCO3)c2ccccc2n1		CHEMBL4470772	=	Inhibition	%	38.0	CHEMBL4601	Homo sapiens	INH	%	38.0
	19294906	CHEMBL4412224	Inhibition of BRK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1ccc(/C=C/c2nc(Nc3cccc(O)c3)c3ccccc3n2)cc1		CHEMBL4571210	=	Inhibition	%	75.0	CHEMBL4601	Homo sapiens	INH	%	75.0
	19294907	CHEMBL4412224	Inhibition of BRK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	Oc1cccc(Nc2nc(/C=C/c3cc4c(cc3Br)OCO4)nc3ccccc23)c1		CHEMBL4436086	=	Inhibition	%	24.0	CHEMBL4601	Homo sapiens	INH	%	24.0
	19294908	CHEMBL4412224	Inhibition of BRK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	O=[N+]([O-])c1cccc(/C=C/c2nc(Nc3cccc(O)c3)c3ccccc3n2)c1		CHEMBL4437669	=	Inhibition	%	46.0	CHEMBL4601	Homo sapiens	INH	%	46.0
	19294909	CHEMBL4412224	Inhibition of BRK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	Oc1ccc(Nc2nc(/C=C/c3cccc(Cl)c3)nc3ccccc23)cc1		CHEMBL4553117	=	Inhibition	%	51.0	CHEMBL4601	Homo sapiens	INH	%	51.0
	19294910	CHEMBL4412224	Inhibition of BRK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	Oc1cccc(Nc2nc(/C=C/c3cccc(Cl)c3)nc3ccccc23)c1		CHEMBL4535076	=	Inhibition	%	0.0	CHEMBL4601	Homo sapiens	INH	%	0.0
	19294911	CHEMBL4412224	Inhibition of BRK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1ccc(/C=C/c2nc(NCCCN(C)C)c3ccccc3n2)cc1		CHEMBL186928	=	Inhibition	%	35.0	CHEMBL4601	Homo sapiens	INH	%	35.0
	19294912	CHEMBL4412224	Inhibition of BRK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Inhibition	%	0.0	CHEMBL4601	Homo sapiens	INH	%	0.0
	19294913	CHEMBL4412224	Inhibition of BRK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Inhibition	%	92.0	CHEMBL4601	Homo sapiens	INH	%	92.0
	19294914	CHEMBL4412224	Inhibition of BRK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Inhibition	%	0.0	CHEMBL4601	Homo sapiens	INH	%	0.0
	19294915	CHEMBL4412224	Inhibition of BRK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1ccc(Cl)c(Nc2ncnc3cc(OCC4CCN(C)CC4)c(OC)cc23)c1		CHEMBL426161	=	Inhibition	%	0.0	CHEMBL4601	Homo sapiens	INH	%	0.0
	19295113	CHEMBL4412232	Inhibition of BRK (unknown origin) preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay	B	COc1ccccc1/C=C/c1nc2ccccc2c(=O)[nH]1		CHEMBL1090672	=	IC50	nM	933.0	CHEMBL4601	Homo sapiens	IC50	nM	933.0
Not Determined	19295114	CHEMBL4412232	Inhibition of BRK (unknown origin) preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay	B	COc1ccccc1/C=C/c1nc(Nc2ccc3c(c2)OCO3)c2ccccc2n1		CHEMBL4476482		IC50			CHEMBL4601	Homo sapiens	IC50		
	19295115	CHEMBL4412232	Inhibition of BRK (unknown origin) preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay	B	Oc1cccc(Nc2nc(/C=C/c3cc4c(cc3Br)OCO4)nc3ccccc23)c1		CHEMBL4436086	=	IC50	nM	956.0	CHEMBL4601	Homo sapiens	IC50	nM	956.0
	19295116	CHEMBL4412232	Inhibition of BRK (unknown origin) preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay	B	O=[N+]([O-])c1cccc(/C=C/c2nc(Nc3cccc(O)c3)c3ccccc3n2)c1		CHEMBL4437669	=	IC50	nM	626.0	CHEMBL4601	Homo sapiens	IC50	nM	626.0
	19295117	CHEMBL4412232	Inhibition of BRK (unknown origin) preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	IC50	nM	5.3	CHEMBL4601	Homo sapiens	IC50	nM	5.3
	19306064	CHEMBL4414919	Inhibition of human BRK using poly[Glu:Tyr] (4:1) as substrate preincubated for 60 mins followed by [gamma-33P]-ATP addition and measured after 120 mins by filter binding method	A	C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1		CHEMBL3936761	=	IC50	nM	33.0	CHEMBL4601	Homo sapiens	IC50	nM	33.0
	19306065	CHEMBL4414919	Inhibition of human BRK using poly[Glu:Tyr] (4:1) as substrate preincubated for 60 mins followed by [gamma-33P]-ATP addition and measured after 120 mins by filter binding method	A	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	18.0	CHEMBL4601	Homo sapiens	IC50	nM	18.0
	19476624	CHEMBL4479772	Inhibition of full-length recombinant human His-tagged PTK6 expressed in baculovirus expression system by Z'-LYTE assay	B	O=C(NCC(F)(F)F)c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)cs1		CHEMBL4569508	=	IC50	nM	1700.0	CHEMBL4601	Homo sapiens	IC50	nM	1700.0
	19476724	CHEMBL4479772	Inhibition of full-length recombinant human His-tagged PTK6 expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)NCC(F)(F)F)c4)cnn3c2)cn1		CHEMBL4550702	>	IC50	nM	100000.0	CHEMBL4601	Homo sapiens	IC50	nM	100000.0
	19476824	CHEMBL4479772	Inhibition of full-length recombinant human His-tagged PTK6 expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCCC[C@@H]5N)c4)cnn3c2)cn1		CHEMBL4568087	=	IC50	nM	390.0	CHEMBL4601	Homo sapiens	IC50	nM	390.0
	19476924	CHEMBL4479772	Inhibition of full-length recombinant human His-tagged PTK6 expressed in baculovirus expression system by Z'-LYTE assay	B	Cc1sc(C(=O)N[C@@H]2[C@H](N)CCCC2(F)F)cc1-c1cnn2cc(Cl)cnc12		CHEMBL4552628	>	IC50	nM	100000.0	CHEMBL4601	Homo sapiens	IC50	nM	100000.0
	20600654	CHEMBL4603606	Inhibition of recombinant full length human His-tagged BRK expressed in baculovirus expression system using tyr01 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL4601	Homo sapiens	IC50	uM	100.0
	20612853	CHEMBL4606499	Inhibition of recombinant human full-length His-tagged PTK6 cytoplasmic domain expressed in baculovirus expression system at 1 uM using Fluorescein-Poly GT as substrate by Lanthascreen assay relative to control	A	Nc1ncnc2c1c(Oc1cc(C(F)(F)F)ccn1)nn2C1CC1		CHEMBL4634455	=	Inhibition	%	50.0	CHEMBL4601	Homo sapiens	INH	%	50.0
	20612854	CHEMBL4606499	Inhibition of recombinant human full-length His-tagged PTK6 cytoplasmic domain expressed in baculovirus expression system at 1 uM using Fluorescein-Poly GT as substrate by Lanthascreen assay relative to control	A	N#Cc1ccnc(Oc2nn([C@H]3C[C@H](F)C3)c3ncnc(N)c23)c1		CHEMBL4642579	=	Inhibition	%	50.0	CHEMBL4601	Homo sapiens	INH	%	50.0
	20694098	CHEMBL4626194	Inhibition of BRK (unknown origin)	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(OC)c1OC		CHEMBL4517408	=	IC50	nM	336.0	CHEMBL4601	Homo sapiens	IC50	nM	336.0
Active	20694099	CHEMBL4626194	Inhibition of BRK (unknown origin)	B	COc1cc(-c2cncc(-c3ccc(C4CCN(C)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4633241		Inhibition	%		CHEMBL4601	Homo sapiens	INH		
	20694140	CHEMBL4626220	Inhibition of BRK (unknown origin) at 1 uM relative to control	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(OC)c1F		CHEMBL4636120	>	Inhibition	%	50.0	CHEMBL4601	Homo sapiens	INH	%	50.0
	22391920	CHEMBL4667071	Inhibition of recombinant human His-tagged full length BRK expressed in baculovirus expression system using Tyr 01 as substrate at 10 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	0.5	CHEMBL4601	Homo sapiens	INH	%	0.5
	22423805	CHEMBL4674478	Inhibition of human BRK using poly[Glu:Tyr](4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	89.57	CHEMBL4601	Homo sapiens	Activity	%	89.57
	22423806	CHEMBL4674478	Inhibition of human BRK using poly[Glu:Tyr](4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	93.14	CHEMBL4601	Homo sapiens	Activity	%	93.14
	22823749	CHEMBL4717047	Inhibition of human PTK6	B	C[C@H]1CC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)CN1C(=O)C1CC1		CHEMBL4103954	=	IC50	nM	60.0	CHEMBL4601	Homo sapiens	IC50	nM	60.0
	22823750	CHEMBL4717047	Inhibition of human PTK6	B	CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4F)c4c(N)nccn34)C2)COC1		CHEMBL4799627	=	IC50	nM	63.0	CHEMBL4601	Homo sapiens	IC50	nM	63.0
	22823751	CHEMBL4717047	Inhibition of human PTK6	B	CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)C2)COC1		CHEMBL4094125	=	IC50	nM	66.0	CHEMBL4601	Homo sapiens	IC50	nM	66.0
	22843488	CHEMBL4720485	Inhibition of human BRK assessed as residual activity using poly[Glu:Tyr](4:1) as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	78.98	CHEMBL4601	Homo sapiens	Activity	%	78.98
	22843838	CHEMBL4720824	Inhibition of human BRK using poly[Glu:Tyr](4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	162.0	CHEMBL4601	Homo sapiens	IC50	10^-7M	1.62
	22844943	CHEMBL4721618	Inhibition of wild-type human partial length BRK (L166 to T451 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	45.61	CHEMBL4601	Homo sapiens	Activity	%	45.61
	22882863	CHEMBL4727427	Inhibition of PTK6 (unknown origin)	B	Nc1nccn2c([C@@H]3CC[C@H]4COC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12		CHEMBL4749037	=	IC50	nM	50.0	CHEMBL4601	Homo sapiens	IC50	nM	50.0
	22882864	CHEMBL4727427	Inhibition of PTK6 (unknown origin)	B	Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12		CHEMBL4106978	=	IC50	nM	42.0	CHEMBL4601	Homo sapiens	IC50	nM	42.0
	22882865	CHEMBL4727427	Inhibition of PTK6 (unknown origin)	B	CC1(C)OC(=O)N2C[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CC[C@H]21		CHEMBL4108687	=	IC50	nM	24.0	CHEMBL4601	Homo sapiens	IC50	nM	24.0
	22882866	CHEMBL4727427	Inhibition of PTK6 (unknown origin)	B	COc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12		CHEMBL4114929	=	IC50	nM	84.0	CHEMBL4601	Homo sapiens	IC50	nM	84.0
	22882867	CHEMBL4727427	Inhibition of PTK6 (unknown origin)	B	Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3OC3CC3)c12		CHEMBL4107779	=	IC50	nM	320.0	CHEMBL4601	Homo sapiens	IC50	nM	320.0
	22950583	CHEMBL4766150	Inhibition of human full length recombinant BRK using poly (Glu,Tyr)4:1 as substrate incubated for 40 mins in presence of [gamma33P-ATP] by radiometric scintillation counting analysis	B	Cc1ccc(NC(=O)c2ccc(C)c(C(F)(F)F)c2)cc1C#Cc1nn([C@H]2CC[C@H](O)CC2)c2ncnc(N)c12		CHEMBL4798527	=	IC50	nM	121.0	CHEMBL4601	Homo sapiens	IC50	uM	0.121
	22952763	CHEMBL4766700	Inhibition of recombinant full length human BRK assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	92.0	CHEMBL4601	Homo sapiens	Activity	%	92.0
	23122462	CHEMBL4804813	Inhibition of human BRK assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	97.0	CHEMBL4601	Homo sapiens	Activity	%	97.0
	23123157	CHEMBL4805401	Inhibition of human BRK assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	100.0	CHEMBL4601	Homo sapiens	Activity	%	100.0
	23123730	CHEMBL4805974	Inhibition of DNA-tagged human BRK assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	100.0	CHEMBL4601	Homo sapiens	Activity	%	100.0
	23124404	CHEMBL4806418	Inhibition of human BRK assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL4601	Homo sapiens	Activity	%	100.0
	23124405	CHEMBL4806418	Inhibition of human BRK assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	99.0	CHEMBL4601	Homo sapiens	Activity	%	99.0
	23128808	CHEMBL4808066	Inhibition of BRK (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)[nH]c3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4874174	=	Inhibition	%	90.0	CHEMBL4601	Homo sapiens	INH	%	90.0
	23128809	CHEMBL4808066	Inhibition of BRK (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)oc3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4859179	=	Inhibition	%	80.0	CHEMBL4601	Homo sapiens	INH	%	80.0
	23128810	CHEMBL4808066	Inhibition of BRK (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(S(C)(=O)=O)sc3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4850066	=	Inhibition	%	34.0	CHEMBL4601	Homo sapiens	INH	%	34.0
	23128811	CHEMBL4808066	Inhibition of BRK (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3n[nH]nc3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4853006	=	Inhibition	%	32.0	CHEMBL4601	Homo sapiens	INH	%	32.0
	23128812	CHEMBL4808066	Inhibition of BRK (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(C(F)(F)F)sc3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4870763	=	Inhibition	%	87.0	CHEMBL4601	Homo sapiens	INH	%	87.0
	23128813	CHEMBL4808066	Inhibition of BRK (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(NC)sc3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4855979	=	Inhibition	%	53.0	CHEMBL4601	Homo sapiens	INH	%	53.0
	23128814	CHEMBL4808066	Inhibition of BRK (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)n(CCN(C)C)c3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4847460	=	Inhibition	%	44.0	CHEMBL4601	Homo sapiens	INH	%	44.0
	23128815	CHEMBL4808066	Inhibition of BRK (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)oc3-c3ccc(F)cc3)cc2F)ccn1		CHEMBL4855209	=	Inhibition	%	77.0	CHEMBL4601	Homo sapiens	INH	%	77.0
	23291237	CHEMBL4839528	Inhibition of human recombinant BRK (174 to 734) at 5 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2Cl)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4467948	=	Inhibition	%	9.0	CHEMBL4601	Homo sapiens	INH	%	9.0
	23291238	CHEMBL4839528	Inhibition of human recombinant BRK (174 to 734) at 5 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4850154	=	Inhibition	%	17.0	CHEMBL4601	Homo sapiens	INH	%	17.0
	23291239	CHEMBL4839528	Inhibition of human recombinant BRK (174 to 734) at 5 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4862806	=	Inhibition	%	-2.0	CHEMBL4601	Homo sapiens	INH	%	-2.0
	23291309	CHEMBL4839552	Inhibition of human recombinant BRK (174 to 734) at 50 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2Cl)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4467948	=	Inhibition	%	39.0	CHEMBL4601	Homo sapiens	INH	%	39.0
	23291310	CHEMBL4839552	Inhibition of human recombinant BRK (174 to 734) at 50 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4850154	=	Inhibition	%	52.0	CHEMBL4601	Homo sapiens	INH	%	52.0
	23291311	CHEMBL4839552	Inhibition of human recombinant BRK (174 to 734) at 50 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4862806	=	Inhibition	%	1.0	CHEMBL4601	Homo sapiens	INH	%	1.0
	23291381	CHEMBL4839576	Inhibition of human recombinant BRK (174 to 734) at 500 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2Cl)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4467948	=	Inhibition	%	85.0	CHEMBL4601	Homo sapiens	INH	%	85.0
	23291382	CHEMBL4839576	Inhibition of human recombinant BRK (174 to 734) at 500 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4850154	=	Inhibition	%	92.0	CHEMBL4601	Homo sapiens	INH	%	92.0
	23291383	CHEMBL4839576	Inhibition of human recombinant BRK (174 to 734) at 500 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4862806	=	Inhibition	%	22.0	CHEMBL4601	Homo sapiens	INH	%	22.0
	23294304	CHEMBL4840139	Inhibition of human BRK at 1 uM using poly[Glu:Tyr](4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	Cc1nc2c(cnn2-c2csc(C(=O)NC3COC3)c2)cc1Nc1c(F)cccc1Cl		CHEMBL4845770	=	Inhibition	%	55.0	CHEMBL4601	Homo sapiens	INH	%	55.0
Not Active	23317297	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23317765	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	75.0	CHEMBL4601	Homo sapiens	% Control	%	75.0
Not Active	23318438	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23318915	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23319555	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23320027	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23320705	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23321173	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	88.0	CHEMBL4601	Homo sapiens	% Control	%	88.0
Not Active	23321803	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	84.0	CHEMBL4601	Homo sapiens	% Control	%	84.0
Not Active	23322271	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	83.0	CHEMBL4601	Homo sapiens	% Control	%	83.0
Not Active	23322960	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23323428	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23324282	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23324917	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23325385	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	99.0	CHEMBL4601	Homo sapiens	% Control	%	99.0
Not Active	23326032	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	96.0	CHEMBL4601	Homo sapiens	% Control	%	96.0
Not Active	23326500	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	99.0	CHEMBL4601	Homo sapiens	% Control	%	99.0
Not Active	23327200	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23327668	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	94.0	CHEMBL4601	Homo sapiens	% Control	%	94.0
Not Active	23328255	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23328723	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23329258	CHEMBL4880965	BRK(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	108.0	CHEMBL4601	Homo sapiens	% residual kinase activity	%	108.0
Not Active	23329669	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23330137	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23330893	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23331361	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23331948	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	99.5	CHEMBL4601	Homo sapiens	% Control	%	99.5
Not Active	23332416	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23333132	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23333771	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23334239	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23335218	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23335686	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	86.0	CHEMBL4601	Homo sapiens	% Control	%	86.0
Not Active	23336313	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	96.0	CHEMBL4601	Homo sapiens	% Control	%	96.0
Not Active	23336781	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23337752	CHEMBL4882123	PTK6 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	99.5	CHEMBL4601	Homo sapiens	% Ctrl	%	99.5
Not Active	23337862	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23338330	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23338942	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23339410	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	97.0	CHEMBL4601	Homo sapiens	% Control	%	97.0
Not Active	23340047	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	80.0	CHEMBL4601	Homo sapiens	% Control	%	80.0
Not Active	23340515	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	96.0	CHEMBL4601	Homo sapiens	% Control	%	96.0
Not Active	23341172	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23341640	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	88.0	CHEMBL4601	Homo sapiens	% Control	%	88.0
Not Active	23342256	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23342724	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	90.0	CHEMBL4601	Homo sapiens	% Control	%	90.0
Not Active	23343354	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	98.0	CHEMBL4601	Homo sapiens	% Control	%	98.0
Not Active	23343822	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	89.0	CHEMBL4601	Homo sapiens	% Control	%	89.0
Not Active	23344460	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23345033	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	97.0	CHEMBL4601	Homo sapiens	% Control	%	97.0
Not Active	23345501	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23346078	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23346547	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23347157	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	86.6	CHEMBL4601	Homo sapiens	% Control	%	86.6
Not Active	23347638	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23348217	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23348685	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23349272	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	95.0	CHEMBL4601	Homo sapiens	% Control	%	95.0
Not Active	23349890	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23350358	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23350963	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23351431	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	92.0	CHEMBL4601	Homo sapiens	% Control	%	92.0
Not Active	23352205	CHEMBL4882894	PTK6 (Brk) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	2.74	CHEMBL4601	Homo sapiens	% Inhibition	%	2.7398
Not Active	23352455	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23352923	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	92.0	CHEMBL4601	Homo sapiens	% Control	%	92.0
Not Active	23353805	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23354273	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23355005	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23355473	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23356109	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23356577	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23357186	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	83.0	CHEMBL4601	Homo sapiens	% Control	%	83.0
Not Active	23357833	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23358301	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	91.0	CHEMBL4601	Homo sapiens	% Control	%	91.0
Not Active	23358887	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	82.5	CHEMBL4601	Homo sapiens	% Control	%	82.5
Not Active	23359485	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	95.0	CHEMBL4601	Homo sapiens	% Control	%	95.0
Not Active	23359953	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	85.0	CHEMBL4601	Homo sapiens	% Control	%	85.0
Not Active	23360538	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	90.0	CHEMBL4601	Homo sapiens	% Control	%	90.0
Not Active	23361006	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23361579	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	89.0	CHEMBL4601	Homo sapiens	% Control	%	89.0
Not Active	23362115	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23362583	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23364225	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23364693	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23365432	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	96.0	CHEMBL4601	Homo sapiens	% Control	%	96.0
Not Active	23365975	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23366565	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	96.0	CHEMBL4601	Homo sapiens	% Control	%	96.0
Not Active	23367033	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	97.0	CHEMBL4601	Homo sapiens	% Control	%	97.0
Not Active	23367483	CHEMBL4883836	BRK ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	84.0	CHEMBL4601	Homo sapiens	% Residual activity with Skepinone-L	%	84.0
Not Active	23367911	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	98.0	CHEMBL4601	Homo sapiens	% Control	%	98.0
Not Active	23368379	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23368978	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	85.0	CHEMBL4601	Homo sapiens	% Control	%	85.0
Not Active	23369446	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	86.0	CHEMBL4601	Homo sapiens	% Control	%	86.0
Not Active	23369986	CHEMBL4884230	BRK(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	104.0	CHEMBL4601	Homo sapiens	% residual kinase activity	%	104.0
Not Active	23370414	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23370882	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23371691	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	81.0	CHEMBL4601	Homo sapiens	% Control	%	81.0
Not Active	23372159	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	76.0	CHEMBL4601	Homo sapiens	% Control	%	76.0
	23372874	CHEMBL4884839	Brk(PTK6LGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL4601	Homo sapiens	pIC50		6.0
	23373283	CHEMBL4885130	Brk(PTK6LGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL4601	Homo sapiens	pIC50		6.0
	23373639	CHEMBL4885416	Brk(PTK6LGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL4601	Homo sapiens	pIC50		6.0
Not Active	23374927	CHEMBL4885921	Brk Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	10.5	CHEMBL4601	Homo sapiens	% Inhibition	%	10.5
Not Active	23375363	CHEMBL4886345	PTK6 protein tyrosine kinase 6 Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	-6.0	CHEMBL4601	Homo sapiens	% inhibition	%	-6.0
Not Active	23375586	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23376054	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23376632	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23377101	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23377959	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	87.0	CHEMBL4601	Homo sapiens	% Control	%	87.0
Not Active	23378427	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	90.0	CHEMBL4601	Homo sapiens	% Control	%	90.0
Not Active	23379594	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23380062	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	82.0	CHEMBL4601	Homo sapiens	% Control	%	82.0
Not Active	23380756	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	99.0	CHEMBL4601	Homo sapiens	% Control	%	99.0
Not Active	23381404	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	92.0	CHEMBL4601	Homo sapiens	% Control	%	92.0
Not Active	23381872	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23382496	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23382964	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
Not Active	23383966	CHEMBL4887572	PTK6 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	98.0	CHEMBL4601	Homo sapiens	% Ctrl	%	98.0
Not Active	23384194	CHEMBL4887789	BRK(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	8.07	CHEMBL4601	Homo sapiens	% inhibition	%	8.07
Not Active	23384879	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	81.0	CHEMBL4601	Homo sapiens	% Control	%	81.0
Not Active	23385346	CHEMBL4879603	KinomeScan assay: inhibition of BRK	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	100.0	CHEMBL4601	Homo sapiens	% Control	%	100.0
